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II. Abstract
Foot-and-mouth disease (FMD), is caused by an Aphthovirus of the family 
Picomaviridae, a group of small positive-sense, single-stranded RNA viruses. FMD 
is one of the most contagious diseases of cloven-hoofed animals, which can be 
characterised by the appearance of vesicular lesions on the feet, lips and tongue. In 
adult sheep and goats, clinical signs can be very mild or frequently subclinical. In 
cattle, chnical signs are generally severe. Among domestic farm animals, the severity 
of disease is usually most severe in pigs and this leads one to hypothesise that the 
porcine host response is particularly activated by FMDV infection.
The main objective of this study was to define the host response of pigs 
infected with FMDV to increase our understanding of the complex effects of 
cytokines in the tissue microenvironment and the resulting pathology. In order to 
achieve this objective, analysis of the induction of some antiviral cytokine mRNA, 
pro-inflammatory cytokine mRNA and TLR (Toll-like Receptor) mRNA at different 
stages of infection was carried out. A viral load study was carried out, by examining 
various tissues at different time points in order to describe the progression of 
infection in the pig.
Pigs were infected with an FMDV strain collected from the UK 2001 
epidemic. Groups of pigs were infected by inoculation or direct contact and 
compared in terms of development of clinical disease, as well as in terms of their 
tissue viral loads, viraemias and cytokine/TLR mRNA induction.
The spread of virus in pigs was plotted based on viral loads in a number of 
tissues sampled at different time points from infection to severe disease. The same 
tissue types were then analysed for levels of antiviral cytokines, pro-inflammatory 
cytokines and TLR mRNAs, thus allowing a connections to be made between the 
behaviour of the virus and the innate antiviral and inflammatory responses of the 
host.
Antiviral and pro-inflammatory cytokine mRNA induction occurred very 
early post infection and this was initially observed in the tissues and lymph nodes of 
the pharyngeal region as well in liver. Later, as clinical signs began to develop.
11
further antiviral and pro-inflammatory cytokine and TLR mRNA inductions were 
observed in the pharyngeal region; however, mRNA induction in the tongue and skin 
exceeded that observed in the pharyngeal region. At this time, the tongue and skin 
became the major sites of viral replication and were the sites where severe clinical 
signs developed in the form of inflammation and vesicular lesions.
While the method of infection determined the time taken for clinical signs to 
develop, as soon as clinical disease began its progression was the same regardless of 
the infection method. Clinical disease continued to increase in severity beyond the 
peak of viraemia and viral load, indicating that viral replication was not solely 
responsible for the severity disease of clinical signs. It is very likely that cytokines 
and TLRs contributed to this, as up-regulated levels of mRNA were observed beyond 
the peak of viraemia and viral load.
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Chapter 1
INTRODUCTION
1. Introduction
1.1. Foot-and-Mouth Disease
Foot-and-Mouth Disease (FMD) is one of the most transmissible and contagious 
viral diseases and remains a considerable threat to the livestock sector despite the 
accumulation of a large amount of knowledge about the disease. As a result of this, 
FMD can be found on the Office International des Epizooties (OIE) list that comprises 
animal infectious diseases which have the potential to cause serious economic impact 
and are notifiable. (OIE, 2005).
FMD is endemic in parts of Asia, Africa, the Middle East and South America and 
routine vaccination is practiced in these areas (Meyer & Knudsen, 2001). The rest of the 
world is considered FMDV free, but sporadic outbreaks do occur (for example Taiwan 
1997, Japan 2000, UK 2001). In countries free of the disease, the main strategy 
employed to eradicate outbreaks is stamping out which involves the slaughter of infected 
and contact animals. This policy is supplemented by movement standstill, disinfection 
and in certain circumstances, by emergency vaccination (Samuel & Knowles, 2001; 
Nandi et al, 1999; Domingo et al, 2002; Bachrach, 1968; Sobrino et al, 2001; Sobrino 
& Domingo, 2001; Alexandersen et al, 2003b; Barnett et al, 2002).
1.1.1. Historical Perspectives and Geographical Distribution
The very first recorded reference to an outbreak of FMD was in 1514, when 
Fracastorius reported the disease in cattle (Bachrach, 1968). Over three hundred years 
later, in 1897, Loeffler and Frosch showed that FMD is caused by a filterable virus 
(Bachrach, 1968; Brooksby, 1982). This was the very first report of an animal disease 
shown to be caused by a virus (Sobrino et al, 2001; Blancou, 2002). The economic 
importance consequences of FMD is the main driving force behind work being done to 
the develop better vaccines and increase knowledge of the factors that influence virus 
transmission and persistence (Sobrino & Domingo, 2001).
1.1.2. Host Species
The host species of FMDV are members of the Order Artiodactyla, commonly 
described as cloven-footed animals or even-toed ungulates. Animals affected include 
cattle, sheep, pigs, goats and deer. Additionally there are over 40 wild animal species 
that are susceptible to a variable degree (FAQ, 2002).
1.1.3. Persistence of Disease in Ruminants
The existence of carrier animals has been known for a long time (Bekkum J.G 
Van. et al., 1959). By definition carrier animals are those animals from which infectious 
FMDV can be isolated from pharyngeal fluid samples (probang samples) for more than 
28 days after infection (Gaggero & Sutmoller, 1965) (Salt, 1993). This technique has 
been used to detect carrier cattle and sheep (Alexandersen et ai, 2002b). In carrier 
cattle, the most favoured site for the persistence of virus is the pharyngeal area (Burrows 
et al, 1981). Recent work has demonstrated FMDV RNA within cells of the soft palate 
and pharynx of persistently infected cattle (Zhang & Kitching, 2001) (Zhang et al, 
2004). Further work analysing early viral decay/clearance and virus clearance half-life in 
oropharyngeal-fluid (OP-fluid) samples has shown that the extent of the reduction of 
viral RNA in OP-fluid samples immediately following peak levels may be a critical 
determinant of the outcome of FMDV persistence (Zhang & Kitching, 2001). It is not 
yet fully understood how the virus persists, however cell lysis has not been observed in 
the pharyngeal region, even early in the infection, so it is not likely that the virus 
changes to become non-cytolytic. It is possible however, that a balance exists between 
the virus and host cells during persistence (Zhang & Kitching, 2001). Carrier animals are 
thought to play a role in the epidemiology of FMD in the field (Salt, 1993), but the 
mechanisms by which FMDV persists in cattle and other ruminants are not clearly 
understood, nor is the means by which the host immune system clears the persistent 
virus (Moonen & Schrijver, 2000). In a recent study, virus levels in ovine nasal swabs 
and serum were quantified. It was noted that the number of samples detected as positive 
was significantly higher in animals that went on to become carriers, as were the mean 
peak levels of virus. It is thought that this may be an indication of a correlation between 
peak viral loads, duration of viral load and the subsequent development of carrier sheep
(Alexandersen et al., 2002c). A great deal more work is required to elucidate the 
mechanisms of persistence of FMDV in order to eliminate the risk posed by carrier 
animals as viral reservoirs (Alexandersen et al, 2003b)
1.1.4 Clinical Signs and Pathogenesis in Domestic Animals
Typically FMD is characterised by the development of vesicles (bhsters) on the 
feet and in and around the mouth. Pigs and cattle infected with FMDV generally exhibit 
obvious vesicles that are usually more severe than those observed in sheep. Vesicles can 
become visible in pigs and cattle as early as 24 to 48 hours after infection. Fever, 
shivering, drooling and hp smacking are all characteristic signs of the disease in cattle. 
Vesicles are most frequently observed on the tongue, in the interdigital cleft and along 
the coronary band of the hooves. Tongue vesicles rupture and epithelium sloughs off 
exposing painfully raw tissue. Ruptured foot vesicles are prone to contract secondary 
bacterial infection causing severe lameness (Bachrach, 1968). Pigs develop similar signs 
to cattle, albeit without the drooling and lip smacking and with the majority of vesicles 
visible on the feet and sometimes around snout and lips (Bachrach, 1968; Alexandersen 
et al, 2001). Examples of such vesicles in pigs as they were observed during the UK 
2001 epidemic are shown in Figure 1.1a and 1.1b. Lesions may also be observed on the 
tongue. Foot lesions may include the shedding of claws in very severe instances; animals 
housed on soft bedding are less likely to develop such severe foot lesions. Clinical 
disease in pigs is usually very severe, more so than disease in other species, and this 
could be a reason to suspect that pro-inflammatory cytokines might have an important 
role to play in the pathogenesis of FMD in that species.
Figure 1.1a FMD lesions on the feet of a pig during the UK 2001 epidemic. Lesions and 
inflammation can be seen along the coronary hands to the extent that the horn of one digit 
(on the right) was loose and ready to fall off, a process known as ‘thimhling’. Picture 
kindly provided by Prof. Soren Alexandersen.
Figure 1.1b FMD lesions on the snout of a pig. Picture kindly provided hy Prof. Soren 
Alexandersen.
In sheep and goats, the clinical signs often less obvious and as a result, the 
disease can go unnoticed (Alexandersen, Zhang, Reid, Hutchings, & Donaldson, 2002c; 
Bachrach, 1968). Sheep excrete most airborne virus over a one to two day period prior to 
the development of clinical signs (Alexandersen et al, 2002b; Alexandersen et al, 
,2003b; Sellers & Parker, 1969). This is not the case in pigs and cattle, these animals 
excrete most airborne virus when the early acute signs of the disease are present 
(Alexandersen et al, 2002c; Alexandersen & Donaldson, 2002; Alexandersen et al, , 
2003b). Clinical signs observed in sheep usually include fever, anorexia, and lethargy; 
lameness may be observed regardless of the absence or presence of vesicles 
(Alexandersen et al, 2003b). Young ruminants and pigs infected with FMD may have a 
high mortality rate due to myocarditis and heart failure (Alexandersen et al, 2003b).
1.1.5 Mechanisms of Spread
The primary means of spread of FMD is by the movement of infected livestock 
(Bachrach, 1968; Donaldson, 1987). The second most important means of distribution is 
by the movement of contaminated animal products, for example milk, or semen. Milk 
products can contain infectious virus for up to four days before the onset of disease in 
the source animals (Donaldson, 1987). Indirect transmission can also occur by means of 
fomites, vehicles and people. All of the above mentioned mechanisms of spread are in 
principle controllable as long as the source of infection has been identified. However, an 
additional means of transmission carriage of virus by wind, is not controllable 
(Donaldson et al  2001; Gloster et al, 2003). FMDV is excreted in the breath of cattle, 
pigs and sheep over a four to five day period during infection, with maximum excretion 
occurring during the early acute stage for pigs and cattle, but with a significant excretion 
from sheep 1-2 days before clinical disease (Donaldson et al, 2001; Sellers & Parker, 
1969). Pigs excrete by far the greatest quantities of airborne virus, as much as 10^  ^
TCID50 over a 24-hour period (Donaldson et al, 1982) but many strains of FMDV are 
excreted at levels around 10^  TCID50 per hour, which is still approximately 60 times 
higher than levels excreted by cattle and sheep (Alexandersen & Donaldson, 2002; 
Alexandersen et al, 2002a). Compared with sheep and cattle, pigs are relatively resistant
to infection by airborne FMDV (Alexandersen & Donaldson, 2002; Alexandersen et al, 
2002a; Alexandersen et al, 2003a; Donaldson & Alexandersen, 2001)
1.1.6 Pathology of Foot-and-Mouth Disease
FMDV has the ability to replicate extremely rapidly, a feature illustrated by the 
fact that it can produce obvious vesicular lesions as soon as 24 hours after infection 
(Bachrach, 1968). It was long believed that the normal route of infection for FMDV was 
through ingestion of contaminated material, with the virus entering the epithelium 
through minor cuts and abrasions in the mouth. Subsequently, it was suggested that the 
nasal mucosae were the primary sites of replication (Kom, 1957) so an aerosol form of 
the virus was thought likely to exist (Burrows et al, 1981). Replication in the lungs has 
been suggested, based on in situ hybridization and virus isolation (Terpstra, 1972). It 
was later demonstrated that early virus multiplication was more likely to be occurring in 
the epithelia of the dorsal soft palate, the pharyngeal walls, tonsils and in the 
retropharyngeal lymph nodes (Burrows et al, 1981). Subsequent work suggested that 
virus in the lymph nodes is most likely to be accumulated from other sites as the result 
of drainage and not viral replication (Alexandersen et al, 2002b). A recent study lends 
further weight to the pharyngeal region as the primary site of infection (Alexandersen et 
al, 2001). This area is exposed to both inhaled and swallowed virus, and this study 
found that in early infection, tissues from the pharynx contained higher levels of virus 
compared with other tissues such as skin, lung or liver. It was then hypothesised that 
FMDV infection began with the inhalation of virus, which was directly deposited on the 
soft palate and tonsilar regions of the pharynx or transported there by ciliary movement 
of virus deposited in the respiratory tract. Virus then entered the bloodstream having 
passed through the local lymph nodes. A number of cells in the stratified squamous 
epithelia become infected, amplifying the virus. If the host was susceptible, this cycle 
progressed until enough epithelial cells in the favoured sites were infected to cause the 
development of vesicular lesions (Alexandersen et al, 2001; Alexandersen et al, 
2003b). Virus released in each cycle resulted in a viraemia lasting for 3-5 days. Virus 
was then released from the respiratory tract of infected animals into the breath
(Alexandersen et ai, 2001). Virus was also abundant in vesicular epithelium and fluid, 
in blood, nasal fluid, milk, urine and faeces.
1.1.7 Immune Response in Foot-and-Mouth Disease
Very little is known about the innate immune response to FMDV (Sobrino et ai, 
2001), but it is clear from the severe disease observed in infected pigs that an 
inflammatory response takes place. It is not known what factors are responsible for the 
innate immune response mounted by infected pigs, so by looking at a number of 
antiviral and pro-inflammatory cytokines as well as some toll like receptors, it is 
anticipated that some of the complex interactions between virus and host can be 
elucidated.
An acute inflammation that begins to develop as soon as 24 hours post infection 
is observed in pigs. Redness and hot feet are among the first clinical signs seen and are 
the result of dilation of blood vessels in the area, which leads to increased blood flow. In 
addition to vasodilation, blood vessels become increasingly permeable to proteins 
leading to the accumulation of protein-rich inflammatory exudates in the extravascular 
space -  this in turn can cause a degree of swelling in the affected areas. A third process 
associated with inflammation is the migration of leukocytes into the exudates (Konig & 
Liebich, 2004). Recruitment of these white blood cells from the blood into the tissues, 
where they can perform their various tasks such as phagocytosis, antigen presentation or 
tissue repair is affected by some of the cytokines studied here i.e. IL-la (Interleukin-1 
alpha) and TNFa. (Tumour Necrosis Factor alpha). During the acute inflammation 
phase, draining of the exudates takes place mainly through the lymphatic system -  a 
series of vessels that form an extensive network in almost all the tissues of the body. 
Lymph drains from them into larger channels and eventually makes its way to the 
thoracic duct or right lymph duct having passed through a series of lymph nodes on the 
way. The ducts then discharge the lymph into veins at the root of the neck. During acute 
inflammation, lymphatic drainage is greatly increased in volume and richer in protein 
(Taussig, 1984). Leucocytes involved in acute inflammation include neutrophils, 
eosinophils, monocytes and macrophages. Neutrophils are granulocytes that release
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degradative enzymes and are usually the first leukocytes at the site of inflammation. 
They also have a phagocytic capability mainly used in bacterial infections. Neutrophils 
release endogenous pyrogen, a factor partially responsible for the development of fever 
during acute inflammation. Eosinophils, the second type of polymorphonuclear 
leukocyte, are usually associated with helminth infections and hypersensitivity reactions. 
Macrophages usually dominate the later phases of acute inflammation, as they have a 
longer life span than neutrophils and can divide at the site of infection. Their main 
function is phagocytosis and they can take up a wider range of substances than 
neutrophils, making them important for the resolution of inflammation later in disease 
(Taussig, 1984). Neutrophils are sources of TNFa and IL-la, while macrophages are 
sources of type-1 interferons, TNFa and IL-la (Gearing & Callard, 1994).
Both humoral and cellular responses are induced as a result of infection with 
FMDV, and therefore recovered animals are protected against a recurrence of disease 
caused by reinfection with the same and antigenically closely related viruses. Humoral 
immunity is considered to be the main protective mechanism against FMD (Aggarwal et 
ai, 2002). An MHC class 1 restricted CDS T cell response is considered to be a likely 
means of viral clearance (Salt, 1993). FMDV particles can be phagocytosed by 
macrophages and granulocytes, especially when complexed with specific antibody 
(McCullough et al, 1992). Work carried out on the mechanism of phagocytosis of 
FMDV has led to the conclusion that the protective immune response is mainly driven 
by antibody mediated opsonization of virus, resulting in improved phagocytosis by cells 
of the reticuloendothelial system (a diffuse system of phagocytic cells derived from bone 
marrow stem cells which are associated with the connective tissue framework of the 
liver, spleen and lymph nodes). So while antibodies do have a direct role at high 
concentrations, without phagocytic activity, immune protection is reduced (McCullough 
et ai, 1992). It has also been suggested that in the absence of opsonization with specific 
antibody, FMDV may be able to survive in monocytic cells for a 10-hour period 
following the initial interaction between these cells and virus. In this period, monocytes 
could act as infectious carriers of virus, delivering it to other parts of the body where it 
may be able to detach and infect cells (Rigden et aL, 2002).
In general, circulating antibodies are detectable 3-5 days after the onset of 
clinical signs; levels peak 2-4 days after this (Alexandersen et al, 2003). Viral clearance 
(from circulation, most organs and bodily excretions) coincides with the appearance of 
antibodies in the circulation, however clearance from the ruminant pharyngeal region 
does not occur completely (Hess et al, 1967; McVicar & Sutmoller, 1974; McVicar & 
Sutmoller, 1976; McCullough et al, 1992) -  with up to 50% of animals developing a 
persistent infection, leading to low-level viral excretion in oesophageal-pharyngeal 
fluids. In cattle, the first neutralizing antibodies appear three to four days after the onset 
of clinical disease and peak at around ten to fourteen days post infection (Salt, 1993). 
The reduction or prevention of viraemia has a corresponding effect on the acute phase of 
the disease. However, ruminant circulating antibodies were not capable of preventing 
primary local infection in the pharyngeal region, so it appears that these antibodies have 
the ability to prevent disease in some instances, but not infection (McVicar & Sutmoller, 
1976). Antibodies can be detected in sheep from four to five days post infection and 
peak by seven days post infection (Alexandersen et al, 2002c). Cattle that have 
recovered from infection with a particular serotype of FMDV are immune to disease due 
to natural re-infection by that serotype for one to three years. Pigs demonstrate a shorter 
period of immunity than sheep and cattle (Bachrach, 1968).
1.1.8 Control of Foot-and-Mouth Disease
The first regulatory measure to be implemented specifically for FMD in England 
was the Contagious Disease (Animals) Act of 1878 and 1892. This act banned the 
movement of animals in the event of an outbreak. At about the same time the Foot and 
Mouth Disease (Slaughter) Order was introduced, whereby infected and contact animals 
were slaughtered and compensation was paid to owners (Henderson, 1978) Vaccination 
has been successfully used since 1938 and has been improving ever since (Blancou, 
2002).
In order to eradicate foot-and-mouth disease, it is clear that extreme measures are 
necessary. Such measures must be implemented rapidly and effectively if they are to be 
effective in preventing outbreaks from reaching epidemic proportions. In order for these 
eradication measures to be successful, viral transmission must be stopped as soon as
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possible. This can be achieved by quickly identifying infected premises and stamping 
out affected and contact animals. Similar measures must be taken on dangerous contact 
premises at risk of contracting the disease. Total stamping out is necessary for the 
success of these measures (Alexandersen et al, 2003)
Emergency vaccination, in certain situations, is an extremely important 
additional measure in the control of FMD. An emergency FMD vaccine contains higher 
levels of antigen than regular prophylactic vaccines; this is to generate a more rapid 
immune response. It is important that emergency vaccines contain antigens related to the 
outbreak virus strain and are available for immediate supply in the event of an outbreak 
(Barnett et al, 2002). The objective of emergency vaccination is to reduce the amount of 
virus in the area and is usually applied as a ring around the infected area. Vaccinate to 
kill or vaccinate to live programmes can be employed and can vary in strategy.
1.2 Foot-and-Mouth Disease Virus
1.2.1 Classification
Foot-and-mouth disease virus (FMDV) has been classified as a member of the 
genus Aphthoviridae in the family Picomaviridae. The only other member of the 
aphthovirus genus is Equine Rhinitis A virus. There are seven known serotypes of 
FMDV. These are A, O, C, Asia-1 and SAT-1, SAT-2 and SAT-3. These seven 
serotypes are very distinct and do not cross-protect against each other, as each one 
stimulates a different immune response (Donaldson, 1987). FMDV is extremely acid 
labile and is quickly inactivated at pH conditions of less than 6 and greater than 9, but it 
is most stable between pH 7.0 to 7.8 (Bachrach, 1968; Racaniello, 2001).
The picomaviruses are currently divided into nine genera. Other members of the 
family include poliovirus (PV, an enterovirus), human rhinoviruses, 
encephalomyocarditis (EMCV, a cardiovirus) and hepatitis A (HAV, a hepatitis virus) 
(Racaniello, 2001). Rhinoviruses acquired their name because of their affiliation for the 
host nasopharyngeal region. Human rhinoviruses (HRVs) are well-recognised causes of 
common colds and associated upper respiratory tract complications such as sinusitis and
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otitis media (Hayden, 2004). There are currently only two members of the Cardiovirus 
genus, the first of which is encephalomyocarditis virus, a rodent virus that can also 
infect humans, elephants and squirrels (Racaniello, 2001). The second species to be 
found in this genus is Theilovirus, which includes Theiler’s murine encephalomyelitis 
virus (TMEV) and Vilyuisk human encephalomyelitis virus (VHEV) (Racaniello, 2001). 
Hepatitis A virus of the hepatoviruses is the commonest cause of acute viral hepatitis. 
This virus was formerly classified in the genus Enterovirus, and was subsequently 
reclassified into its own genus as a result of sequence homology studies (Melnick,
1992).
Perhaps the most important enterovirus in relation to FMD is SVDV. This virus 
also causes a vesicular disease in pigs, which in the severe form is indistinguishable 
from FMD. As a result of this, SVDV is on the OIE list of notifiable disease (Escribano- 
Romero et al, 2000; OIE, 2005).
1.2.2 Virus Structure
All picomaviruses have a number of features in common, however there are a 
number of molecular features of FMDV that distinguish it from the other members of 
this family (Belsham, 1993). Picomavimses have a single stranded, positive sense RNA 
genome. A series of adenosines can be found on the 3’ terminus and a small vims- 
encoded protein called VPg can be found covalently attached to the 5’ 
terminus (Racaniello, 2001). The picomavirus virion is icosahedral in shape and consists 
of sixty subunits each of which is made up by the four virus-encoded stmctural proteins: 
VPl, VP2, VP3 and VP4 (Donaldson, 1987). The sixty subunits formed by the stmctural 
proteins are arranged as twelve pentamers. This is a very economical way of encasing 
the genome as multiple copies of the same protein are used and as a result, a smaller 
genome that encodes fewer proteins can be used. These surface particles alone are 
sufficient to induce an antibody response (Chinsangaram et al, 2001). Of the four 
surface proteins, only three are surface orientated. VPl, VP2 and VP3 are clustered into 
trimers, which in turn are arranged in pentamers around the apexes of the icosahedral 
virion capsid. VP4 is quite different being an internal protein (Racaniello, 2001).
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The structure of the surfaces of FMDV and Human Rhinovirus (HRV) are 
compared in Figure 1.2. The five protomers can be seen arranged into a pentamer 
forming the 5-fold axis of symmetry of the capsid. Although the arrangement of the 
three exposed proteins is similar amongst picomaviruses, their surface architecture 
varies and accounts for the different vims genera and for the different types of cell- 
receptor interactions (Flint et al,  2000). Conservation in picomavimses occurs at the 
protein stmcture level, but not at the amino acid level, with the result that amino acids 
can vary greatly without affecting the basic stmcture of the icosahedron. The majority of 
picomavimses have deep depressions in their capsids due to the protmsion of VPl 
molecules making up the five-fold axis of symmetry. This axis forms a prominent 
stmcture surrounded by a valley or canyon shown as yellow areas in Figure 1.2. These 
canyons are known to act as the receptor binding sites (Flint et al, 2000; Racaniello,
2001).
Each FMDV particle is approximately 25-30 nm in size and contains a single copy 
of the RNA genome (Belsham, 1993; Donaldson, 1987). The aphthovims virion capsid 
utilises the same format as that of other picomavimses. Canyons are not present on the 
FMDV capsid, and it is quite smooth. However, the major immunogenic G-H loop of the 
VPl protein protmdes from the surface of the capsid. This loop joins the p-strands G 
and H and contains an RGD motif, which in-vivo is a highly conserved three-amino-acid 
sequence, Arg-Gly-Asp (Beard et al,  1999; Mason et al,  1994).
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Figure 1.2 Composite illustration depicting the external surfaces of FMDV (coloured 
orange and yellow) and HRV 14 (lilac and yellow). The surfaces that protrude are coloured 
orange and lilac, respectively, while yellow areas denote canyons. The two fold icosahedral 
symmetry is superimposed on the composite virion to show the pentameric organisation of 
the capsid. Adapted from VIPER (see http://mmtsb.scripps.edu/viper/) (Reddy et al., 2001)
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1.2.3 Genomic Structure and Protein Expression
Type one poliovirus genome was the first picomavirus RNA to be fully 
sequenced and cloned into cDNA (Racaniello, 2001). Since then, similar work has been 
done on many picomaviruses and they have exhibited similar pattems of genomic 
organization.
All picomaviral proteins are expressed as a large, single polyprotein. This protein 
is then proteolytically cleaved to produce the functional viral proteins. Polyacrylamide 
gel electrophoresis was used in 1969 to study the structural proteins of FMDV when the 
four major proteins, VP1-VP4, were demonstrated (Brooksby, 1982). It was also shown 
that VP4 was common to all seven serotypes of FMDV, but that the pattems of VPl- 
VP3 differed sufficiently to allow differentiation of the serotypes (Brooksby, 1982)
The genome stmcture of FMDV and the proteins that it encodes are illustrated in 
Figure 1.3. The FMDV genome is slightly larger than that of the other picomavimses, 
being approximately 8400 bases in length (Belsham, 1993; Sobrino et al, 2001). The 
FMDV RNA genome contains a single open reading frame (ORF) of approximately 
7000 nucleotides, and there are two untranslated regions (UTR), one either end of the 
genome. The 5’ UTR contains approximately 1300 nucleotides and the 3’ UTR contains 
approximately 100 nucleotides plus a genetically encoded poly (A) tract. The very large, 
single ORF makes up the main portion of the FMDV genome. This ORF encodes a long 
polypeptide chain that is cleaved during translation by three vims-encoded proteinases to 
generate 12 protein products (Racaniello, 2001) The L proteinase has the ability to 
release itself from the polyprotein by cleaving between its C-terminus and the N- 
terminus of VP4 (Racaniello, 2001). The 2A protein of aphthovimses and cardioviruses 
is not proteolytically active as it is in other picomaviruses where it cleaves the capsid 
precursor protein PI from the non-structural region of the genome P2-P3 (Racaniello, 
2001; Blom et ai,  1996). In FMDV and all picomavimses, cleavage of the stmctural 
region of the polyprotein from the enzymatic region is mediated by the proteinase 3C 
(Blom et ai, 1996). The FMDV 2A protease causes its own separation from the junction
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with 2B using an unknown mechanism (Donnelly et al, 1997; Donnelly et al,  2001; 
Racaniello, 2001).
The sections of the UTR flanking the protein coding regions are highly 
conserved within the individual viruses and contain signals for the initiation of 
translation at the 5’ end and for the initiation of RNA synthesis at the 3’ end (Racaniello, 
2001). The 5’ UTR of the FMDV genome is long when compared with other 
picomaviruses such as poliovims, which has a 5’ UTR of 740 nucleotides. The reason 
for this extended UTR remains unexplained (Agol, 1991; Belsham, 1993; Mason et al, 
2003). A short segment called the S-fragment is found in the FMDV 5’ UTR. It’s 
thought that the S-fragment may prevent exonuclease digestion of FMDV genomes in 
infected cells where the VPg protein is absent. The S-fragment is followed by a poly(C) 
tract, a feature that aphthovimses share with encephalomyocarditis vimses (Racaniello, 
2001).The length of the poly(C) tract varies among vims isolates (Sobrino et al, 2001). 
The S-fragment and poly-C tract are followed by a number of pseudoknots of unkown 
function, and then by a predicted ere (cis-acting replicative element) potentially involved 
in RNA replication (Mason et al, 2003). Each picomavims ere stmcture contains a 
conserved motif of AAACA that acts as a template for uridylylation of VPg (3B) by the 
viral RNA polymerase to produce primers for initiation of viral RNA synthesis 
(Belsham, 2005). It is now thought that this element should be named the “3B- 
uridylylation site” as it is thought to have the ability to act in trans as well as cis 
(Belsham, 2(X)5). The location of the FMDV ere differs from other picomavimses where 
it is generally found within protein encoding regions of viral genomes (Mason et al, 
2003).
The FMDV 1RES (intemal ribosome entry site) is located after the predicted ere 
element. It permits cap-independent translation and is actually more efficient than the 
cap-dependant translation initiation found in eukaryotic mRNA. The translation 
initiation signals employed by FMDV are two AUG codons, which follow the 1RES 
(Sobrino et al, 2001). Uniquely to FMDV, the VPg (3B) protein has three different 
forms (Belsham, 1993), these are encoded simultaneously by the vims (Racaniello, 
2001). The 3’ UTR contains a poly (A) tract, which can vary in size among
15
picomaviruses (Racaniello, 2001; 2002b). Ail picomavims 3’ UTRs are thought to 
function like polyA tracts of cellular mRNAs and are likely to be involved in RNA 
replication (Mason et al, 2003)
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The Leader proteinase or is responsible for the shut-off of host protein 
translation. Depending upon which 1RES start codon is used to initiate translation, two L 
proteins can be synthesised, Lab and Lb (Piccone et al, 1995). The autocatalytic 
cleavage of either of these proteins from the growing polypeptide chain, at their 
carboxyl terminals, initiates the maturation of the adjacent capsid proteins (Porter,
1993). FMDV L^ '^  ^ cleaves the cellular translation initiation complex eIF4G allowing 
only cap-independent mRNA translation (Mason et al, 2003).
There are twelve proteins encoded by the FMDV monocistronic genome. All 
picomaviruses make use of polyprotein synthesis, the positive sense RNA genome is 
translated to generate one large polyprotein, which is, as previously mentioned, 
processed by three vims encoded proteases L, 2A and 3C. Picomaviral cleavage 
pathways vary between vims species (Rueckert & Wimmer, 1984). The FMDV 
polyprotein consists of four main sections, L, P I-2A, P2 and P3. P1-2A is processed to 
yield capsid proteins; the P2 and P3 sections generate non-structural proteins required 
for RNA synthesis and protein processing (Belsham, 1993). In the case of enterovimses 
and rhino vimses, the procapsid protein PI is cleaved from the replicative portions of the 
polyprotein by the protease 2A, which cleaves at its own N terminus. The corresponding 
cleavage in FMDV occurs at the C terminus of the 2A protease (Figure 1.3). The 3C 
proteinase mediates a primary cleavage between 2C and 3A. The PI protein undergoes 
further secondary cleavage by 3C, to generate the three components of the self­
assembling capsid, VPO, VP3 and VPl (Ryan & Flint, 1997). VPO is a precursor for VP2 
and VP4 and is only cleaved upon encapsidation of the genome RNA (Racaniello, 2001; 
Belsham, 1993). The P2 protein is cleaved from the P3 precursor protein by 3C. The 
remaining two proteins of P2, 2A and 2B, are then cleaved by the 3C protease. The 
remaining precursor protein, P3 is cleaved by the 3C protease yielding 3AB and a 
protease precursor 3CD. 3AB is cleaved by 3C yielding 3A and 3B (VPg). The 3CD 
protease is cleaved by 3C giving rise to the 3C protease and the RNA polymerase 3D, 
which is required for replication (Flint et al, 2000; Porter, 1993).
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1.2.4 Protein Function
The functions assigned to the proteins produced by picomaviral RNA are shown 
in Table 1.1.
1.2.5 Picomavirus Cellular Infection Cycle
Vims infection occurs in a series of steps, some of which are quite well 
understood for picomavimses, however it remains a complex process and is highly 
dependent on the presence of cellular membranes (Porter, 1993). The generic life cycle 
for all viruses begins with adsorption, which involves the specific binding of the vims 
particle to the cell surface via a receptor interaction. Penetration and uncoating are the 
next steps in which the vims penetrates the cell membrane and is uncoated to release its 
nucleic acid into the cytoplasm. This is followed by biosynthesis; that is viral translation 
and genome replication using cellular machinery. Assembly of newly translated virus 
proteins to form virion particles follows with the packaging of the viral genome into the 
protective capsid. The final step of the infection cycle is egress of the new virions by 
means of cell lysis or budding in membrane blebs (Donn et al, 1995; Yilma et al, 
1978). These viruses are now fully capable of infecting a new host.
FMDV utilises mechanisms of integrin-mediated attachment and intemalisation 
(Tiiantafilou et al., 2001). Three Uv integrins (Uypl, avp3, and Uypb) have been shown to 
be used by field isolates of FMDV (Jackson et al,  2002; Jackson et al,  2004;Miller et 
al,  2001). The integrins are a family of cell surface glycoproteins used by cells for 
attachment to extracellular matrices and to mediate cell-cell adhesions and signalling 
events (Dedhar & Hannigan, 1996). Integrin molecules are heterodimers composed of 
two transmembrane polypeptide subunits, a and (3. Each a and p subunit has one large 
and one short extracellular domain and a transmembrane region (Triantafilou et al,
2001). The G-H loop of FMDV VPl protein contains the highly conserved amino acid 
sequence Arg-Gly-Asp (RGD) and this sequence is recognised by the extracellular 
domains of many integrins (Triantafilou et al, 2001; Miller et al, 2001). Once bound to 
the receptor the virus is situated close to the cell membrane, this binding event triggers a 
conformational change in the virion whereby VP4 is lost and the RNA genome can
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penetrate the cell membrane and be delivered to the cellular cytoplasm most likely in 
endosomes (Racaniello, 2001).
The FMDV genome is a positive sense single stranded RNA, which acts like a 
cellular mRNA, see Figure 1.3, and as a result it is inunediately infective upon entry into 
the cell. Translation in the cell is normally initiated when a ribosome binds to the 5’ 
methylated cap-structure (m^GpppN...) of the mRNA, and then scans along it to find the 
first AUG initiation codon (Racaniello, 2001). The FMDV L-protease shuts down this 
cap-dependent protein synthesis on cellular mRNA soon after infection. This protease 
has the ability to cleave a component of the cap-binding-complex or eukaryotic 
translation initiation factor elF4G with the result that only cap-independent translation 
can occur (Ryan & Flint, 1997). The viral 1RES can then initiate protein synthesis using 
the remaining portions of elF4G. Cellular ribosomes can then begin translation of 
genomic RNA, almost as soon as it enters the cell (Li et aL, 2001). Processing of the 
large FMDV polyprotein begins immediately, as previously mentioned, even before its 
translation has been completed.
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Genome
Segment
Protein Protein Function
L L proteinase Autocatalytic cleavage at the L/Pl junction, 
cleaves translation initiation factor p220
PI VPl Structural Protein, contributes to formation of 
Antigenic sites
VP2 Structural Protein, contributes to formation of 
Antigenic sites
VP3 Structural Protein, contributes to formation of 
Antigenic sites
VP4 Structural Protein, intemal
P2 2A Cleaves at own C terminus (Donnelly, Gani, 
Flint, Monaghan & Ryan 1997)
2B RNA Synthesis (Bernstein et al., 1986)
2C RNA Synthesis (Flint et aL, 2000; Li & 
Baltimore, 1988)
P3 3A Possible virulence factor (Knowles et aL, 2001; 
Pacheco et aL, 2003)
3B/VPg Genome linked, initiation RNA Synthesis, Host 
Range, Pathogenicity (Pacheco et aL, 2003)
3C Protease/Main mediator of cleavage
3D RNA Polymerase
Table 1.1 FMDV Protein Functions. The segment of genome where the protein is encoded 
is shown in the fîrst column.
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An RNA dependent RNA polymerase (RDRP) is the product of the P3 portion of 
the FMDV genome. As soon as the viral RDRP has been translated, and has cleaved 
itself from the P3 portion of the polyprotein, RNA synthesis can begin. Proteins 
involved in RNA synthesis are transported to membrane vesicles and replication occurs 
on the surface of these vesicles (Flint et al, 2000). The positive strand genome is copied 
into negative strands, which are used as templates for the synthesis of more positive 
strand genomes. Some of these new genomes can serve as templates for further 
translation or for more negative strand RNA, while others are packaged into progeny 
virions (Racaniello, 2001). Replication takes place in the cytoplasm of the cell, in 
association with membranous vesicles and smooth membranes. This results in an 
inhibition of the transport of these vesicles from the endoplasmic reticulum to the cell 
surface (Flint et al, 2000). The switch from protein synthesis to genome replication is 
poorly understood, but it must occur early in infection (Belsham, 1993). The mechanism 
used by picomaviruses to package their genomes is also not fully understood. However, 
it is most likely that a concerted mechanism of assembly is used (Hint et al, 2000), 
whereby the stmctural proteins of the virion capsid only assemble in association with the 
RNA genome.
During assembly, protomers containing one copy each of VPO, VPl, and VP3 are 
formed; these protomers are the 5S stmctural unit. The release of most non-enveloped 
vimses including FMDV particles in cell culture is mainly thought to be associated with 
the lysis of the infected host cell (Hint et al, 2000).
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1.3 Innate Inmiunity
1.3.1 The Complement System
Some infecting organisms may activate the complement system. Binding of 
activated complement components to these organisms may act as an opsonin, enhancing 
phagocytosis of the organisms. Activation of complement will also promote local 
inflammation at the site of infection, through the release of chemo-attractant and 
vasoactive components. The complement system is a potent mechanism for initiating 
and amplifying inflammation. This is mediated through fragments of complement 
components found in serum. It consists of more than 30 proteins engaged in host 
defense. These are present in the blood serum in an inactive state and are activated by 
immune complexes (the classical pathway), by carbohydrates (the lectin pathway), or by 
other substances, mainly of bacterial origin (the alternative pathway) (Spear et al,
2001). These serum protein levels can be measured and quantified as an indicator of 
inflammation (Roitt., 1994). Once activated, the complement system operates in a 
cascade-like fashion in which one component activates the next. The alternative pathway 
is a component of the innate immune system (Roitt, 1994; Janeway. & Medzhitov,
2002).
1.3.2 Non-specific Effector Mechanisms
Innate immunity is the driving force behind many inflammatory responses. The 
same effector cells are utilised by both the innate and the adaptive immune systems, 
however the innate system activates these cells non-specifically. The main cells 
responsible for innate immunity are monocytes, macrophages and neutrophils, which 
phagocytose microbial pathogens and trigger the cytokine network. This results in the 
development of inflammatory and specific immune responses (Janeway & Medzhitov,
2002). The first lines of defence are the non-specific effector mechanisms of the host, in 
particular the phagocytic cells such as neutrophils and macrophages (Roitt., 1994). 
When the cells of the innate immune system are unable to clear an infection alone, the 
innate system can assist the adaptive immune response by informing it of what kind of 
pathogen has invaded the body. This is achieved through the expression of costimulatory
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molecules on the surface of dendritic cells (Janeway & Medzhitov, 2002). Activation of 
the NF-kB pathway leads to the initiation of the adaptive immune response by 
production of pro-inflammatory cytokines such as IL-1, TNF-alpha and induction of 
costimulatory molecules (Hatada et aL, 2000).
Inflammation is a complex response to local injury or other trauma, resulting in 
redness, heat, swelling and pain. It is the result of a cascade of events in which pro- 
inflammatory cytokines play a major role. Cytokine production, cell trafficking, 
extravasation, mediator production, coagulation, fibrinolysis and changes to 
haemodynamic parameters and microvascular permeability are all steps in this very 
intricate response that can, ultimately lead to death (Holtzman et aL, 2002). IFNy is a 
major pro-inflammatory cytokine as a result of its ability to activate macrophages and 
endothelial cells (with IL-10 being able to operate in reverse through down-regulation of 
the production of pro-inflammatory cytokines by macrophages) (Dumoutier & Renauld, 
2002; Renauld, 2003; Samuel, 2001). However, IFNy has a weaker direct antiviral 
activity, not being directly induced by viral infection (Samuel, 2001). TNFa and IL -la  
are both crucial pro-inflammatory factors for the initiation and propagation of 
inflammatory processes. When they are administered to humans, they produce fever, 
inflammation, tissue destruction, and, in some cases, shock and death (Dinarello, 2000a)
1.3.3 Toll-like Receptors
The innate immune system also makes use of intracellular recognition systems 
when pathogens gain access to intracellular compartments. For example, protein kinase 
PKR is activated when it binds to dsRNA (Le Page et al, 2000) (produced during viral 
replication). Many cells of the innate immune system possess pattern recognition 
receptors (PRRs) that recognize pathogen associated molecular pattems (PAMPS) from 
vimses, bacteria, fungi and protozoa (Sousa, 2004). Toll-like receptors (TLRs) are a 
group of recently discovered PRRs. Recent findings in the Toll-like receptor family, first 
discovered in Drosophila, further elucidate the processes used by the innate immune 
system to develop inflammatory and specific responses. A large number of TLRs have 
been grouped together into a single family known as the Interleukin-1 Receptor/Toll-like
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Receptor Superfamily. Members of this family are involved in the host response to 
injury and infection (Opal & Huber, 2002) and all share a conserved cytosolic region 
termed the Toll-IL-IR (TIR) domain (O'Neill, 2000). It is thought that TLRs operate by 
enabling cells of the innate immune system such as macrophages and dendritic cells to 
recognize PAMPS, which are used to distinguish antigen from self and also to 
differentiate pathogens. Upon infection, dendritic cells and macrophages express TLR 
on their surface and bind to PAMPs. This binding initiates a signalling pathway that 
leads to the stimulation of host defences in the form of reactive oxygen and nitrogen 
intermediates. Simultaneously, adaptive immunity is initiated as APC are activated 
through the upregulation of pro-inflammatory cytokines (Werling & Jungi, 2003). TLRs 
are likely to be very important to the link between innate and adaptive immunity 
(O'Neill, 2000). Immature dendritic cells mature upon encountering a pathogen and 
TLRs permit them to do this. Mature dendritic cells can then go on to prime naïve 
antigen specific T cells, thereby activating the adaptive immune system (Janeway & 
Medzhitov, 2002).
Recent developments have linked TLRs to viral recognition and innate antiviral 
reponses. Both TLR3 and TLR4 have been shown to be associated with the activation of 
antiviral genes (Doyle et al., 2002). TLR3 recognises double stranded RNA (dsRNA) 
(Werling & Jungi, 2003; Vaidya & Cheng, 2003). Experiments have shown that TLR3 
binds the viral RNA mimic poly-inosinic-polycytidylic acid (Alexopoulou et ah, 2001), 
and that although TLR3 is utilised in many viral infections to signal an antiviral 
response, it is not universally required for the generation of an effective response 
(Edelmann et at., 2004). Normally the result of viral replication, dsRNA is a PAMP as it 
is not constitutively found in host cells. This recognition process leads to the production 
of type-1 Interferon. It is likely that viral dsRNA bound to surface expressed TLR3 has 
come from virally infected and subsequently lysed cells (Werling & Jungi, 2003). More 
recent work has revealed a TLR3-stimulated pathway that provides a link between 
dsRNA and interferon production in mammalian cells (Matsumoto et al,  2004). TLR4 
recognises bacterial and viral PAMPs. It has been shown to recognise the F protein of 
respiratory syncytial virus (Haynes et al,  2001) and the envelope proteins of mouse
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mammary tumour virus (Rassa et aL, 2002) leading to the induction of pro-inflammatory 
cytokines that were assayed in this study including IL-la and TNFa..
1.4 Adaptive Immunity
1.4.1 Humoral Immunity
Viruses have coexisted with mammals for millions of years and have devised 
numerous ways of evading the immune system (Alcami & Koszinowski, 2000). A key 
function of the immune system is the production of immunoglobulins by B cells that 
bind and inactivate specific foreign antigens. When the B cell receptor immunoglobulin 
binds antigen, that cell is activated to proliferate and create plasma cells secreting 
immunoglobulins to bind that specific antigen. B cell activation also creates memory 
cells with the same antigen specificity that do not actively secrete immunoglobulin but 
provide for rapid future immune responses to the same antigen (Roitt., 1994). B cells are 
not activated by antigen on their own, but require interaction with helper CD4 T cells to 
become activated and to proliferate. This interaction occurs as B cells migrate through 
lymphoid tissues populated with armed T cells and is known as a T cell dependent 
antibody response (Roitt., 1994). The B cell first expresses immunoglobulin on the cell 
surface as the B cell receptor. If the B cell receptor immunoglobulin binds specific 
antigen this leads to the transcriptional activation of genes associated with B cell 
activation, then the cell internalises the antigen. It is then either broken down or 
transported to an intercellular compartment and presented to T cells in MHC II where it 
is recognised by the T cell receptor (Bachmann & Zinkemagel, 1997).
1.4.2 Cellular Immunity
T cells are one of two subpopulations of lymphocytes involved in the mammalian 
immune system. They are responsible for the antigen specific cell-mediated immune 
response mounted by the body against all non-self antigens. The thymus is the main 
lymphoid organ where precursor T cells develop into mature T cells. T cells remain 
naïve until they encounter MHC-peptide complexes for which their T cell receptors 
(TCRs) have a high affinity (Berard & Tough, 2002). Another function of the thymus is 
to eliminate T cells that express self-reactive T cell antigens (Mondino et aL, 1996). T
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cells that survive two selection processes join the peripheral pool of T cells. They bear 
receptors for specific antigens and they are also restricted to either MHC class I (CDS) 
or MHC class II (CD4) (Janeway, 2001). T cell activation is initiated when T cells 
encounter specific antigens in draining lymphoid tissues (Roitt, 1994). CD4 T cells can 
be subdivided into T helper (Th) 1 or (Th) 2 types. These subsets can be distinguished 
based on the different cytokine genes that they express (O'Garra & Arai, 2000). Since T 
cells can only recognise their specific antigen in combination with MHC, this means that 
they are best equipped to deal with intracellular pathogens such as viruses (Roitt, 1994). 
MHC class I is expressed on the surface of all nucleated cells but neurons and a small 
percentage of all proteins within the cells are continuously processed by a low molecular 
weight protease. These proteins are then complexed with MHC class I and presented at 
the cellular surface to be sampled by CDS T cells. Only a limited group of cells express 
class II MHC, this group includes the antigen presenting cells (APC). The principal 
APCs are macrophages, dendritic cells, and B cells. Exogenous proteins taken in by 
endocytosis are fragmented by proteases in an endosome and complexed with MHC 
class II these complexes are expressed on cellular surfaces in pairs and are recognised by 
CD4 T cells (Roitt, 1994). Cytokines produced by APCs are the major inducers of CD4 
Thl and Th2 subset development. In humans IE-12 and IFNy are important for the 
development of the Thl subset, while IL-4, IL-5, IL-6, IL-9, IL-10 and IL-13 are 
important in promoting the development of the Th2 subset (Luther & Cyster, 2001; 
Mosmann & Sad, 1996).
IFNa, IFNP and IFNy all have the ability to elevate the expression of MHC I, 
promoting the CDS T cell response. However, only IFNy has the ability to induce MHC 
II activity and the associated CD4 T cell responses (Goodboum et aL, 2000; Samuel, 
2001). After their activation, CD4 T cells will differentiate into two subsets defined by 
the cytokine expression profile that they exhibit (Le Page et aL, 2000). Thl cells 
promote cell-mediated immunity. Their production is enhanced by the elevation of IL-12 
synthesis by APCs under the influence of IFNs. The development of Th2 cells is 
inhibited through IFN mediated blocking of IL-4. NK cells become activated by Thl 
cytokines following viral infection, as a result NK cell activity is increased and IFNy
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production is induced. In turn, IFNy activated macrophages produce EL-12, which has 
the ability to activate NK cells, and IL-I8, which has the ability to induce IFNy. The 
overall effect is to enhance the innate antiviral response. Th2 cells can suppress this 
response during the humoral immune response by producing IL-10, which has the ability 
to reduce EL-12 production, inhibiting NK cell functions and IFNy production (Boehm et 
al,  1997; Le Page et al, 2000).
There is a small population of T cells in humans that does not express T-cell 
receptors (TCR) composed of the conventional oc/p chains, but are characterised by y/0 
TCR. These y/0 T cells appear to overlap in function with oc/p T cells, but also have their 
own exclusive and as yet relatively poorly understood functions (Kaufmann, 1996). Pigs 
have a larger proportion of y/ô T cells than other species that are susceptible to FMDV 
and it is possible that these cells may have a role to play in an elevated innate immune 
response of pigs to FMDV (Takamatsu et al,  2002; Yang & Parkhouse, 2000).
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Figure 1.4 A simplified model of the signalling pathways leading to TLR3 and TLR4 
specific gene expression. Activation of TLRs by the ligands shown above leads to an 
association between the TLR TIR domain and MyD88 (adaptor molecule, myeloid 
differentiation factor 88). A series of further associations between MyD88 and the serine- 
threonine kinase IRAK, TRAF6 (TNF-receptor associated factor 6), MAPK (mitogen 
activated protein kinase) and the I k k  complex (I kappa B kinase). The I k k  complex induces 
phosphorylation of Ik B ,  which renders I k B  competent for uhiquination and degradation. 
This leads to the liberation of N F -k B  (nuclear factor-icB) allowing it to translocate to the 
nucleus, where it can induce target gene expression. TLR4 can activate N F -k B  and MAPK 
in a MyD88 independent and TIRAP/TOLLIP-dependent (TIR adapter protein/Toll- 
interacting protein) manner. This leads to the phosphorylation and nuclear translocation 
of IRF3 (interferon regulatory factor 3), which is involved in IFN-inducihle gene 
expression (Barton & Medzhitov, 2003; Haynes et aL, 2001; Rassa et aL, 2002). (Figure 
adapted from Akira, 2003).
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1.5 Cytokines
1.5.1 Role of Cytokines
Cytokines are low molecular weight soluble proteins that are involved in and can 
regulate the host response to infection, inflammation and immunity, cell growth and cell 
differentiation. They are primarily secreted by leucocytes but can also be secreted by 
nearly every all nucleated cell type. Acting as chemical communicators between cells, 
cytokines bind to specific receptors on cell surfaces initiating signal transduction 
pathways.
Cytokines are grouped into structural families, see Table 1.2. The cytokine 
profiles produced by human T cells have led to their division into two subsets. Thl T 
cells produce IL-2 and IFNy, while Th2 T cells produce IL-4, IL-5, IL-6, IL-9, IL-10 and 
IL-13. A further subset of T cells named ThO T cells produces both kinds of pattems. 
The cytokine environment in which naïve T cells first encounter antigen in association 
with antigen presenting cells (APCs) in a very important regulator of the polarisation 
process (Renauld, 2003; Harris et al,  2000). Good correlations between the Thl and 
Th2 cells and their cytokine profiles have been demonstrated in humans. For example, 
Thl cells are involved in cell-mediated inflammatory reactions, meaning that the 
cytokines produced by Thl cells induce cytotoxic and inflammatory reactions, 
macrophage activation and to a lesser extent antibody help (Mosmann & Sad, 1996; 
Mosmann, 2000). The pattern of cytokines expressed by Thl cells are more effective 
against intracellular parasites and viruses and can promote, through B cell help, the 
synthesis of particular Ig isotypes. Th2 cytokine pattems are better directed against 
helminths, by helping B cells in the synthesis of Ig isotypes associated with defence 
against these extracellular pathogens (Mosmann, 2000). Th2 cells are involved in 
important B cell interactions and in allergic responses and appropriately, their cytokines 
are important in the encouragement of antibody responses and in the stimulation of 
eosinophils (Berger, 2000; Mosmann, 2000). B cells are known to produce IL-10, IL-6, 
LT-a, TNF-a, IL-2, IL-4, IFNy and IL-12, more recently studies have shown that B cells 
may use these cytokines to regulate T cells activity or function (for example when
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presenting antigens to T cells) (Harris et al, 2000). It is clear that cytokines are central 
to the mammalian immune response and that they can act singly or together to form a 
large intercellular communication network with the ability to direct host defences 
against pathogens.
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Cytokine Family Members Receptor Type
Haematopoietins 
(4 alpha-helical 
bundles)
11^2, IL-3, IL-4, IL-5, IL-6, IL-7, IL- 
9,
11^13, G-CSF, GM-CSF, CNTF, 
OSM, LIF, EPO
Cytokine receptor class I
11^  10, IFNo, IFNP, IFNy Cytokine receptor class II
M-CSF Tyrosine kinase
EOF
(beta-sheet) EGF, TGFa Tyrosine kinase
beta-Trefoil FGFo, FGFP
Split tyrosine kinase
ILl-a, ILl-p, ELl-Ra ILrl receptor
TNF
(Jelly roll motif) TNFoc, TNFP, LTP NGF/TNF receptor
Cysteine knot
NGF NGF/TNF receptor
TGFpi, TGFP2, TGFp3 Serine/threonine kinase
PDGF, VEGF Tyrosine kinase
Chemokines- 
(triple-stranded, 
anti-parallel beta- 
sheet in Greek 
key motif)
IL8, MIP-la, MIP-ip, MIP-2, PF-4, 
PBP, I-309/TCA-3, MCP-1, MCP-2, 
MCP-3, yIP-10
Rhodopsin superfamily
Table 1.2 Structural families of cytokines (adapted from Gearing & Callard, 1994). 
Cytokines reviewed in this report are highlighted in blue for antiviral and red for pro- 
inflammatory.
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1.5.2 Antiviral Cytokines
The type-1 interferons, IFNa and IFNp both play a very important role in 
antiviral defence. The antiviral system is composed of three main steps beginning with 
the detection of viral infection and synthesis and secretion of interferon by eukaryotic 
cells. This is followed by the binding of interferon to its receptors and transcriptional 
induction of interferon stimulated genes. Thirdly, antiviral enzymes and proteins are 
manufactured in order to inhibit key cellular functions for prevention of viral replication 
(Weber et al,  2003; Williams & Sen, 2003; Taniguchi & Takaoka, 2002; Samuel, 2001; 
Le Page et al, 2000).
1.6 Interferons and their Antiviral Impact
1.6.1 Interferon Genes
Interferons (IFNs) were discovered in 1957 as a result of their interference with 
virus replication (Sen & Lengyel, 1992; Weissmann & Weber, 1986). They were 
initially named after the cells from which they were produced, for example leukocyte 
IFNs, fibroblast IFNs and immune IFNs. Leukocytes were found mainly to produce 
IFNa, while fibroblasts produce IFNP in the greatest abundance. These two types of 
IFNs are more closely related to each other than to IFNy and so were grouped together 
as Type 1 IFNs (Sen & Lengyel, 1992; Weissmann & Weber, 1986).The third form of 
interferon, IFNy is produced by immune cells and was discovered in 1965. It was 
designated as Type 2 interferon since it had different biological and physiochemical 
properties from the Type 1 interferons (Weissmann & Weber, 1986)
Most types of cells, when virally infected, can produce IFNa/p (in cell culture) 
(Siegal et al, 1999). Mainly a few particular cells of the immune system that are natural 
killer (NK) cells, macrophages, CD4 Thl cells and CD8 cytotoxic T cells produce IFNy 
(Le Page et al, 2001). The genes encoding the Type 1 interferons are members of a 
superfamily, located on a single chromosome (Sen & Lengyel, 1992). A single gene 
exists for Type 2 interferon and it encodes IFNy (Weissmann & Weber, 1986).
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1.6.2 Interferon Production and Signal Transduction
The production of interferons is induced in many cell types as a result of virus 
infection. The induction of these cytokines results in the inhibition of viral replication 
due to the establishment of an antiviral state in uninfected cells and the induction of 
apoptosis in infected cells. IFNa/p not only act upon their own target cells, but also 
stimulate increased activity of NK cells, a group of non-specific cytotoxic cells (Sato et 
al., 2001). Transcriptional activation of the genes encoding the various homologues of 
IFNa is a primary cellular response to viral infection (Le Page et al, 2000). IFNa/p 
induction is mainly mediated by transcriptional activation involving the virus responsive 
element (VRE) sequences in the 5’ regions of the genes (Barnes et al, 2002). The VRE 
of IFNp gene promoter contains an NF-kB site, the IFNa gene promoter does not 
contain an NF-kB site (Goodboum et al, 2000), but does contain sites that can bind IFN 
regulatory factors (IRF) (Barnes, Lubyova & Pitha, 2002). Less is known about the 
activation of the IFNy gene. It is thought that the molecular basis of IFNy gene induction 
revolves around the activation of STAT4 by IL-12 and NF-kB by IL-18 (Goodboum et 
al, 2000).
The IFN receptors belong to the class II cytokine receptors, see Table 1.2. The 
Type 1 IFN receptor is common to a and p interferons. The Type II IFN receptor is the 
receptor for IFNy and is expressed on almost all cell types (Le Page et al, 2000). Upon 
the binding of IFNs to their receptors, multiple pathways of signal transduction are 
activated. IFNs utilise JAK kinases (Janus Tyrosine Kinases) and STAT proteins in 
order to mediate signal transduction for the activation of transcription of IFN-inducible 
genes (Goodboum et al, 2000).
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Figure 1.5 Simplified overview of interferon production and interferon activity. IFNa and 
IFNp are produced by leukocytes, fibroblasts macrophages and epithelial cells as a result 
of viral infection or by the presence of dsRNA. IFNy is produced as a result of stimulation 
of T lymphocytes, macrophages and natural killer cells by various mitogens, antigens, IL 
1, IL-2 and IFNy itself. IFNa, IFNp and IFNy bind to specific surface receptors on primary 
target cells (not always the same cell as indicated above). This leads to the induction of 
transcription of various genes involved in the antiviral response. (Adapted from 
Goodboum et a l, 2000)
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1.6.3 Proteins Induced by Interferon
IFN-activated genes encode mRNA, which is translatable into IFN-inducible 
proteins and many of these proteins are important for the antiviral activities of IFNs (Sen 
& Lengyel, 1992) Examples of these proteins include dsRNA-dependant protein kinase 
R (PKR), a protein synthesis inhibitor. It is present in the cell at low levels and becomes 
activated by binding to dsRNA, which leads to the activation of PKR (Le Page et al, 
2000). The 2’, 5’-01igoadenylate Synthetase or RNase L system produces extensive 
cleavage of both viral and host mRNA, which leads to the inhibition of protein synthesis 
(Le Page et al, 2000). Mx proteins are a group of GTPases that are induced by IFNa 
and IFNp but not by IFNy. It has been shown that Mx alone has the ability to inhibit 
viral replication in the absence of any other IFN-inducible proteins (Samuel, 2001).
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Figure 1.6 The intracellular interferon signalling pathway. Binding of IFNo/p activates the 
intracellular IFN signalling hy causing dimérisation of the receptor suhunits IFNARl and 
IFNAR2. The intracellular IFN signalling pathway involves mainly JAKl (Janus Kinase) 
and TYK2 (a Janus Kinase) and STATl (signal transducer and activator of transcription). 
The JAKs phosphorylate and activate the STATs, which homo- or heterodimerize and 
translocate to the nucleus to induce the expression of the IFN-stimulated genes (ISGs). The 
STAT heterodimer complexes with nuclear protein p48, and this complex hinds to the IFN- 
stimulated response element (ISRE) sequences in the promoters of ISGs. (Adapted from 
Katze et al., 2002).
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1.6.4 Impact of Interferon on FMDV Infection
Interferons are critical for antiviral defence, however many viruses have evolved 
mechanisms to evade this hurdle (Weber et al, 2003) and FMDV is no exception to this
rule. The antiviral effects of interferons do have an impact on FMDV, however it has
been demonstrated that FMDV has devised ways to counteract the effects of interferons 
on the course of its infection. While FMDV infection of cells does induce the 
transcription of the IFNo/p genes, the first FMDV protein to be translated in the infected 
cell could effectively eliminate the antiviral effects of IFNa/p. The L proteinase, as 
mentioned previously cleaves the host translation initiation factor eIF4G permitting only 
viral cap-independent protein translation to take place (Flint et al, 2000). There is 
further evidence to support the inhibition of IFNs by FMDV. Bovine kidney cells were 
induced to produce IFN by Poly I:C and shortly after were infected with a wild type 
FMDV; a reduction in the amount of IFN produced was seen (Ahl, 2000). This ability to 
suppress IFN synthesis is important for FMDV, as it has been demonstrated that L- 
deleted FMDV mutants do not have the ability to grow as well in cell culture as wild 
type virus (Chinsangaram et al, 2001). It is also thought that L-deleted viral inhibition is 
mediated by IFNs through the dsRNA-dependant protein kinase R pathway. IFNa/p 
treatment of cells demonstrated an inhibition of viral protein translation, even in the 
presence of newly synthesised viral RNA (Chinsangaram et al, 2001).
1.7 Tumour Necrosis Factor Alpha (TNFa )
1.7.1 Genes and Proteins Induced by TNF
Tumour necrosis factor alpha (TNFa) is a potent mediator of inflammation and 
the innate immune response in mammals. It is produced mainly by activated monocytes 
and macrophages, but can also be secreted by B cells, T cells and fibroblasts (Gearing & 
Callard, 1994). TNFa is grouped together with IL-1 and IFNy -  the pro-inflammatory 
cytokines. Their expression is rapidly induced in response to infection or any kind of 
intrusion into the body. As a result of their expression, the transcription of a large 
number of other genes is indirectly stimulated. These genes code for a large number of 
other immunoregulatory molecules -  other cytokines, chemokines and adhesion
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molecules. Acting against these cytokines are the members of the anti-inflammatory 
cytokines group, DL-4 and lL-10, all of whom have dual roles as activators of B cells 
(Dinarello, 2000a)
Both TNFa and ILla are simultaneously produced at the site of infection and it is 
believed that there is a level of synergy between the two cytokines (Dinarello, 2000a). 
The pro-inflammatory cytokines induce the transcription of genes that code for pro- 
inflammatory enzymes. For example, PLA2(II) or type two phospholipase, iNOS or 
inducible nitrous oxide synthase and COX-2 or cyclooxygenase, leading to the 
production of the inflammatory mediators, prostaglandins (O'Neill, 2000;Dinarello, 
2000a). Endothelial adhesion molecules (cell surface proteins involved in cell-cell 
binding) and chemokine (facilitate leukocyte migration) synthesis is also up regulated. 
These up regulated molecules in turn induce elevated levels of their target cells or 
molecules causing an inflammatory reaction (O'Neill, 2000; Dinarello, 2000a). The 
effects of TNFa and EL-la on hepatocytes initiates the acute phase response, which 
results in an increase in the synthesis of acute phase proteins such as C-reactive protein 
and haptoglobin. Acute phase proteins act as opsonins and facilitate the complement 
system (Roitt, 1994)
1.7.2 Receptors of TNF
The binding of TNFa to its receptors stimulates the recruitment of effector 
proteins that interact with the cytoplasmic domains of the receptors such as TRADD 
(TNFRl associated death domain protein), which in turn mediates the activation of 
proteases, protein kinases, transcription factors and phospholipases. The over expression 
of TRADD is believed to be sufficient to cause the activation of NFkB and apoptosis 
(Liu & Han, 2001). The activation of TNFRl results in many cellular responses 
including cytokine production, cell growth inhibition and cytotoxicity among others 
(Schluter & Deckert, 2000).
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1.7.3 Signal Transduction by TNF
TNF has the ability to elicit a wide range of biological responses by activating 
different effector functions through its receptors. These include the protein kinase JNK, 
transcription factor NF-kB, and apoptosis. Mitogen-activated protein kinases (MAPKs) 
are important mediators for intracellular signaling in cells (Schaeffer & Weber, 1999; 
Dong et al, 2002). The protein c-Jun N-terminal kinase (JNK) is a mitogen activated 
protein kinase, also known as stress activated protein kinase (SAPK). It is believed that 
JNK is activated by TNF through a MAPK cascade (Liu & Han, 2001).
TNFa is one of the most potent physiological inducers of NF-kB, mediating 
inflammation, cellular immune response, and affects the functions of virtually every cell 
type (Schutze et al, 1995). Activated NF-kB translocates to the nucleus and activates 
the transcription of genes involved in immune response, inflammation and cell apoptosis 
(Beutler & Bazzoni, 1998). TNFa induced apoptosis and the activation of NFkB have 
been shown to be linked, and NFkB has been shown to play a protective role in TNFa 
induced apoptosis (Beg & Baltimore, 1996).
1.8 Interleukin 1 (IL-I)
1.8.1 IL-1 Genes and Proteins
Interleukin 1 (IL-1) is a general name for two distinct proteins, IL-1 a and IL-lp, 
which are members of a family of regulatory and inflammatory cytokines (Roux- 
Lombard, 1998). IL-1 a, IL-1 receptor antagonist (IL-lRa) and IL-18, play an important 
role in the up and down-regulation of acute inflammation (Torigoe et al, 1997).
Human IL-la  and IL-lp are quite similar on the genetic and three-dimensional 
structure level, they exhibit very different mechanisms of expression, synthesis and 
excretion (Roux-Lombard, 1998). Another member of the IL-1 family of proteins is the 
IL-lRa or IL-1 receptor agonist. It acts as a specific inhibitor of IL-1 a and IL-lp by 
binding to their IL-1 receptors without inducing an intracellular signal, thereby
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preventing a biological response to IL-1 (Dinarello, 2000b; Inui, 2001; Roux-Lombard, 
1998)
1.8.2 IL-1 Receptors and Signalling
IL-1 a and IL-lp exert their effects by binding to specific receptors, which 
induces an increase in the level of expression of genes involved in the elimination of 
infection (O'Neill, 2000). Two distinct IL-1 receptors, plus a non-binding signalling 
accessory protein, IL-1 receptor accessory protein, have been identified. Each has 
extracellular immunoglobulin-like (Ig-like) domains, grouping them in the type IV 
cytokine receptor family (Roux-Lombard, 1998) see Table 1.2. The two receptors are 
named type I IL-1 receptor (IL-1 RI) and type II IL-1 receptor (IL-1 RII), respectively. 
IL-Rl is a member of the IL-IR/TLR superfamily, whose other members encode a 
variety of receptors that are involved in the processes of inflammation and host defence. 
The BL-IR/TLR superfamily is divide into two subgroups based on sequence similarities 
in the receptors’ extracellular domains (O'Neill, 2000). IL-lRl and IL-1R2 belong to the 
first subgroup, whose defining motif is the Toll-IL-IR (TIR) domain. IL-1 RI is 
considered to be a signal transducing receptor, while IL-1 RII is believed to be a decoy, 
or activity down-regulating dummy-receptor. EL-1 signalling is generated by the IL-1 RI 
complexed with IL-1 RI accessory protein (EL-1 RacP), which only interacts with EL-1 
RI. IL-1 binds relatively weakly to IL-lRl affecting a conformational change that 
enables the binding of EL-1 RacP resulting in signal transduction (Fantuzzi, 2001). When 
IL-lRa (EL-1 receptor agonist), a naturally occuring cytokine binds to the IL-IR, signal 
induction is prevented because IL-1 can not bind to the cells (Dinarello, 2000b). IL-1 
activates NF-kB, MAPK and JNK signalling pathways. The cascade of events that leads 
to the activation of NF-kB and MAP kinases such as JNK, in turn leads to the activation 
of TNFa, IL-1 a and EL-12 (Dong, Davis & Flavell, 2002)
1.8.3 Proteins Induced by IL-1
IL-1 is expressed by many cells and has multiple functions including local 
inflammation. Cells known to express IL-1 are macrophages, lymphocytes, endothelial 
cells, fibroblasts and chondrocytes among others. Following the release of IL-1 into a
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local environment, IL-1 impacts a number of cells. Capillary endothelial cells secrete 
chemokines and upregulate the expression of vascular adhesion molecules, thus 
facilitating neutrophil, monocyte and lymphocyte infiltration into an area of early 
inflammation. IL-1 also induces expression of itself in newly arriving monocytes, thus 
reinforcing the overall process of local inflammation (Dinarello, 2000b).
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Figure 1.7 TNFa and IL-la production and signal transduction. Binding of TNFa/IL-la 
with their receptor result in the formation of receptor complexes containing important 
adaptor proteins. This in turn leads to the activation of the transcription factor NFkB. 
DNA binding motifs for NFkB are found in the protomers and enhancers of many genes 
that are known to be associated with inflammation. (Adapted from O’Neill, 2000)
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1.9 Scientific Objectives
It has been observed that pigs develop a more severe clinical disease than other 
species susceptible to FMDV infection. The host’s innate immune, inflammatory and 
antiviral responses to disease production will be investigated as the disease develops.
The main objective of this study is to define the host response of pigs infected 
with FMDV. In order to achieve this objective, analysis will be made of the induction of 
some antiviral cytokine mRNA, pro-inflammatory cytokine mRNA and TLR mRNA at 
different stages of infection.
A viral load study will be carried out, looking at various tissues at different time 
points in order to describe the progression of infection in the pig.
This will be followed by a study of clinical disease to assess the host response to 
infection during early and late disease.
Groups of pigs will be infected by inoculation or direct contact and can be 
compared in terms of the development of clinical disease, tissue viral load, viraemia and 
cytokine/TLR mRNA induction.
By understanding the nature of the host response, it is anticipated that the 
pathogenesis of FMDV in pigs can be better described.
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Chapter 2
MATERIALS AND METHODS
2. Materials and Methods
2.1 Virus Strains and Experimental Animals
2.1.1 Foot and Mouth Disease Virus Strains
The FMDV vims used as inoculum was derived from a suspension of vesicular 
epithelium collected on 20 Febmary 2001 from a pig with FMD at Brentwood Abattoir, 
Essex, UK during the 2001 FMD epidemic (Alexandersen and Donaldson, 2002; 
Alexandersen et al, 2002b; 2003a,b). The isolate was designated FMDV O UKG 
34/2001. The original vims suspension was passaged once in experimental pigs and the 
clarified homogenate from foot epithelial tissues from these animals constituted the 
stock inoculum that contained 10 ’^^  TCIDso/ml in BTY cells. The genomic sequence of 
another isolate from the same farm collected at the same time, designated FMDV O 
UKG 35/2001, was described previously (Mason et al, 2003).
2.1.2 Other Viruses
Vesicular Stomatitis Vims (VSV) strain NJ that was grown in BHK-21 cells was 
provided in 50% glycerol and was obtained from Nigel Ferris, World Reference 
Laboratory (WRL), lAH.
2.1.3 Animals
A total of 134 Landrace x Large White female pigs weighing between 20-30 kg 
were used in 5 separate experiments that aimed to produce FMDV infected animals at 
various stages of disease and at periodically defined time points. All the animals were 
from the Institute’s farm at Compton. The choice of animals for inoculation or those 
used as direct contact was random.
2.1.4 Inoculum Production
The experimental inoculum was prepared from a stock vims solution (see 2.1.1) 
which was diluted in maintenance medium so that 0.25 ml and 0.5 ml contained around 
10^  ^and 10^  ^TCID50, respectively.
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2.1.5 Foot pad Inoculation of Figs
Inoculations were done by intradermal and subcutaneous routes in the heel pads 
of the left forefoot as described previously (Alexandersen et al, 2002). Animals that 
presented with severe lesions were killed by euthanasia within a day of the observation 
of clinical signs. Only one run of an experiment was done at any one period as described 
in Section 2.6.
2.1.6 Observation of Clinical Signs
The pigs were monitored for clinical signs of disease and temperatures recorded 
daily for the first two weeks of the experiments. Clinical signs were noted and a score 
assigned to the individual signs as follows: lameness, 1; lesions on one foot, 1; lesions 
on two feet, 2; lesions on three feet, 3; lesions on four feet, 4; lesions on the tongue, 
mouth or snout, 1. A pig with lesions on any foot other than that in which the injection 
was made was taken to be lame as well. The addition of these scores represented the 
overall score and the higher it was the more severe the disease. A pig could therefore 
score a maximum of 6 points (Quan et al, 2004).
2.1.7 Blood Collection and Serum Preparation
Pigs were restrained on their backs on a cradle with the head extended. They 
were bled from the anterior vena cava with a needle attached to a vacutainer inserted 
into the left or right axillary depression in the direction of the opposite hip joint. After 
drawing blood the needle was discarded into a ‘Cinbin’ for later incineration and the 
outside of the tube containing the blood was disinfected by placing briefly in FAM 
(Evans Vanodine International, Preston, UK). The tubes were placed in a rack inside a 
double metal bin system for return to the laboratory.
In the laboratory the vacutainer tubes were disinfected by washing in FAM 
solution and rinsed with tap water. Blood was allowed to clot at RT for 1 hour and 
processed immediately or samples were stored at 4 ° C for no longer than 24 h if 
processing could not be done immediately. The tubes were centrifuged at 4 ° C and
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3,000 rpm for 10 min. In a Class II Biological Safety Cabinet serum was separated into 2 
labelled 2 ml microcentrifuge tubes for every sample. The tubes were disinfected with 
FAM, rinsed with water and stored at -70 ° C until required.
2.1.8 Euthanasia and Post Mortem Collection of Tissues
At the specified times or if clinical disease in a pig was judged to be severe, the 
animal was restrained using the standard procedure and humanely killed by injection of 
pentobarbitone (Euthatal; Merial Animal Health, Lyon, France) followed by 
exsanguination. The body cavity was opened and tissue samples were collected using a 
forceps, scissors and scalpel. A sterilised set of forceps, scissors and scalpel were used at 
the start of each day. When tissue samples from more than one animal were collected in 
one day, the instruments and plastic cutting board were washed in FAM and then rinsed 
in water between animals. A new scalpel blade was used for each animal.
The tissues were collected by dissecting the sample from the surrounding tissue 
or by removing the organ or a portion of the organ using blunt dissection or a scalpel 
blade. If needed, the tissue sample/organ was placed on the plastic cutting board, 
unwanted surrounding tissue removed and the sample cut to the correct size. Usually 
tissue samples of liver, spleen, cervical lymph node (CLN), mandibular lymph node 
(MLN), retropharyngeal lymph node (RPLN), soft palate, pharynx, tonsil, tongue, and 
foot coronary band epithelium were collected into 1.00 ml of RNAlater (Ambion, 
Huntingdon, UK), and stored at -80 ° C. Materials from visible lesions were taken 
preferentially where possible.
2.1.9 Extraction of mRNA from Tissue Samples
Approximately 0.02 gram of tissue dissected from each tissue sample was 
homogenized in 600 pi of lysis buffer (from Roche mRNA Tissue II Kit) in a tissue 
homogeniser (Fast Prep, Bio 101) for 3 x 40 seconds at maximum speed, and placed on 
iced between sessions. Then, 3(X) pi of the homogenate was added to 600 pi of capture 
buffer from a Roche mRNA Tissue II kit to make up the required 900 pi volume for the 
Roche MagNA Pure LC (Roche, Lewes, UK) - an automated robotic system, used to 
extract the tissue mRNA.
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2.2 Cell Culture
2.2.1 Maintenance of MDBK Cells
MDBK (Madin-Darby bovine kidney) cells were obtained from the Central 
Services Unit, lAH and maintained in 175 cm  ^ flasks at 37 ° C and passaged once a 
week at a split ratio of 1:10. Briefly, the growth medium from the flask was aseptically 
discarded and the cell layer was washed with a suitable volume of Ca/Mg free PBS that 
was then discarded. The cell layer was washed with about 2 ml of trypsin-versene 
solution (TVS) held at 35 ° C to 39 ° C and fresh 2 ml of TVS was added to the flask 
and held at 35 ° C to 39 ° C. After about 5 min, the flask could be gently tapped to 
remove the cell sheet. The cell sheet was suspended evenly by pipetting and 0.2 ml of 
the cell suspension was pipetted into a 175 cm^ flask with 25 ml of Glasgow Eagles 
medium with added 10% PCS (foetal calf serum) and returned to the incubator at 35 ° C 
to 39 ° C. The growth of the cells was monitored microscopically.
2.2.2 96-well Plate Culture of MDBK Cells
One 175 cm  ^flask of MDBKs was suspended as in 2.2.1 but using 4 ml of TVS. 
A 1 in 6 split of the cell suspension was carried out (= 0.66ml) and this was added to 10 
ml of Glasgow Eagle’s medium with added 10% PCS, the amount required for a 96-well 
plate. 0.1 ml of the cell suspension was pipetted into a 96-well plate (Falcon Primaria, 
Beckett Dickinson) and incubated overnight at 37 ° C in 5% CO2.
2.2.3 Propagation of VSV in MDBK Cells
Flasks of MDBK cells in MEM were infected with 1 ml of a 1:10 dilution of 
VSV stock in Glasgow Eagles medium with 10% PCS and incubated at 37 ° C for 1 
hour. The 25 ml Glasgow Eagles medium with 10% PCS was added into the flask and 
incubated at 37 ° C. Complete CPE was observed after 24 h and the virus was harvested 
after cell disruption by three successive cycles of freezing (at -70 ® C) and thawing (at 
37 ° C), the cellular debris was removed by centrifugation at 4000 g for 10 min and the 
supernatant was stored at -70 ° C in aliquots of 1 ml. This stock VSV suspension 
contained 1.15x10^ PFU/ml enumerated by plaque assays in MDBK cells.
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2.2.4 Plaque Assay of VSV in MDBK Cells
The virus concentration in the stock VSV suspension was estimated by plaque 
assay in MDBK cells. A 175 cm^ flask of MDBK cells was used to prepare the cell 
suspension. Cells were trypsinized and homogenised as described in 2.2.1 and 
resuspended in 20 ml of fresh warmed Glasgow Eagle’s medium with 10% PCS from 
which 3 ml of cell suspension was placed in each well of 6-well tissue culture plates. 
The plates were incubated at 37 ° C in 5% CO2 until they were almost confluent, usually 
overnight.
Serial 10-fold dilutions of stock VSV suspension (10'  ^ to 10' )^ were prepared in 
Glasgow Eagle’s medium with 10% PCS in final volumes of 2 ml. The medium from the 
6-well tissue culture plates was discarded and 200 pl/well of the relevant virus dilution 
was placed into each of five wells of the labelled plate, in one well of each plate 200 pi 
of growth media was used as a negative control. Thus each dilution was tested in 5 wells 
of separate 6-well plates. The virus was allowed to adsorb for about 1 h at 37 ° C and 
then the inoculum was discarded cells. The cells were covered with 3 ml of overlay 
medium (0.9 % Noble agar in Glasgow Eagle’s medium with 10% PCS at 40 ° C). When 
the agar was set the plates were covered with a vented lid and incubated inverted at 37 ° 
C in 5% CO2. Plaques were observed after 48 h and the cell layer was stained with 
methylene blue at 37 ° C by flooding the agar with 1 ml of staining solution (99.1 ml 
distilled water, 0.9 ml glacial acetic acid, 0.1 g methylene blue). The agar was then 
removed and the plaques counted microscopically. The average number of plaques per 
well was used in the calculation below to derive the concentration of the stock virus in 
plaque forming units (pfu) in 1 ml.
Number of pfu/ml = Mean no. of plaques x login value of resultant dilution
Volume of inoculum
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2.2.5 Propagation of FMDV in BTY Cells
This procedure was done in a Class II Biological Safety Cabinet. FMDV was 
propagated in Leighton tubes containing monolayers of BTY (Primary bovine thyroid) 
cells seeded at 2 x lO^cells/ml (obtained from WRL, lAH). Cell monolayer(s) to be 
infected were washed with sterile PBS, pre-warmed to 37 ° C. Cell culture(s) were then 
inoculated with 0.2 ml. of sample per 2.0 ml of medium per Leighton tube taking care 
not to disrupt the monolayer. The outside of tubes were washed in a disinfecting solution 
and incubated stationary at 37 ° C, for 30 to 60 minutes. Cell monolayers were then 
washed three times with sterile pre-warmed PBS and 2ml of Maintenance Medium was 
added to infected cell monolayers. The outside of tubes were rinsed in disinfecting 
solution then incubated at 37 ° C, in a rotating drum, for 3 days. The inoculated cultures 
could be read daily for the presence of cytopathic effect.
2.3 Serum Tests
2.3.1 Interferon Bioassay
This test was done in a Class II Biological Safety Cabinet. The serum samples 
were thawed and an aliquot of each sample was acid treated to destroy INF y. Briefly, a 
separate 2 ml Sarstedt tube with 1 pi of phenol red was used for each sample, and 3(X) pi 
of serum was added and mixed in a vortex mixer. Then 30 pi of 5M HCl was added to 
each sample and mixed and then incubated at RT for 1 h. At this stage samples were 
yellow in colour. They were then diluted 1:2 with Advanced DMEM (Gibco, USA) and 
20 pi 5M NaOH was added to each sample and mixed gently by flicking. The colour 
change was noted and the sample was adjusted to neutral by the addition of HCl or 
NaOH, 1 pi at a time, until the solution was a pale pink colour. With phenol red a dark 
pink/purple indicated a basic solution while yellow was acidic. All samples were mixed 
thoroughly to ensure that they remained neutral after addition of HCL and NaOH.
Serial 2-fold dilutions were made of every treated sample in Advanced DMEM 
(Gibco, USA), (125 pi volumes were used), in duplicate in a separate 96-well tissues 
culture carrier plate. Thus the starting sample dilution was 1:4. Similarly, the interferon
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standard was also diluted, starting with 32 units. The top and bottom rows of the plate 
were not used and each plate held 3 serum samples and the control samples in duplicate.
A corresponding plate with 90-95% confluent MDBK cells was prepared for 
every carrier plate. From every well of the carrier plate 100 pi of diluted serum or 
control was transferred to the corresponding well on the MDBK plate using a multi­
channel pipette. The plate was incubated for 6 hours at 37 ° C and 5% CO2.
About 5 ml of viral suspension containing 3000 pfu/50 pi was made from stock 
VSV. It was warmed to 37 ° C before 50 pi was added to each well of the plates with 
MDBK cells that also contained sample and standards. A separate control plate without 
virus was also included. The plates were sealed with clear plastic seals and incubated for 
16 h at 37 ° C with 5% CO2. The extent of cytopathic effect in each well was noted and 
scored as a percentage. One unit of IFNa protected approximately 50% of MDBK cells, 
so an end point activity was described as the reciprocal of the dilution that reduced the 
number of VSV infected cells to 50% compared to untreated MDBK cultures. 
Recombinant porcine IFNa was used as a positive control (Green et al., 1976)
2.4 Peripheral Blood Mononuclear Cells (PBMC)
2.4.1 Isolation and Enumeration of PBMC
A Beckman Coulter Allegra 6R centrifuge and Histopaque-1077 were used to 
isolate PBMCs unless otherwise stated. A vacutainer tube containing approximately 10 
ml of blood was centrifuged for 10 min at 4 ° C and 1800 rpm. The huffy coat 
(approximately 1 ml) was carefully removed from the interface between the plasma and 
red blood cells. This was suspended in 3 ml of calcium/magnesium free phosphate 
buffered saline in a 30 ml universal container (Steiilin 30 ml Universal Container, 
128A). The resulting 4 ml huffy coat suspension was carefully under laid with 4 ml of 
Histopaque-1077. This was done by using a 10 ml Pasteur pipette to place the 
Histopaque-1077 (a solution of polysucrose and sodium diatrizoate adjusted to a density 
of 1.077+/-0.001 g/ml; polysucrose 5.7 g/dl, and sodium diatrizoate 9.0 g/dl) underneath 
the PBMC suspension. Next the suspension was centrifuged at room temperature for 
exactly 30 min. After centrifugation, the upper layer was carefully aspirated and
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discarded with a Pasteur pipette to within 0.5 cm of the opaque interface containing the 
PBMC. The opaque layer was carefully transferred to a new universal container 
containing 5 ml calcium/magnesium free PBS and mixed by gentle aspiration. The 
PBMC were then centrifuged at room temperature and 2000 rpm for 10 min. 
Immediately after centrifugation, the supernatant was decanted and the PBMC (-1x10^ 
cells) were resuspended in 400 pi of calcium/magnesium free PBS. PBMC were counted 
using a cell counting chamber (ARH, Laboratory and Clinical Supplies) and the 
following formula was used to calculate the number of cells/pl suspension:
Number of cells counted 
(area used in mm)^ x (chamber depth in mm) x (dilution)
2.4.2 Stimulation of PBMC
Isolated, washed and counted PBMC (see 2.4.1) were stimulated and the RNA 
extracted from these cells was used to validate the RT-PCR assays. Briefly, 1x10  ^cells 
were added to each well of a 6-well tissues culture plate (Multiwell, Falcon) that had 1 
ml of RPMI (with HEPES) medium with fungizone and penicillin/streptomycin, 10% 
foetal bovine serum and 5 pg/ml lectin from Phaseolus vulgaris, the red kidney bean, 
and mixed by gentle aspiration. One of the wells on the plate contained media only, in 
order to provide a negative control. The cells in each well were harvested after a given 
period of exposure by aspirating the contents of each of the wells into a 1.5 ml 
microtube followed by centrifugation at 13000 rpm for 2 min (Heraeus Biofuge Pico). 
The supernatant was discarded. One ml of lysis buffer (Roche mRNA HS kit) was added 
to the cell culture well to remove any remaining cells and then transferred to the 1.5 ml 
microtube containing the cell pellet and an additional 200 pi of lysis buffer was added to 
give a final volume of 1.2 ml (the volume required for Roche mRNA HS extraction kit). 
Finally, the cells in lysis buffer were vortex mixed and stored at -80 ° C.
2.4.3 Extraction of mRNA from PBMC
An aliquot of 120 pi of PBMC, which was equivalent to 3x10^ cells, was added 
to 1.68 ml of lysis buffer (from Roche mRNA HS kit) to a final volume of 1.8 ml as 
suggested by the manufacturer. An aliquot of 600 pi from the above 1.8 ml suspension
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of PBMC in lysis buffer contained 1x10  ^cells -  the quantity of cells required for mRNA 
extraction. The suspensions were vortex mixed and stored at -80 ° C until required.
An automated robotic system (Roche MagNA Pure LC) was utilized for the 
extraction of mRNA from porcine PBMC. The mRNA HS (high sensitivity) kit was 
selected for the mRNA extractions described in this report. This kit has advantages over 
pure RNA extraction kits because it is capable of extracting mRNA from a higher 
number of cells (10  ^rather than 10  ^cells) and is also mRNA specific, reducing the level 
of background nucleic acid in the samples.
2.5 Generation of Cytokine, TLR and GAPDH Standard RNA
2.5.1 Reverse Transcription of mRNA
The TaqMan RT kit (Applied Biosystems) was used to reverse transcribe all 
RNAs described in this report. The lOx buffer, dNTP mix, 25 mM MgCh, and random 
hexamers were thawed fully. Before use, the solutions were mixed fully to avoid 
localized salt concentrations. (The kit dNTPs were ahquoted into 200 pi portions to 
reduce freezing and thawing). A master mix of reagents was prepared for the appropriate 
number of reactions required by multiplication of the proportions described below 
(given for 1 reaction):
lOx TaqMan RT buffer (500 mM K Cl, 100 mM Tris-HCl, pH 8.3): 1.50 pi
25 mM MgClz: 3.30 pi
dNTP solution (2.5 mM each, with dTTP): 3.00 pi
50 pM random hexamers: 0.75 pi
RNase inhibitor (20 U/pl): 0.30 pi
Multi scribe reverse transcriptase (lOOU/pl Moloney RT): 0.25 pi
The RT master mix was mixed thoroughly and could be kept on ice for up to 2 h. 
Nine pi of RT master mix was then placed into each of the appropriate number of wells 
of a 96-well PCR plate (Thermo-Fast 96, Non-Skirted, AB Gene). Finally, negative 
control wells were included by using master mix containing Nuclease Free Water
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(Promega) instead of reverse transcriptase. A volume of 6 pi of RNA was added to each 
well giving a final volume of 15 pi. The plate was centrifuged at 1000 rpm for 1 min 
(Sorvall RC3C Plus) and incubated in a thermal cycler with a heated lid at 48 ° C for 45
minutes and 95 ° C for 5 minutes (Techne Touchgene Gradient). The resulting cDNA
was stored at -20 ° C.
2.5.2 Conventional PCR
The HotstarTaq Master Mix Kit (Qiagen) was used for conventional PCR. Each 
reaction consisted of:
HotstarTaq Master Mix 12.5 pi
Forward primer (lOpmol): 0.50 pi
Reverse primer (lOpmol): 0.50 pi
Distilled water: 9.00 pi
cDNA: 2.50 pi
Negative controls were included by adding distilled water instead of cDNA in 
one or more tubes. A thermal cycler with a heated lid (Techne) was used with the 
following programme: 95 ° C for 15 min, followed by 35 3-step cycles of 95 ° C for 55 
sec, 56 ° C for 55 sec and 72 ° C for 90 sec, and a final a 10 min extension at 72 ° C. 
PCR products were stored overnight at 2-8 ° C or -20 ° C for longer term storage.
2.5.3 Purification of PCR products
The QIAquick Nucleotide Removal Kit designed for general cleanup of DNA up 
to 10 kb in size from enzymatic reactions was used to purify PCR products (GAPDH, 
cytokine and TLR). For example, 500 pi of PN buffer (containing sodium perchlorate 
and isopropanol) was added to a 50 pi reaction sample. This buffer promotes the 
adsorption of the small cDNA fragments to the QIAquick silica-gel membrane. A 
QIAquick column was assembled into a collection tube, the sample and PN buffer mix 
were applied to the QIAquick column and centrifuged for 1 min at 6000 rpm. The flow­
through that contained unwanted primers and impurities was discarded and the column
54
was placed back into the collection tube. The column was washed through with 500 pi 
of PE buffer (containing ethanol) by centrifugation for 1 min at 6000 rpm. The flow­
through was discarded and the column was again replaced into the same collection tube 
and centrifuged for 1 min at 13000 rpm. The QIAquick column was then placed in a 
clean 1.5 ml microcentrifuge tube and 40 pi of buffer EB (10 mM Tris-Cl, pH 8.5) was 
placed directly onto the centre of the membrane. The column was allowed to stand for 1 
min and then centrifuged at 13000 rpm for 1 min in order to elute the DNA. Purified 
PCR products were checked by electrophoresis in a 1.5 % agarose gel to ensure that 
purification had been successful.
2.5.4 Poly A Tailing of Purified PCR Products
The cytokine PCR products were modified using an A-tailing procedure in order 
to facilitate their ligation into pGEM-T Easy vectors. Each poly-A-tailing reaction 
contained 7 pi of each cytokine PCR product, 1 pi (5U) of Taq DNA polymerase, 1 pi of 
10 X reaction buffer with MgCE (Qiagen PCR buffer), 1 pi of 2 mM dATP (generated 
by adding 1 pi stock [100 mM] to 49 pi H%0) in a final reaction volume of 10 pi. The 
reaction was then incubated at 60 °C for 30 min (using Techne Touchgene Gradient).
2.5.5 Ligation and Transformation of PCR Products
The ligation reactions were prepared as described bellow:
2x Rapid ligation buffer: 5.00 pi
pGEM®-T or pGEM®-T Easy vector (50 ng): 1.00 pi
A-tailed PCR product (or 2 pi positive control insert DNA): 3.00 pi
T4 DNA ligase (3 Weiss units/pl): 1.00 pi
The reactions were mixed by aspirating gently and incubated overnight at 4 ° C.
A positive control was included by using the control insert DNA provided with the kit 
instead of PCR product.
Transformations were carried out according to the Promega pGEM-T/Easy 
protocol. Petri dishes with LB agar supplemented with ampicillin/IPTG/X-gal that allow
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selection of transformed bacteria were prepared as follows. Molten LB agar, 500 ml, 
was held at 50 ° C before the addition of ampicillin to a final concentration of 100 pg/ml 
(500 pi of 50 mg/ml stock). Plates with 30-35 ml of agar were supplemented with 100 pi 
of 100 mM IPTG (isopropyl-beta-D-thiogalactopyranoside, filtered using 0.2 pm filter 
and syringe to remove bacteria), and 20 pi of 50mg/ml X-Gal by spreading over the 
surface of the agar. [Transformed bacteria can grow in the presence of ampicillin 
because they express the Amp*^  gene of the plasmid. IPTG induces the LacZ gene whose 
product is beta-galactosidase. X-Gal is a substrate of beta-galactosidase and will change 
colonies to a blue colour in the absence of an insert. The LacZ gene is interrupted in the 
presence of an insert and will result in white colonies].
Tubes containing ligation reactions (see above) were centrifuged for 10 seconds at 
13000 rpm and 2 pi of each ligation reaction was placed into sterile polystyrene culture 
tubes (Simport) on ice. Frozen JM109 High Efficiency Competent Cells were removed 
from -70 ° C storage and placed in an ice bath until just thawed. These were mixed 
gently and 50 pi of cell suspension were carefully transferred into each sterile 
polystyrene tube and mixed by gentle aspiration. The tubes were left on ice for 20 min 
and then heat shocked for 50 sec in a water bath at exactly 42 ° C; care was taken not to 
shake the cells. Immediately after heat shocking, the tubes were returned to ice for 2 min 
and then 950 pi of LB broth (at room temperature) supplemented with 2 M glucose 
(1 ml 2M glucose per 100 ml LB broth) was added to them. Next, they were incubated at 
37 ° C for 90 min with shaking (Inceltech LH Series F200) and 100 pi of each 
transformation culture was spread onto duplicate LB/ampicillin/IPTG/X-Gal plates that 
had been equilibrated to room temperature. These were then incubated overnight at 37° 
C. Individual white colonies on the LB/ampicillin/IPTG/X-Gal plates were selected and 
subcultured in 5ml LB broth supplemented with 100 pl/ml Ampicillin for 24 hours in a 
37 ° C shaking incubator.
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2.5.6 Plasmid Purification
The Wizard Plus Minipreps DNA Purification System (Promega) was used for 
plasmid purifications, which were carried out according to the manufacturer’s 
instructions.
2.5.7 Verifietion of Insert: Restriction Enzyme Analysis and Sequencing
The IFNp and ILla, fragments were inserted into pGEM-T vectors. The IFNa, 
IFNy, TNFa, TLR3, TLR4 and GAPDH fragments were inserted into pGEM-T Easy 
vectors. Unless otherwise stated, the restriction enzyme EcoRl was used to digest the 
pGEM-T Easy vectors, while the restriction enzymes Apal and Pst\ were used to digest 
the pGEM-T vectors.
Restriction enzyme analysis (REA) was performed according to the following 
methods. For each digestion reaction for pGEM-T Easy the components were:
dHaO (Promega): 16.3 pi
Buffer H (Promega): 2.00 pi
EcoR 1 (Promega, 12 U/pl): 0.50 pi
BSA (Promega): 0.20 pi
DNA: 1.00 pi
The mix was incubated for one hour at 37 ° C followed by 5 min at 70 ° C to inactivate 
the enzyme. The digestion products were separated by electrophoresis on a 1.5 % 
agarose gel to check for the correct band size. EcdRl added 16 base pairs to the insert, 
so this was taken into account when estimating band sizes.
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For each digestion reaction for pGEM-T the components were:
dBbO (Promega): 16.3 pi
Buffer 4 (Promega): 2.00 pi
Apa\ (Promega, lOU/pl): 0.50 pi
Pstl (Promega, lOU/pl): 1.00 pi
BSA (Promega): 0.20 pi
The reaction mix for each sample initially included Apal alone and was incubated for 
1 h at 25 ° C. Then, 1 pi Pstl was added to each sample and incubated for a further 1 h 
at 37 ° C followed by 5 min at 70 ° C. Finally the products were analysed by 
electrophoresis on a 1.5 % agarose gel. Digestion with Apal and Pstl left 60 base pairs 
with the insert, so this was taken into account when looking at fragment band sizes.
Sequencing was performed with the f-mol DNA cycle sequencing system 
(Promega) and an ALFexpress H sequencing machine (Pharmacia) for inserts of IFNp, 
ILla, IFNa, IFNy, and TNFa. TLR3 and TLR4 inserts were verified by cycle 
sequencing with Dye Terminator Cycle Sequencing (DTCS) with Quick Start Kit and an 
automated CEQ™ 8000 sequencer (Beckman Coulter).
For the f-mol kit the master mix for each sample was prepared as follows and 
stored in the dark:
Purified Template DNA: 3.00 pi
5x sequencing buffer: 4.00 pi
Cy5-labelled primer pUC/M13 10 pmol/pl (not with kit): 2.00 pi
Sequencing grade Taq polymerase (5 U/pl): 1.00 pi
DEPC-H2O: 11.0 pi
Four wells in a 96-well plate were prepared for each sample to be sequenced, 
labelled in the order A C G T and 2 pi of d/ddNTP nucleotide mixes (Deaza) were added 
into each well. The plate was centrifuged briefly and stored at 4 ° C until ready to use
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when 4 pi of master mix was added to each A C G T well. The plate was centrifuged at 
1000 rpm (Sorvall RC3C Plus) and a drop of mineral oil was added to each sample well. 
The plate was incubated using the following thermal cycling conditions; 1 cycle of 94° 
C for 2 min, 30 cycles of 92 ° C for 1 min, 55 ° C for 1 min, 72 ° C for 90 sec (Techne 
Touchgene Gradient). Finally, 4 pi of Cyc5 stop solution (0.05g dextran blue in 10 ml 
deionized formamide) was added to each well and incubated at 90 ° C for 2 min before 
10 pi of each A C G T sample was then loaded into the corresponding well of the 
sequencing gel.
The ALFexpress II was prepared according to the manufacturers instructions. 
The polyacrylamide gel was prepared from Reprogel (Amersham Pharmacia Biotech 
AB), applied to the plates by capillary action and polymerized under the Reproset UV- 
box for 15 minutes. The plates were then inserted into the ALFexpress II, the troughs 
were filled with 0.5X TBE, and the laser transmittance was checked to ensure a level 
greater than 90 %. The gel temperature was allowed to reach 50 ° C and then 10 pi of 
each sample was added to separate wells and electrophoresis was performed overnight 
(900 minutes). Sequences were analysed with Omiga 2.0 GCG Link 1 (Oxford Molecular 
Ltd).
For the (DTCS) with Quick Start Kit the master mix for each sample was 
prepared on ice as follows:
dH20 (to adjust total volume to 20 pi): 0 to 9.5 pi
DNA template: 0.5 to 10.0 pi
DNA sequencing primer (1.6 pmol/ pi): 2.0 pi
DTCS Quick Start Master Mix: 8.0 pi
Thermal cycling conditions were 96 ° C for 20 sec, 50 ° C for 20 sec, 60 ° C for
4 min for 30 cycles and held at 4 ° C thereafter. Sequencing products of each tube was 
precipitated in an individual 1.5ml microtube by the addition of 4 pi of Stop Solution 
(1.5 M sodium acetate, 50 mM EDTA prepared fresh daily by mixing equal volumes of 
the 3 M sodium acetate, pH 5.2 and 100 mM EDTA) and 1 pi of Pellet Paint NF co- 
precipitant. Then 60 pi of cold 95% (v/v) ethanol/dH20 at -30 ° C to -5 ° C was added
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to it and mixed thoroughly and centrifuged immediately at 13,000 g at 4 ° C for 15 min. 
The supernatant was carefully removed with a micropipette (the pellet should be 
visible). The pellet was rinse twice with 200 pi of 70% (v/v) ethanol/dHiO at -20 ° C at
13,000 g at +4 ° C for 5 min and dried in air for at least 40 min. It was resuspended in 
40 pi of the Sample Loading Solution, transferred to a well in the 96-well CEQ sample 
plate and overlaid with a drop of mineral oil.
Sequencing was carried out automatically in capillaries in a CEQ 8000 sequencer 
according to the manufacturer’s instructions (Beckman Coulter). Sequences were 
analysed with the LaserGene suite of programmes (DNAStar, USA).
2.5.8 In Vitro RNA Transcription from Plasmid DNA
All cytokine plasmids were linearised using the restriction enzymes Sail or Ncol 
(Promega). The restriction enzyme was chosen on the basis of which plasmid promoter 
would be used to initiate in vitro RNA transcription. This in turn was determined by the 
direction of the insert. For inserts in the 5’ to 3’ direction, the Sp6 promoter was utilized 
and Ncol was used to linearise the plasmid. For inserts in the 3’ to 5’ direction, the T7 
promoter was utilized and Sail was used to linearise the plasmid.
Two reactions for each insert were performed. One reaction was as follows:
dH20 6.30 pi
lOx Buffer D 2.00 pi
Acetylated BSA (10 pg/pl) 0.20 pi
Sail (10 U/pl) or Ncol (10 U/pl) 0.50 pi
Plasmid DNA 10.0 pi
The reagents were mixed together gently by pipetting and then incubated for 2 h 
at 37 ° C. these reactions were pooled giving a 40 pi volume and 60 pi of dFLO was 
added to give a final volume of 100 pi.
After the addition of 0.5 pi of blue glycogen an equal volume (100 pi) of Phenol: 
Chloroform: Isoamyl Alcohol 25:24:1 (Sigma, saturated with 10 mM Tris, pH 8.0,
60
1 mM EDTA) was mixed with the DNA solution in a 1.5 ml microcentrifuge tube. This 
solution was emulsified then centrifuged for 2 min at 13000 rpm (Biofuge). The aqueous 
(upper) phase was transferred to a new tube and the interface and organic (lower) phase 
were discarded. These steps were repeated until no protein was visible at the interface. 
Then, 1 volume of chloroform isoamyl alcohol was added to the aqueous phase mixed 
for 1 min and then centrifugation for 2 min at 13000 rpm to remove any residual phenol. 
The upper phase was transferred into a new tube and the DNA was precipitated by the 
addition of half volume (about 50 pi) of 7.5 M ammonium acetate (Sigma), and 2 
volumes (about 200 pi) of 100 % ethanol and placed at -70 ° C overnight. The solution 
was allowed to thaw and the DNA was collected by centrifugation for 30 min at 13000 
rpm. The supernatant was discarded, the pellet was carefully washed with 70% ethanol 
and the pellet was allowed to dry for 3 min. The pellet was suspended in 6 pi of 
nuclease-free H2O and linearization was checked by electorphoreseis on a 2.0% agarose 
gel. DNA was stored at -20 ° C.
RNA transcription was carried out using the Riboprobe Combination Systems -  
SP6/T7 RNA polymerase (Promega). This kit is designed for in vitro preparation of 
microgram quantities of defined RNA transcripts from cloned DNA inserts.
Each transcripton reaction consisted of the following that were added in the order
listed:
Transcription Optimized 5x Buffer 10.0 pi
lOOmM DTT 5.00 pi
Recombinant RNasin Ribonuclease Inhibitor (100 U) 1.25 pi
rATP, rGTP, rCTP, rUTP (mix 2.5 pi each to give 10 pi) 10.0 pi
Linearized template DNA 4.00 pi
T7 or SP6 RNA polymerase (50 U) 3.25 pi
Nuclease-free water 16.5 pi
The reaction was incubated for 2 h at 37 ° C (Techne Touchgene Gradient). The 
DNA template was then removed by digestion with 2 pi of RQl RNase free DNase 1 at
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37 ° c  for 1 h and complete plasmid digestion was checked by electrophoresis of a 2 pi 
sample of the reaction mixture. An untreated negative control was included. Transcribed 
RNA was precipitated by the addition of a 0.5 volume of 7.5 M ammonium acetate to 
the 50 pi reaction, mix thoroughly, and 3 volumes of 100 % ethanol (RNase free) was 
added and the solution was stored at -70 ° C overnight. The next day, the RNA was 
removed from -70 ° C storage and peleted by centrifugation at 4 ° C for 30 min at 13000 
rpm (Heraues Biofuge Fresco). Next, the supernatant was carefully aspirated off. Then 1 
ml 70% ethanol (RNase free) was added and the solution was inverted to wash the 
pellet. This step was repeated 2 or 3 times. As much ethanol as possible was removed 
without losing the pellet, then it was allowed to dry on ice until all of the ethanol had 
evaporated, about 5 min. Next, the pellet was dissolved in 20 pi of nuclease-free H2O. If 
the pellet was very small, a smaller volume of H2O, such as 10 pi, was used. The 
concentration of the RNA could then be determined.
2.5.9 Determination of Copy Number of Standard RNA
Spectrophotometery was used to measure the amount of RNA produced by in 
vitro RNA transcription. Depending on the quantity of sample and how concentrated it 
was, a dilution (usually 1:20) in 20 pi or 20 pi of the sample was placed in a microquartz 
capillary tube (Jenway) avoiding air bubbles. The tube was inserted into the sample 
holding chamber of the spectrophotometer. The OD260 reading obtained was then used to 
calculate the copy numbers per ml of standard RNA. First the approximate molecular 
weight of the ssRNA was determined using the following formula:
Molecular weight (MW) of ssRNA = (number of nucleotides x 320.5) + 159.0 
The mass weight was calculated next using the following formula:
RNA mass weight (g/ml) = (40x10“^ ) x OD260 x Dilution Factor
These two values were then used to determine the copies per ml of standard RNA as 
follows:
Copies/ml = 1(6.023x10^^) x (RNA mass weight)]
MW of ssRNA)
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2.5.10 Real Time Quantitative RT-PCR Analysis
A GeneAmp 5700 Sequence Detection System (SDS) (Applied Biosystems) was 
used for all quantitative RT-PCR analysis described in this report. This instrument 
incorporates a PCR-based assay with laser scanning technology to excite fluorescent 
dyes present in the specially designed TaqMan probes. The system includes a built-in 
thermal cycler, a laser to induce fluorescence, CCD (charge-coupled device) detector, 
and real-time sequence detection software. The nonextendable TaqMan probe (20-30 
bp), is dual-labelled with a reporter dye FAM (6-carboxyfluorescein) at one end and a 
quencher dye TAMRA (6-carboxytetramethylrhodamine) at the other. As long as the 
probe is intact, fluorescence resonance energy transfer (FRET) occurs where the 
fluorescence emitted by the reporter dye is absorbed by the quencher dye. During 
amplification the TaqMan probe is degraded due to the 5' to 3' exonuclease activity of 
Taq DNA polymerase, thereby separating the quencher from the reporter during 
extension, which results in an increase of reporter dye fluorescence. An increase of 
fluorescence intensity of the reporter dye is only achieved when probe hybridization and 
amplification of the target sequence has occurred, so the TaqMan assay offers a sensitive 
method to determine the presence or absence of specific sequences. During the entire 
amphfication process this light emission increases exponentially, and this increase is 
registered by the sequence detector in “real time”. Subsequent computations calculate a 
ARn using the following equation: ARn = Rn^ -Rn", where Rn^ is the fluorescence 
emission at each time point and Rn is the fluorescence emission of the baseline. So this 
equation describes the degradation of the probe during the PCR process. Amplification 
plots are constructed by the software plotting the ARn values against the cycle number. 
A threshold of ARn 0.1 was used for all experiments described in this report. Threshold 
cycle values (Ct values) are then calculated from the point at which fluorescence exceeds 
the chosen threshold ARn. Therefore, as the amount target sequence increases, Ct values 
decrease linearly providing a method of quantitatively measuring the target.
Primers and probes (see Table 1) for all cytokine target sequences were designed 
using the computer program Primer Express, a software program provided with the 
GeneAmp 5700. Where possible, special care was taken to prevent coamplification of 
genomic DNA when designing primers. Primer sequences for IFN gamma and TNF
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alpha were located on intron-exon junctions. Primers were designed as close as possible, 
keeping expected amphfication product lengths to less than 100 bp.
One 25|xl TaqMan reaction contained:
Forward primer (10 pmol/pl): 2.25 pi
Reverse primer (10 pmol/pl): 2.25 pi
Probe (5 pmol/pl): 1.00 pi
2x TaqMan Universal PCR master mix: 12.5 pi
dIÎ20: 6.00 pi
cDNA: 1.00 pi
The TaqMan Universal PCR master mix contains AmpliTaq Gold DNA 
polymerase, which has 5’-3’ exonuclease activity and AmpErase, uracil-N-glycosylase 
(UNG), which cleaves amplified PCR products at sites where uracil was previously 
incorporated, thus minimizing carryover and false positive results. Sufficient master mix 
was made for 80 reactions and 24 pi of master mix was placed into 72 wells (64 for test 
samples and 8 for standards) of a MicroAmp optical 96 well reaction plate (Applied 
Biosystems) avoiding air bubbles. Next Ipl cDNA was carefully added to each well and 
the wells were sealed with optical caps (Applied Biosystems). Finally, the plate was 
centrifuged for 1 min at 3000 g to collect the reactions at the bottom of the wells and 
placed into the instrument. The thermal cychng profile was: 2 min at 50 ° C (UNG 
digest) then 10 minutes at 95 ° C (dénaturation and heat activation of TaqGold) followed 
by 50 cycles of a two-step cycle 95 ° C for 15 sec and 60 ° C for 60 sec.
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Target Gene®
IRESofFMDV
typeO
INFy
INFa
INFp
TNFa
TLR3
TLR4
GAPDH
Primer
Function
Forward
Reverse
Probe*’
Forward
Reverse
Probe
Forward
Reverse
Probe
Forward
Reverse
Probe
Forward
Reverse
Probe
Forward
Reverse
Probe
Forward
Reverse
Probe
Forward
Reverse
Probe
Forward
Reverse
Probe
Sequence (5’-3’)
CACYTYAAGRTGACAYTGRTACTGGTAC
CAGATYCCRAGTGWCICITGTTA
CCTCGGGGTACCTGAAGGGCATCC
AGCAAGACATGTTTCAGAGGTTCCT
GCGCTGGATCTGCAGATTATCTA
CGAAGTCATTCAGTTTCCCAGAGCTACCATT
GCCTCCTGCACCAGTTCTACA
TGCATGACACAGGCTTCCAG
TCCCTGAGCTGCTGATCCAGTCCA
GCGTGGAATGAAACCGTCATT
CCAGGATTGTCTCCAGGTCATC
TCTGCCCATCAAGTTCCACAAGGATAGTCT
GCTATGAGCCACTTCCTGGG
AATCTTCCCGTTGGCTGCT
CTCTAAGACATCCAGGCTAAACTTCAAGGACAGTGT
GGCCCCCAGAAGGAAGAGT
TGAGTCCTTGGGCCAGAGG
CCAGCTGGCCCCTTGAGCATCA
TGA ACC ATG CAC TCT GTT TGC
GGC ATT TAT CCG TTG MTT CTG A 
TGTTTAAATCTCATTGCATCTTGAACTGGCCA
CTC TGC CTT CAC TAC AGA GAC TT 
CCT TCC GAC TTT TGT GGA A 
TGGCCATTCGCTGCCAACATCA
TGGGCATGAACCATGAGAAGT
GGCATGGACTGTGGTCATGAG
TGACAACAGCCTCAAGAT
Reference
Reid et al, 2002
Alexandersen,
personal
communication
Alexandersen,
personal
communication
Alexandersen,
personal
communication
Alexandersen,
personal
communication
Alexandersen,
personal
communication
This study 
(Appendix A l)
This study 
(Appendix A l)
Alexandersen, 
personal 
communication
INF, interferon; IL, interleukin; TNF, tumor necrosis factor; TLR, toll-like receptor.
TaqMan Probe dual-labeled with FAM and TAMRA.
Table 2.1 Primer and Probe Sequences for FMDV, Porcine Cytokines, toll-like receptors and 
GAPDH
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2.6 Experimental Infection of Pigs
2.6.1 Biologically Secure Animal Accommodation
The experiments were conducted in the same biologically secure isolation 
building; ISO 7B, where the animals were housed in one of five separately serviced 
rooms each with dedicated biologically secure (HEPA) air handling facilities. Some 
rooms were also partitioned with temporary walls of about 1 metre to provide cubicles 
as indicated (see Figure 2.1). Access to these rooms were from a ‘clean’ corridor 
through double doors interrupted by a shower cubicle and serial access from one box to 
another was only permitted after disinfection with FAM, followed by a shower and 
through the Clean Corridor (see Figure 2.1). Therefore, there was no cross­
contamination from one room to another. All the boxes were also connected on the other 
side by a Dirty Corridor that was used for post-mortem examinations and waste disposal.
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2.6.2 Experiment 1: MIN 17
The main objectives of this experiment were to investigate and compare the role 
of cytokines in pigs infected by inoculation or contact when they had severe signs of 
FMD and to study FMDV transmission from infected to in contact pigs.
Twenty female Landrace x Large White pigs, weighing between 20-30 kg body 
weights were used. Four pigs (UU98, UU99, UVOO, UVOl) were placed in Room 5 of 
ISO 7B. Groups of four pigs (UU82 -  UU97) were placed in each of Room 4-1 (with 2 
pigs in each cubicle (see Figure 2.2). The four donor pigs in Room 5 were inoculated in 
the morning of day 0 by heel pad inoculation (subcutaneous/ intradermal inoculation on 
the left fore heel bulbs) with 0.5 ml FMDV inoculum (i.e. around 10^  ^  per animal). The 
direct contact pigs were infected by being allowed to mix freely as a group with the 
inoculated pigs for a period of 2 hours. At dayl p. i. the 4 inoculated pigs from Room 5 
were transferred to Room 4 for 2 hours and then moved back. At day 2 p. i. the 4 pigs 
from Room 5 were transferred to Room 3 for 2 hours as described above. At 3 days after 
inoculation, the 4 pigs from Room 5 were transferred to Room 2 for 2 hours as described 
above. At 4 days after inoculation, the 4 pigs from Room 5 were transferred to Room 1 
for 2 hours as described above.
The progression of disease was recorded in the inoculated and direct contact pigs 
as were the clinical signs, and body temperatures. Relevant samples (blood; with and 
without heparin) and nasal swabs, (one in maintenance medium and one in Trizol) were 
taken every day. Pigs were selected and killed when showing either early or severe signs 
of FMD and tissues collected in RNAlater, formalin, ETOH/acetic acid and frozen 
above dry ice for subsequent analysis. Remaining pigs not showing severe FMD were 
killed no later than 28 days after virus inoculation or exposure.
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Figure 2.2 Design Schematic of Experiment 1. Four pigs were placed in Room 5 of ISO 
7B. Groups of four pigs were placed in each of Rooms 4-1. The four donor pigs in Room 5 
were inoculated in the morning of day 0. The direct contact pigs were infected by being 
allowed to mix freely as a group with the inoculated pigs for a period of 2 hours. At dayl 
p. i. the 4 inoculated pigs from Room 5 were transferred to Room 4 for 2 hours and then 
moved back. This was repeated up to day 4 p. i.
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2.6.3 Experiment 2: MIN 18
The main objectives of this experiment were to determine and compare the 
pathogenesis of FMDV, strain O UKG 34/2001 in pigs infected by inoculation or by 
contact and to study virus transmission from infected to in-contact pigs when kept one- 
on-one or in a group.
Twenty two Landrace x Large White pigs, female only and between 20-30 kg 
body weights were used in this experiment. Two control pigs (UW35, UW36) were 
killed to provide control samples the week before the experiment started. Four pigs 
(UW27 -  UW30) were placed in Room 5 of ISO 7B to be used as donors to infect 
contact pigs in a one-to-one set up (i.e. one inoculated and one contact pig together) (See 
Figure 2.3). Groups of three pigs were placed in each of Rooms 4-1 (UW37 -  UW48) 
with 1 pig in each cubicle and 1 pig in the space adjacent to the cubicles, i.e. 3 pigs in 
each room but separated by the wooden panels. Four pigs (UW27-UW30) in Room 5 
were inoculated heel pad (s/c + i/d inoculation on the left fore heel bulbs) with 0.25 ml 
of FMDV inoculum (diluted 1:10 in maintenance medium, i.e. around 10^  ^  per animal). 
At 1 day after inoculation, 3 of the inoculated pigs from Room 5 were transferred to 
Room 4, 1 inoculated with each of the 3 contact pigs in the box (i.e. 1 donor and 1 
contact in each “cubicle/space”) for 2 hours and then back to Room 5. This process was 
repeated on days 2, 3 and 4 pi using the same inoculated pigs placed with contact pigs in 
the different rooms.
On day 4 post inoculation, a further group of four contact pigs were mixed with 
the four inoculated pigs as a group for 2 hours.
The post challenge procedures were the same as for Experiment 1.
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Figure 2.3 Design Schematic of Experiment 2. Four pigs were placed in Room 5 of 
ISO 7B. Sets of three pigs were placed in each of Rooms 4-1, with 1 pig in each cubicle and 
1 pig in the space adjacent to the cubicles. The four donor pigs in Room 5 were inoculated 
in the morning of day 0. The direct contact pigs were infected by being allowed to one-to- 
one with three of the inoculated pigs for a period of 2 hours. At dayl p. i. three of the 
inoculated pigs from Room 5 were transferred to Room 4 for 2 hours and then moved 
back. This was repeated up to day 4 p. i.
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2.6.4 Experiment 3: MIN 19
The objective of this study was to determine and compare the pathogenesis in 
pigs of FMDV, strain O UKG 34/2001 infected by inoculation or by contact and to study 
virus transmission from infected to in-contact pigs when kept as a group. The objectives 
were to; study the influence of the inoculation dose; to determine the viraemia levels in 
pigs after infection; to determine levels of virus excretion and probable role of cytokines 
in the pathogenesis of FMD in pigs; to kill pigs when showing early or late signs of 
FMD (depending on chnical score) and to collect tissues for analysis of viral load and 
cytokine levels.
Sixteen Landrace x Large White pigs, of between 20-30 kg weight were used. 
Four pigs were placed in each of Room 1-4 of ISO 7B (in the space adjacent to the 
cubicles) (see Figure 2.4). Two of the pigs in each of Rooms 1-4 were inoculated (s/c + 
i/d inoculation on the left fore heel bulbs) with 0.25 ml FMDV of inoculum. The donor 
pigs in Room 4 (UW96, UW97) and 3 (UW92, UW93) were given a 1:10 dilution in 
maintenance medium, i.e. around 10^  ^  per animal, while the donor pigs in Room 2 
(UW88, UW89) were given a 1:100 dilution (~10"^^ ) and in Rooml (UW84, UW85) a 
1:1000 dilution (-10^'^); starting with the most diluted inoculum first. The other 2 pigs 
in each of Rooms 1-4 (UW86, UW87, UW90, UW91, UW94, UW95, UW98 and 
UW99) were kept as direct, continuous contacts.
The post challenge procedures were the same as for Experiment 1.
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2.6.5 Experiment 4: MIN 20
Experiment 4 and 5 are runs of the same experimental procedure. They are 
separated here for ease of identification of animals and times. The objective of 
experiment 4 was to compare viral load and cytokine mRNA levels in different tissues 
collected at hourly and daily intervals over the course of infection. Thirty-eight Landrace 
X Large White pigs, female of between 20-30 kg body weights were used. Two control 
pigs (UY42, UY43) were killed the week before the experiment to provide normal 
samples. Six pigs were placed in each of Rooms 1-4 of ISO 7B (UY06 -  UY29) (in the 
space adjacent the cubicles). Twelve remaining pigs were placed in Room 5 as two 
groups of six (Room 5 having been suitably partitioned in two halves to allow this) 
(UY30 -  UY41). Three of the pigs in each of Room 1-4 and three of the pigs in each 
“section” of Room 5 were inoculated (s/c + i/d inoculation on the left fore heel bulbs) 
with 0.25 ml FMDV inoculum. All eighteen of these pigs in Rooms 1-5 were given a 
1:10 dilution in maintenance medium, i.e. around 10^  ^per animal. The other 3 pigs in 
each of box 1-4 and the other 6 pigs in box 5 are kept as direct, continuous contacts. The 
progression of disease was recorded in the inoculated and direct contact pigs as were the 
clinical signs, and body temperatures. Two inoculated and two contact pigs were 
selected at random at euthanased at the following time points post infection; 2h, 4h, 6h, 
24h, 48h, 72h, 96h, 120h.
2.6.6 Experiment 5: MIN 21
The objective of this experiment was the same as Experiment 4. Forty pigs were 
used and four control pigs (VB03 -  VB06) were killed the week before the experiment 
to provide normal samples. Six pigs were placed in each Rooms 1-4 of ISO 7B (VA67 -  
VA90) (in the space adjacent to the cubicles). Twelve remaining pigs (VA91 -  VA99, 
VBOO -  VB02) were placed in Room 5 as two groups of six as in Experiment 4. 
Challenge and post-challenge procedures were the same as for Experiment 4.
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2.7 Data Management
2.7.1 Assessment of Quality and a Description of Process and Tools
A standard cDNA dilution series for each of the various cytokine and TLRs was 
included with every PCR assay. These served both as positive controls and as a means of 
calculating the copy number per gram of tissue of the cytokine or TLR being assayed. It 
was found that the standard curves were consistently reproducible. They were compiled 
into a database and used to generate an average standard curve for each individual 
cytokine or TLR (see Appendix 2).
All the samples were normalised to the housekeeping gene GAPDH in order to 
eliminate the effect of mRNA extraction efficiency. Samples that fell outside 10-1000% 
of normal GAPDH content were excluded from the database.
Data were exported from the real-time PCR ‘sequence detection system’ 
software into Excel (Microsoft ® Excel Professional 2003) and ordered by pig ID and 
day post infection or disease stage. Ct-values were converted to copies per reaction by 
using the slope and intercept values of the average standard curve generated from the 
standard database. This value was then converted to copies per gram and normahsed to 
GAPDH.
Copies per gram of tissue = [(copies mRNA per reaction)/(mg tissue per 
reaction)]/(Sample GAPDH to Average GAPDH Ratio)
2.7.2 Exploratory Data Analysis (EDA)
Initially raw data were used to generate a series of graphs illustrating the changes 
in mRNA profiles in different tissues at different stages of disease. However it was 
difficult to compare mRNA levels from the virus and various cytokines from the raw 
data as they produced inconclusive results and the importance of subtle changes in 
mRNA levels could not be distinguished. As a result it was decided to model the data as 
described in 2.7.3.
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2.7.3 Statistical Modelling
Statistical modelling of the data was carried out in consultation with Dr. Carlos 
Barahona, Senior Statistician, University of Reading.
Data were fitted to a mixed model in which the results for an individual pig were 
included as a random effect. The fixed effects in the models included:
For Test 1: (data from two stages of the disease derived from Experiments 1, 2 
and 3) run, tissue, group and time were included as fixed effects. The models included 
all interactions between the factors of interest (tissue, group and time). All the tests 
carried out were adjusted by the effect of “run”, by the inclusion of “run” as a fixed term 
in the model.
For Test 2: (time course data from Experiments 4 and 5) the fixed effects were 
run, tissue, group and hour. Inoculated and contact pigs were grouped together into a 
single database following a time adjustment of 38 hours which was the time taken for 
contact pigs to reach the same point in disease as inoculated pigs (based on chnical 
signs, see 4.1 for a description). All effects are adjusted by the run number.
The assumptions behind the models fitted were checked by inspection of the 
residual scatter plots, i.e. the adjusted residuals versus the predicted values.
Analyses were carried out using Proc Mixed in SAS version 9. Mean values and 
standard errors presented in the graphs were taken from the adjusted estimates derived 
from the modelling process (corrected for nuisance factors such as run etc). A P-value 
less than 0.05 was considered statistical significant.
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Chapter 3
UNINOCULATED CONTROL PIGS
3. Uninoculated Control Pigs
3.1 Introduction
In order to generate a databank of normal values for porcine mRNA expression 
in tissues, healthy pigs were euthanased to provide uninfected control tissue samples. 
Subsequent tissue samples, collected from pigs infected with FMDV at various stages of 
disease, were then normalised to the control samples. This allowed levels of different 
mRNAs to be expressed relative to the normal levels described in this Chapter. Levels of 
mRNA for the housekeeping gene glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) were also measured. GAPDH is constitutively expressed in almost all tissues 
at high levels, so it was used as a denominator for the comparison of samples. The 
following tissue samples were collected; liver, spleen, cervical lymph node (CLN), 
mandibular lymph node (MLN), retropharyngeal lymph node (RPLN), soft palate (SP), 
pharynx, tonsil, tongue and skin (coronary band area).
3.1.1 GAPDH values
Total mRNA was extracted from tissues and assayed for levels of GAPDH 
mRNA by real-time RT-PCR. Figure 3.1 illustrates the quantities of GAPDH mRNA 
found in various tissues.
GAPDH mRNA quantities were not found to be the same in the different types 
of tissues that were sampled. Skin samples (always taken from the coronary band area) 
consistently contained lower levels of GAPDH mRNA than other tissues, with 10^^  ^
copies/gram of tissue being the average value. One possible reason for this lower level 
of GAPDH mRNA/gram of tissue is the presence of a large amounts of dead cells 
depleted of mRNA in the upper layers of epithelial tissue. This was further compounded 
in skin samples from pigs with lesions, as there was a great deal of tissue damage and 
dead tissue at these sites resulting in low overall levels of GAPDH mRNA. In addition, 
there may be sampling error associated with the measurement of GAPDH mRNA in skin 
samples that contain lesions, since there was no way to “standardise” the amount of 
lesion material collected. This could theoretically make the GAPDH values fluctuate
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more in the infected pigs than in the control pigs. It is likely that the fluctuation was 
greater in severe disease than in early disease.
With the exception of skin samples, it was found that quantities of GAPDH 
mRNA were generally greater, in all tissues tested, than quantities of cytokine and TLR 
mRNAs. Tongue samples were consistently found to contain the greatest quantities of 
GAPDH mRNA amongst all of the tissues sampled (10^  ^^  copies/gram). All the other 
tissues sampled contained GAPDH mRNA in quantities ranging from a minimum of 
10^^° copies/gram (liver) to a maximum of 10^  ^^  copies/gram (tonsil). Tissue samples 
from infected pigs were normalised to GAPDH in tissue samples from the control pigs. 
Infected pig liver GAPDH mRNA levels were normalised to control pig liver GAPDH 
mRNA and so on.
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Figure 3.1 Average GAPDH and IFNa mRNA levels. Ten tissues were assayed for 
quantities of (a) GAPDH and (b) IFNa mRNA (see text). Tissues were collected from 
healthy pigs to provide uninfected control samples. Quantities are expressed as logio copies 
of mRNA/gram of tissues (Y-axis), and tissue samples are shown on the X-axis. Error bars 
represent standard error of average mRNA levels in each tissue sampled. Cervical lymph 
node (CLN), Mandibular lymph node (MLN), Retropharyngeal lymph node (RPLN), Soft 
palate (SP)
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3.1.2 Normal Cytokine mRNA values
Total mRNA was extracted from tissues and analysed for levels of different 
cytokine mRNA by real-time RT-PCR (see 2.5.10). Figures 3.2 to 3.4 illustrate the 
average quantities of cytokine mRNAs found in various tissues.
IFNa
IFNa mRNA levels in tissue samples (see Figure 3.1) were lower than GAPDH 
mRNA levels. In general, quantities were below 10^ '^^  copies IFNa mRN A/gram of 
tissue, and most were between 10^ ^^  copies/gram and 10^ ®'^  copies/gram found in liver 
and in CLN samples respectively. The only tissue found to contain higher levels of IFNa 
mRNA was the soft palate, where levels of 10^  ^^copies/gram were recorded.
IFNP
IFNp mRNA levels were the lowest of all the cytokines tested in normal tissues 
(Figure 3.2) in the ten normal tissues sampled. Quantities ranged from 10  ^^  copies/gram 
in skin samples to 10^  ^copies/gram in tonsil. IFNp mRNA levels were low in soft palate 
samples compared with levels in other tissues (10  ^"^ copies/gram), and this was in 
contrast to IFNa where the soft palate had the highest level of IFNa mRNA. IFNp 
mRNA levels appeared to be maintained at higher levels in spleen, lymph node tissue 
and tonsil than in the other tissues analysed.
IFNy
IFNy mRNA levels showed a wide variation in the different tissues sampled 
(Figure 3.2). Pharynx and skin contained low levels of IFNy mRNA, ranging from 10  ^"^ 
copies/gram in skin to 10^  ^ copies/gram in pharynx samples. All other samples 
contained greater than 10^  ^ copies/gram of IFNy starting with soft palate (10^^ 
copies/gram) and liver (10^^ copies/gram) up to spleen and MLN (both containing 10^  ^'^  
copies/gram). CLN, RPLN and tonsil contained slightly lower levels of IFNy mRNA. As
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previously seen with IFNP; IFNy mRNA levels appeared to be maintained at higher 
levels in spleen, lymph node tissue and tonsil than in the other tissues analysed for this 
cytokine.
ILla
ELla mRNA levels were all above 10 °^'° copies/gram of tissue (Figure 3.3). Liver 
(10^^  ^ copies/gram), pharynx (10^^  ^ copies/gram) and skin (10^°^ copies/gram) 
contained the lowest levels of IL la mRNA. Tonsil (10^  ^  ^copies/gram) and soft palate 
(lO^  ^"^ copies/gram) contained the greatest quantities. It was observed that in addition to 
high IL-la mRNA, the soft palate also contained the highest levels of IFNa (see Figure 
3.1.).
TNFa
The lowest levels of TNFa mRNA were observed in liver (10^^ copies/gram), 
soft palate (10^^ copies/gram), pharynx (10^^ copies/gram), tongue (10^^ copies/gram) 
and skin (lO^ "^  copies/gram) (Figure 3.3). As was the case for IFNp and IFNy, higher 
levels of TNFa mRNA were observed in spleen, lymph node tissue and tonsil than in the 
other tissues sampled. It appeared that TNFa mRNA was maintained at higher levels in 
these tissues compared with the other tissues analysed for this cytokine.
Tissues grouped by Cytokine
In Figure 3.4, where all tissues sampled are viewed grouped by cytokine, a 
pattern emerges. In general, liver and skin appear to contain the lowest levels of 
cytokine mRNA. In the case of IFNa and IL-la, the SP contains the highest mRNA 
levels. The lymphoid tissues, shown in green, contained intermediate levels of mRNA 
for all four cytokines measured. However, IL-la mRNA appears to be present in greater 
quantities overall in all tissues when compared with the other four cytokines, while IFNP 
was present in the lowest quantities overall.
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Figure 3.2 Average IFNp and IFNy mRNA levels. Ten tissues were assayed for quantities 
of (a) IFNp and (b) IFNy mRNA (see text). Tissues were collected from healthy pigs to 
provide uninfected control samples. Quantities are expressed as logio copies of 
mRN A/gram of tissues (Y-axis), and tissue samples are shown on the X-axis. Error bars 
represent standard error of average mRNA levels in each tissue sampled. Cervical lymph 
node (CLN), Mandibular lymph node (MLN), Retropharyngeal lymph node (RPLN), Soft 
palate (SP)
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Figure 3.3 Average TNFa and IL-la mRNA levels. Ten tissues were assayed for quantities 
of (a) TNFa and (b) IL-la mRNA (see text). Tissues were collected from healthy pigs to 
provide uninfected control samples. Quantities are expressed as logio copies of 
mRN A/gram of tissues (Y-axis), and tissue samples are shown on the X-axis. Error bars 
represent standard error of average TNFa levels in each tissue sampled. Cervical lymph 
node (CLN), Mandibular lymph node (MLN), Retropharyngeal lymph node (RPLN), Soft 
palate (SP)
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Figure 3.4 Average cytokine mRNA levels. Ten tissues were assayed for quantities of 
different mRNA (see text). Tissues were collected from pigs to provide uninfected control 
samples. Quantities are expressed as logio copies of cytokine mRN A/gram of tissues (Y- 
axis), and cytokines analysed are shown on the X-axis. Cervical lymph node (CLN), 
Mandibular lymph node (MLN), Retropharyngeal lymph node (RPLN), Soft palate (SP)
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3.1.3 Normal Toll-Like Receptor mRNA values
Total mRNA was extracted from tissues and analysed for levels of different Toll­
like receptor (TLR) mRNA by real-time RT-PCR (see 2.5.10). Figure 3.5 illustrates the 
average quantities of TLR mRNA detected in various tissues.
TLR3
TLR3 mRNA levels were of the cytokines analysed (Figure 3.5). Skin samples 
contained levels as low as 10^  ^  copies/gram of tissue. MLN (10^^ copies/gram), RPLN 
(10^^ copies/gram), tonsil (10^^ copies/gram) and tongue (10^^ copies/gram) also had 
levels of TLR3 mRNA below 10  ^^  copies/gram tissue. Liver (10^ ° copies/gram), spleen 
(10^^ copies/gram), soft palate (10^^ copies/gram) and pharynx (10^^ copies/gram) had 
mRNA levels of lO^^copies/gram of TLR3 or greater. The greatest quantity of TLR3 
mRNA was observed in the pharynx, conversely, none of the cytokines that were tested 
were found to be at a maximum in pharynx samples.
TLR4
TLR4 mRNA levels were closer to those observed for IFNa, IFNy, TNFa and 
IL la than to the levels of TLR3 seen in the tissues sampled, see Figure 3.5. (IFNp was 
present at levels lower than the other cytokines analysed). Liver (10  ^"^ copies/gram) and 
skin (10^^ copies/gram) samples contained the lowest levels of TLR4 mRNA at less than 
10  ^^  copies/gram of tissue. Higher levels were observed in MLN (10^‘^  copies/gram), 
RPLN (10^^ copies/gram), soft palate (10^^ copies/gram), pharynx (10^ "^  copies/gram), 
tonsil (10^^ copies/gram) and tongue (10^^ copies/gram), while the greatest quantities 
were seen in spleen (10^^ copies/gram) and CLN (10^^ copies/gram) samples. TLR4 
mRNA level patterns were comparable to those of cytokine mRNA observed, with liver 
and skin containing lower levels and immune related tissues containing higher levels.
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Figure 3.5 Average TLR3 and TLR4 mRNA levels. Ten different tissues were assayed for 
quantities of TLR3 and TLR4 mRNA (see text). Tissues were collected from a group (14) 
of healthy pigs to provide uninfected control samples. Quantities are expressed as logio 
copies of mRN A/gram of tissues (Y-axis), and tissue samples are shown on the X-axis. 
Error bars represent standard error of average mRNA levels in each tissue sampled. 
Cervical lymph node (CLN), Mandibular lymph node (MLN), Retropharyngeal lymph 
node (RPLN), Soft palate (SP)
3.2 Discussion
The objective of the studies reported in this Chapter was to determine the normal 
levels of certain cytokine and TLR mRNAs in a selection of tissues collected from 
healthy pigs. As a result, a databank of normal values for porcine mRNA expression in 
tissues was produced. When the same procedures were followed for infected pigs 
(Chapter 4), the changes in mRNA levels during infection could be compared.
Liver and spleen samples were collected because of their role as sources of a 
variety of specialised macrophages and dendritic cells that are important for innate 
immunity. Three different lymph nodes were collected from control pigs. Each lymph 
node serves to drain lymph from areas considered significant in FMDV infection. The 
CLN located close to the shoulder joint, drains the skin of the neck, shoulder and 
forelimb. The MLN is located close to the facial vein and the angle of the jaw. It drains 
the superficial structures of the face ventral to the palate, the inter-mandibular space and 
occasionally the eyelids. The RPLN, located above the pharynx drains the deep 
structures of the head and receives lymph from other lymph nodes of the head. In 
addition, three different tissues were collected from the throat region. These were the 
soft palate (SP), the pharynx and the tonsil. These tissues were selected as it is thought 
that this region is the primary site for the deposition and possibly replication of FMDV 
(Oleksiewicz et al, 2001; Alexandersen et al, 2001; Zhang & Kitching, 2001). 
Epithelial samples were collected from both tongue and coronary band samples. These 
areas are major sites of FMDV replication.
In the control samples, those from the liver and coronary band skin contained the 
lowest levels of cytokine and TLR mRNA. The only exception to this was TLR3, where 
liver samples were amongst the tissues that had the highest levels of TLR3 mRNA. A 
pattern emerged involving IFNp, IFNy and TNFa. These cytokine mRNAs were 
observed at greater levels in spleen, lymph nodes and tonsil samples than in the other 
tissues analysed. Since these samples were collected from healthy pigs it is likely that 
these cytokines are constitutively present in these tissues as part of the innate immune 
systems continuous protection against antigenic challenges.
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The findings described later in this thesis illustrate that IFNa mRNA is not up- 
regulated to a great degree, unlike IFNp mRNA which is observed at above normal 
levels both early and late in infection. It is possible that the higher quantities of IFNp 
mRNA in some of the immune-related tissues (spleen, lymph nodes and tonsil) could 
account for it’s response to FMDV infection. However, greatly increased levels of IFNp 
mRNA were also observed in tongue and skin (see Chapters 5 and 6) even though these 
tissues, especially skin, have low constitutive levels of IFNp mRNA. It is possible that 
the higher viral loads measured in these tissues (see Chapter 4) and higher fibroblast 
content (IFNp producers) could account for this large induction of IFNP mRNA.
Both IFNa and ILla were present to the greatest degree in the soft palate -  a 
tissue thought to permit FMDV persistence in ruminants (Zhang & Kitching, 2001; 
Alexandersen et al, 2003). Persistence of FMDV does not occur in pigs and it is 
possible that the cytokine profile of tissues in the soft palate and pharyngeal area may 
play a role in this. FMDV is present at low levels during persistence; it may be that the 
constitutive presence of antiviral cytokines in the soft palate and surrounding area is 
enough to prevent the virus from establishing a persistent infection.
The toll-like receptors (TLRs) presented very different patterns of expression in 
normal tissues compared to those observed for cytokines in normal tissues. TLR3 
mRNA levels were quite low when compared to levels of TLR4 and levels of the 
cytokines in the same tissues. A further difference between TLR3 mRNA levels and the 
other mRNAs tested was that TLR3 was observed in greatest quantities in pharyngeal 
samples. TLR4 was similar to the cytokines analysed in that its mRNA quantities were 
lowest in liver and skin samples. Like IFNp, IFNy and ILla, TLR4 mRNA was higher in 
spleen, CLN and MLN samples. On the other hand, unlike those cytokine mRNAs, 
TLR4 mRNA was not constitutively higher in RPLN and tonsil when compared with the 
other tissues tested for TLR4. Spleen and lymphoid tissue may express pathogen 
recognition receptors associated with their role in innate immunity, explaining why 
TLR4 mRNA was present in greater quantities in these tissues than in the other tissues 
tested.
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Chapter 4
FMD EM EXPEREMENTALLY EMFECTED PIGS
4. FMD in Experimentally Infected Pigs
4.1 Introduction
The onset and progression of FMD was observed in inoculated pigs and in 
pigs housed together with the inoculated pigs (contact pigs) in Experiments 1, 2 and 
3 (see Sections 2.6.1-2.6.3). These experiments were originally designed to study 
various effects of dose or transmission, but provided a source of inoculated and in­
contact pigs for these studies. Additionally, Experiments 4 and 5 were carried out 
specifically to study the early pathogenesis of FMDV in pigs. Clinical signs during 
the development of the disease from Experiments 1 to 3 and the combined data from 
the Experiments 4 and 5 are presented in this Chapter. They were used to describe 
the progression of disease and its relationships to viral loads in various tissue 
samples in both inoculated and contact pigs.
In Experiments 1, 2 and 3 clinical signs including the development of vesicles 
on the feet and in the mouth were observed in inoculated and contact pigs. A typical 
vesicle (unruptured) is illustrated in Figure 4.1(a). When vesicles rupture erosions 
result and so lesions are normally observed late in disease. Figure 4.1(d). The 
vesicles observed as a result of experimental infection of pigs with FMDV were the 
same as those seen in the field (see Figure 1.1a and 1.1b). However, the trauma 
conditions in the field are generally greater with the result that those pigs often 
develop a more severe disease. The development of clinical signs was evaluated 
throughout the course of disease using a subjective scoring system with the following 
formula [(lame: 1) + (one to four affected feet: 1 to 4) + (tongue: 1)]. Thus the 
highest clinical score possible was 6 (Quan et a l, 2004). Pigs with a score of 1-3 had 
early signs of disease, while pigs with a score of 4-6 had late signs of disease and 
were grouped accordingly. For example, a score of 1-3 represents a lame pig with up 
to 2 feet bearing lesions and a score of 4-6 represents a lame pig with three or more 
feet bearing lesions and lesions in the mouth. The early pigs (i.e. score = 1-3) 
generally did not have any ruptured vesicles and were still eating and moving around 
freely. The late pigs (score = 4-6) generally had at least one ruptured vesicle and had 
become recumbent, anorexic and pyrexic.
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4.2 FMD in Inoculated and Contact Pigs
The scoring system used to evaluate clinical signs was found to be accurate 
and the resulting clinical sign scores were very consistent. See Table 4.1 for the 
average scores observed in inoculated and contact pigs. Overall, in Experiments 1, 2 
and 3, the progression of disease in 52 inoculated and 76 contact pigs was recorded 
(2.6.1-2.6.3).
The progression of disease was consistent in inoculated pigs with vesicles 
appearing at 24 hours p.i. (normally this was a vesicle observed at the site of 
inoculation on the heel pad). By 48 hours p. i. in the inoculated pigs, most had 
vesicles on three feet or two feet and the tongue. These pigs scored 4 and were 
already considered to have late signs of disease. By 96 hours p. i. all pigs had severe 
disease with a maximum score of 6. Similar scores were observed in the contact pigs 
albeit after a delay of 24-48 hours.
It was noted that regardless of how the pigs were infected, disease progressed 
the same way beyond a certain time point. This point is represented by a clinical 
score of 2. Before this stage, the progression of disease was probably related to the 
dose of virus that infected the pig. Dose did not have an effect on disease progression 
beyond the stage of where there was a clinical score of 2. This means that both the 
inoculated and contact groups of pigs may be considered the same in terms of the 
progression of disease, allowing for the delay of 24-48 hours in the onset of clinical 
signs for contact pigs. This is supported statistically by results reported in Chapter 6 
where inoculated and contact data were grouped together.
92
(a)
Hour PI Oh 2h 4h 6h 24 48 72 96 120
Inoculated 0 0 0 0 1 4 5 6 6
Contact 0 0 0 0 0 0 2 5 6
(b)
Hour PI Oh 2h 4h 6h 24 48 72 96 120
Inoculated 3&8 - - - 3&6 3&6 39.7 39.7 39.3
Contact 3&8 - - - 38.7 39.0 3&3 39.3 39.6
Table 4.1(a) Average scores observed in inoculated and contact pigs at 0 to 120 hours 
post inoculation (p.i.); (b) Average rectal temperatures recorded daily from 0-120 
hours p. i.
Tissue Inoculated Contact
Liver 17.4(48) 16.4(72)
Spleen 18.6(48) 17.1(96)
CLN 19.9(48) 19.4(96)
MLN 17.3(48) 15.8(96)
RPLN 17.2(48) 16.8(96)
SP 17.8(48) 16.1(96)
Pharynx 16.9(48) 15.9(96)
Tonsil 18.4(48) 20.3(96)
Tongue 22.8(48) 23.5(96)
Skin 22.9(48) 23.5(96)
Table 4.2 Predicted Mean Peak viral loads measured as LN (copies FMDV per gram of 
tissue) in inoculated and contact pigs. Hour post infection is shown in brackets.
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Figure 4.1 FMD lesions in experimentally infected pigs, (a) early vesicles (unruptured) 
on the coronary band (b) unruptured vesicles 48 hours p. i. (c) typical vesicle 
development at the site of inoculation 24 hours p.i. (d) severe ruptured vesicles -  loss of 
hoof (thimbling) (e) small pin point vesicles typically seen on the upper lip (f) lesion on 
the snout (g) lameness in severely affected hind foot (h) example of a tongue lesion post 
mortem.
94
4.2.1 Dose Effects in Inoculated and Contact Pigs
In Experiment 1 the donor pigs received approximately 10^^ TCID50 of 
FMDV per animal. In Experiment 2 the donors received 10  ^^  TCID50 per animal and 
in Experiment 3 the dose ranged from 10^^ down to 10^^ TCID50 per animal. Despite 
the differences in dose, 1 0  out of the 16 inoculated pigs in these experiments had 
visible clinical signs at 2 days p. i. and all had visible clinical signs at 3 days p. i. 
Similarly, in Experiments 4 and 5, where donor pigs received 10^^ TCED50 of FMDV 
per animal, 17 out of 20 inoculated pigs had visible clinical signs at 2 days PI and all 
had visible clinical signs at 3 days p. i. Dose did not appear to affect the onset of 
clinical signs in inoculated pigs with 75% of pigs presenting clinical signs by 2 days 
p. i. and 100% by 3 days p. i.
In the case of contact pigs, the onset of disease was more variable. It 
depended on whether the contact pigs were in continuous contact with the donor pigs 
(as in Experiment 3) or whether they were hmited to 2 hours exposure (as in 
Experiments 1 and 2). Another factor was the stocking density during exposure, for 
example in Experiment 2 contact pigs were exposed one-to-one to the donors, in 
Experiments 1 and 3, group exposure was used. In Experiments 4 and 5, where there 
were 6  pigs per group (3 inoculated and 3 contacts) the contact group onset of 
disease was consistently delayed by between 24 and 48 hours.
4.2.2 Viral Load in Tissues from Inoculated and Contact Pigs
Total mRNA was extracted from the tissues collected in Experiments 4 and 5 
and analysed for levels of virus RNA by real-time RT-PCR (see Chapter 2.5.10). 
Figures 4.2 and 4.3 illustrate the average quantities of FMDV observed (expressed as 
LN genome copy numbers/gram)
Liver and Spleen
FMDV RNA was detected in liver and spleen samples of inoculated and 
contact pigs from 24 hours p. i. Peak viral loads in inoculated pigs occurred at 48 
hours p. i. and were on average 17.4 and 18.6 LN (genomes per gram) of liver and 
spleen respectively. In contact pigs, peak viral loads in liver occurred at 72 hours p. i. 
and were on average 16.5 LN (genomes per gram). In spleen the peak was measured
95
at 96 hours p. i. and was on average 17.0 LN (genomes per gram). The peak viral 
loads in liver and spleen coincided with the appearance of severe clinical signs, this 
was the case for both groups of pigs -  albeit approximately 24 hours later for the 
contact pigs. The levels were quite similar in the two groups.
Lymphoid Tissue
The tonsil and three lymph nodes in each pig were tested for levels of viral 
RNA. The lymph nodes were the cervical lymph node (CLN), mandibular lymph 
node (MLN) and the retropharyngeal lymph node (RPLN). The CLN sample was 
always collected from same side (left) as the inoculated foot. Viral RNA was 
detected in this tissue as soon as 2 hours p. i. in inoculated pigs, albeit at a low level 
and in one pig only (UY30). This level did not increase at 4 or 6 hours p. i. (but was 
still detectable in two pigs positive at 4 hours, UY36 and VA99 and in three pigs 
positive at 6 hours, UY38, VA92 and VA93) and by 24 hours p. i. a predicted mean 
of 16.1 LN (genomes per gram) CLN was measured. In contact pigs, a low level of 
FMDV RNA was detected 4 hours PI in CLN of one pig (VA94). No viral RNA was 
detected at 6 hours p. i. and it was not observed again until 24 hours p. i. Peak viral 
load in inoculated CLN occurred at 48 hours p. i. and measured 19.9 LN (genomes 
per gram) on average. A much later peak but equivalent viral load for CLN was 
observed in the contact pigs at 120 hours however, levels were high from 72 hours 
p. i. The two other lymph nodes tested (MLN and RPLN) contained lower levels of 
viral RNA early in viraemia for the inoculated group and then peaked alongside the 
CLN. In contact pigs, it was the MLN that featured early in infection -  this was the 
only lymph node to contain a considerable amount of virus at 24 hours p. i.; RPLN 
and CLN did not become positive for viral RNA until 48 hours p. i. when virus was 
detectable in the blood. Viral RNA was detected in tonsil at 6 hours p. i. in one 
inoculated pig (VA93), and contact tonsil samples contained detectable viral RNA 
from 24 hours p. i. In the inoculated pigs, tonsil had an identical pattern to that of 
CLN, while of the lymphoid tissues in contact pigs tonsil was one of the earliest to 
contain virus and had the greatest peak viral load at 96 hours p. i. Peak viral loads in 
all of the lymphoid tissues coincided with the development of severe clinical signs in 
both inoculated and contact pigs.
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Throat Samples
Viral RNA was detected in SP and pharyngeal samples, again in some pigs at 
2 hours p. i. (VA97 and UY30) but not at 4 hours p. i. By 6 hours p. i., viral RNA 
was observed at low levels in pharynx (in one inoculated pig, VA93). Peak viral 
loads in SP were measured at 48 hours p. i. in inoculated pigs and at 96 hours p. i. in 
contact pigs. In pharynx samples from inoculated pigs, peak viral load was measured 
at 48 hours p. i. and at 96 hours p. i. in pharyngeal samples from contact pigs. Peak 
virus levels in SP and pharynx (Table 4.2) were lower in contact pigs.
Tongue and Skin
Epithehal samples were collected from the tongue and coronary band (skin), 
and where possible samples included vesicle material (but non-lesion material still 
contained virus, as previously shown (Alexandersen et a l, 2001). Tongue and skin 
samples generally contained the highest levels of virus RNA of the tissue samples 
analysed. Viral RNA was observed in skin samples from some individual inoculated 
pigs at 2 (UY30) and 4 hours p. i. (VA91), but not at 6 hours. In the contact pigs it 
was tongue samples where viral RNA was detected early (4 hours p. i.). Peak viral 
loads were measured at 48 hours p. i. for inoculated pigs and 96 hours for contact 
pigs. Peak levels of viral RNA were measured in both groups of pigs coinciding with 
the development of severe clinical signs. Tongue and skin peak levels measured on 
average 22.8 LN (genomes per gram) in inoculated pigs and on average 23.5 LN 
(genomes per gram) in contact pigs - the only instance where a contact peak viral 
load was greater than that measured in inoculated pigs.
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4.3 Discussion
The progress of FMD in infected pigs was studied by observing the development 
clinical signs. The dynamics of FMDV was followed by determining viral loads in the 
following tissues: liver; spleen; cervical lymph node (CLN); mandibular lymph node 
(MLN); retropharyngeal lymph node (RPLN); soft palate (SP); pharynx; tonsil; tongue 
and skin (coronary band area). Tissue samples were collected from both inoculated and 
contact infected pigs at different stages of disease (early and late in Experiments 1, 2 and 
3) and at a series of eight time points from 2 hours to 120 hours p. i. (in Experiments 4 
and 5). In addition to this, blood samples were collected so that viraemia and it is 
relationship to tissue viral load could be observed.
A number of interesting results were obtained from the experiments described in 
this Chapter. Most notably, it appeared that irrespective of the method of infection used, 
once disease became established, it progressed similarly in all pigs. Other variables 
included the number of infected animals present. While all of these variables influenced 
the transmission rate of the virus and the onset of chnical signs, a very predictable 
pattern of disease progression followed thereafter.
In general, vesicles appeared in the majority of inoculated pigs by 24 hours p. i. 
regardless of the type of challenge. The onset of vesicular disease in contact pigs varied 
more and was dependant, as mentioned above, on the type of exposure. Pigs infected by 
direct continuous contact as a group developed disease more quickly than those that 
were held in contact on a one-to-one basis or those that had time limited exposure to 
donor pigs. The onset of clinical signs in contact pigs was generally 24-48 hours after 
that of donor pigs. This could be extended by up to a week for pigs that were exposed 
for a 2 hour period to donors that were one day p. i. (some of these pigs were not 
infected). Previous studies have shown that the number of infected animals and the 
number in direct contact is important in the efficiency of spread (Alexandersen et al, 
2003). In recent study, it was shown that increasing the number of donor pigs 
synchronizes infection in the contact group and that the rate of increase of FMDV levels 
in infected pigs is independent of dose (Quan et al, 2004).
100
However, the time differences in the onset of clinical signs in all of the 
experiments discussed in this thesis did not affect this study as pigs were selected based 
on clinical score, regardless of the time taken to reach that score. It was noted that 
disease progression was highly comparable in all pigs despite differences in route of 
infection, dose and stocking density.
The scoring system that was used to evaluate the severity of clinical signs was 
found to give consistent results. So much so, it was noted that if one took a score early in 
the development of disease (i.e. a score of 2) then from this point onwards increase of 
score progressed at the same rate in all pigs regardless of the method of infection, dose, 
grouping or number of infected pigs. This system therefore was a very useful tool that 
allowed a comparison of pigs from different experiments. The time of onset of clinical 
signs in both inoculated and contact pigs to a score of approximately 4 to 5 was about 48 
hours for both groups (Figures 4.2 and 4.3).
In general the results obtained in Experiments 4 and 5 showed that the 
appearance of vesicular lesions was coincident with the peak of viral loads and with 
peak viraemia in inoculated pigs. In contrast, peak clinical scores were observed 48 
hours later. This showed that the severe stage of disease occurred late with respect to the 
virus that had already reached peak levels in tissues. This suggests that viraemia may not 
be a good indicator of the stage of disease especially late in the infection. It would seem 
that the appearance of vesicles begins at the same time as peak viral loads in tissues. 
Thereafter viral loads decline but the severity of the lesions increase, suggesting that the 
increased severity of clinical disease is related to antiviral and pro-inflammatory 
cytokine activity and not to viral replication.
A delay of about 2 days was observed before the development of peak viral loads 
in tissues from contact pigs compared with those from inoculated pigs and in some 
instances (i.e. SP, pharynx) contact peak viral loads were lower than those observed in 
the same tissues collected from inoculated pigs (Figures 4.2 and 4.3). The dose that 
infected the contact pigs could not be determined but was assumed to be sufficiently 
high. Virus could be detected in some tissues from contact pigs 24 hours p. i., but not in
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the blood unlike the inoculated pigs where virus was detectable in the blood at this stage. 
In a previous study virus was also measured in contact infected pig tissues at 24 hours 
p. i. (Alexandersen et al, 2001), however in this study virus was also detectable in blood 
at 24 hours p. i., this may be a result of a different method of RNA extraction used 
(resulting in a greater quantity of RNA, albeit less pure). Levels detected in the 
Alexandersen study were low at 24 hours p. i. and it is possible that virus was below the 
detection limit of that assay. This absence of detectable virus in early contact serum 
samples was the main difference between the two groups of pigs, apart from the 
difference in time to peak viral load. This difference may be related to the method of 
infection; inoculation versus inhalation/ingestion, perhaps in naturally infected pigs i.e. 
contacts, the virus has the ability to avoid entering the circulation from the throat region 
by remaining in the lymph system (a suggestion supported by the early appearance of 
virus in the tonsil and MLN of contact pigs, see Figure 4.3), whereas in inoculated pigs 
virus was injected subcutaneously into the heel pad and some virus may have entered the 
blood stream straight away. This observation is further discussed in Chapter 6 with 
regard to the measurement of IFNa protein levels in the serum from 0-96 hours p. i. 
(section 6.4). (High expression levels of IFNa from 0-24 hours p. i. may have had an 
antiviral effect)
In most species, lymph enters into the secondary lymphoid organs through the 
blood, circulates through the organs and then leaves again through the lymphatic vessels. 
This circulation pattern is reversed in the pig, where lymph enters lymphoid organs 
through the lymphatic vessels and exits directly into the blood (Konig & Liebich, 2004). 
It is the inverted structure of the pig lymph node that facilitates this reversed circulation 
pattern (Pescovitz et al, 1998) and it is possible that FMDV uses this system as a means 
of disseminating throughout the body in the first 24 hours p. i. This may explain the lack 
of detectable virus in serum samples from contact pigs up to 24 hours p. i.
Figures 4.2 and 4.3 illustrate viral loads, viraemia and clinical signs data for the 
inoculated and contact groups, respectively. In inoculated pigs in the very early phase of 
infection (2-4 hours p. i.), CLN, pharynx, tonsil and skin were positive for viral RNA. 
These tissues also proved to be important later as they developed high viral loads. It
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appears that after inoculation, virus travelled to the CLN, as this lymph node drains the 
leg region. The virus then moved to the pharynx and tonsil, where it appeared to be 
accumulating, as levels were higher at the next time point. At 24 hours p. i., while all 
tissues were positive for viral RNA, the tonsil, CLN and spleen, two lymphoid tissues, 
contain the highest levels. By 48 hours p. i., when peak viraemia was measured in the 
serum and peak viral load all tissues were measured. At the same time clinical signs 
were beginning to develop. At 72 hours p. i., clinical signs continued to increase in 
severity and peak viral loads were gradually declining.
In contact pigs, tissues from the pharynx, MLN and tongue were the first to 
become infected. Viral RNA in MLN supports the hypothesis that infection occurred by 
the alimentary route but other routes may have been possible. At 24 hours p. i., all 
tissues with the exception of CLN and RPLN, were positive for viral RNA. Skin 
contained the greatest levels followed by liver, tongue, SP/pharynx, spleen and MLN. 
No viraemia was detectable at this stage, suggesting the virus was restricting itself to the 
lymphoid tissues and lymph nodes where it may have passively accumulated as was 
observed in the inoculated pig tissues. At 48 hours p. i. a viraemia was detected and 
skin, tongue, tonsil and SP/pharynx contained the highest level of viral RNA. This again 
shows a strong viral presence in lymphoid tissues early in disease, as well as in the 
preferred replication sites e.g. tongue and skin. Peak viral loads and viraemia occurred at 
96 hours p. i. with tongue and skin containing the most viral RNA, followed by tonsil 
and CLN. Clinical signs, which began at 72 hours p. i. were becoming severe at this 
stage and continued to increase in severity as viral loads levelled off or declined 
suggesting that viral replication was not the only factor influencing clinical disease. This 
shows that antiviral and pro-inflammatory cytokines are also likely to be influencing the 
development and severity of disease.
Table 4.2 shows the peak viral loads in the various tissues from inoculated and 
contact pigs. Also shown in the Table is hour p. i. when the peak viral loads occurred. In 
the inoculated group, peak viral load occurred at 48 hours p. i. in all tissues. However, in 
the case of liver tissue from inoculated pigs, a further peak was observed at 120 hours 
p. i. where the number of genomes (or partial genomes) per gram was almost as high as
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that seen in tongue and skin tissues. This indicates that the liver plays a role in the 
clearing of virus as the secondary immune system begins to activate in response to 
infection. It is possible that a similar pattern would emerge in liver tissue from contact 
pigs, but after 120 hours p. i. Viral loads were quite comparable in other tissues from 
two groups. CLN, tonsil, tongue and skin contained more virus per gram than the other 
tissues. Inoculated spleen and soft palate samples contained slightly more virus per gram 
in inoculated than contact pigs. Overall the two groups had the same peak viral loads 
once the severity of disease was similar in both groups.
In general, FMDV accumulated in lymphoid tissue early in infection (0-6 hours 
p. i. It was concluded that in the contact group virus used the lymph system for transport 
to various tissues. This is supported by the detection of virus in lymphoid tissues and 
tissues from the throat region soon after infection and a lack of detectable viraemia up to 
24 hours p. i. This was not the case in the inoculated group as virus could be detected in 
the blood at 24 hours p. i. However, this could have been the result of the artificial route 
of infection. The path taken by the virus in contact pigs is likely to be closer to that 
under field conditions. The next stage was the replication of virus in the tissues drained 
by the MLN and tonsil. The MLN drains the oral cavity, including the tongue and teeth, 
the salivary glands, the inter-mandibular space and the masticatory muscles, while the 
tonsils form a ring of lymphatic tissue around the pharynx. This was followed by the 
dissemination of virus throughout the body where epithelial cells were the favoured sites 
of replication. Clinical signs started at 24-48 hours p. i. (inoculated) or 72-96 hours p. i. 
(contact), by which stage peak viraemia was recorded. The highest levels of virus 
occurred at sites where vesicular lesions formed, namely the tongue and skin. Finally, 
clinical signs increased in severity, but viraemia began to decline after 48 hours in 
inoculated or 96 hours in contact pigs. This suggests that viral replication may not be the 
only influencing factor in terms of the development of clinical disease. Other factors that 
have to be taken into account include the innate immune system operating through the 
effects of antiviral and pro-inflammatory cytokines and toll like receptors. These 
immune factors can affect the response of the body to viral infection and can sometimes 
have a detrimental effect. In Chapters 5 and 6 the role of such cytokine and toll like 
receptors are discussed in terms of the pathogenesis of FMD.
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Considering the similarities between the two groups of pigs with respect to the 
peak viral loads in different tissues, it was decided to compare the development of 
clinical signs. Using a graph illustrating the viral load for epithelium and also depicting 
clinical signs (Fig. 4.4) it was evident that the inoculated group took 32 hours to develop 
a clinical score of 2 this took the contact group 70 hours; giving a 38 hour difference 
between the two groups. Thus by removing the 38 hour time difference one could 
pinpoint the same stage of disease for both groups.
The cytokine and toll like receptor data discussed later in Chapter 6 was time 
shifted in order to align the development of clinical signs in inoculated and contact pigs. 
It was preferable to use clinical signs as a means of grouping pigs because viraemia and 
temperature (Table 4.1 (b)) were less reliable indicators of the stage of disease. As a 
result of grouping the inoculated and contact pigs together, there were eight pigs for 
every time point thereby improving the accuracy of the statistical analysis.
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Chapter 5
COMPARISONS OF EARY AND LATE STAGES OF
FMD
5. Comparison of Early and Late Stages of FMD
5.1 Introduction
FMD is an extremely severe and rapidly progressing viral vesicular disease of 
pigs and other cloven hoofed species. Experimental infection produces clinical signs, in 
particular vesicles that can be observed as early as 24 hours later. Early indicators of 
viral infection are depression, warm feet and a febrile response (>39 ° C, as seen in 
Chapter 4 Table 4.1b). These signs are followed by the development of early vesicular 
lesions on one or more feet by 24 hours post infection p. i. At 48 hours p. i. vesicles are 
generally present on all four feet and sometimes the lips, snout and tongue. At this stage, 
some vesicles may have ruptured and pigs are usually lame and in severe pain. By 72 
hours p. i. most pigs will have ruptured vesicles on all four feet and the tongue; they will 
be anorexic and will generally lie down to avoid using their painful feet. At this stage in 
very severe cases, thimbhng or loosening of the hoof may occur. Such severely ill pigs 
are also very susceptible to secondary bacterial infections. By 96 hours p. i., pigs begin 
to recover from disease and the exposed dermis on the feet and mouth begins to heal. 
Pigs exposed to disease by contact with infected pigs develop disease in the same way 
but with a delay of 24-48 hours.
In order to better understand the pathogenesis of FMD in pigs. Experiments 1, 2 
and 3 (see sections 2.6.2-2.6.4) were performed. In these experiments, the development 
of clinical signs in infected pigs was closely observed on a day-to-day basis. For the 
work described in this Chapter, the results for 14 uninfected control pigs and 56 pigs 
with FMD were included. The pigs were all housed in the same biologically secure 
building, and the choice of animal for inoculation or those used as direct contact 
infection was random. Inoculations were done in the heel pads of the left forefoot as 
described previously (Alexandersen & Donaldson, 2002; Alexandersen et a l, 2002). 
Animals that presented with severe vesicles were killed by euthanasia within a day of 
the observation of clinical signs. Only one experiment was done at any one period, as 
described in Chapter 2.
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Depending on the stage of disease observed, pigs were given a clinical score (see 
Chapter 4 section 4.1 for a description of the scoring system). The purpose of the 
observational study was to select pigs at the early and late stages of disease. Pigs at the 
early stage of disease had warm feet, an above average rectal temperature and at least 
one early un-ruptured vesicle. These pigs had a clinical score of between one and three. 
Pigs at a late stage of disease were lame on at least two feet, they had visible vesicles on 
at least two feet, usually ruptured and visible vesicles on the tongue, snout or lips. In 
order to gain an insight into the pathogenesis of FMD a series of markers were studied at 
these two stages of disease. The markers selected included a number of antiviral 
cytokines (IFNa, IFNp and IFNy) and pro-inflammatory cytokines (TNFa, IL-la). 
Activation of antiviral cytokines is a very good indicator of the innate immune response 
to viral infection and by measuring the levels of induced mRNA to these cytokines in 
different tissues it was possible to elucidate the path taken by the virus in the course of 
disease as well as better understanding the host response to infection. Similarly by 
analysing the activation of pro-inflammatory cytokines in different tissues at different 
stages of disease, the interactions between virus and host could be followed.
5.2 Clinical Findings
Pigs were selected by clinical score, as described earlier (Section 4.1) and 
grouped according to their stage of disease i.e. early or late. Pigs at the early stage of 
disease generally had warm feet, pyrexia and at least one early un-ruptured vesicle. They 
were usually not lame at this stage and their behaviour was normal. Pigs at the late stage 
of disease were lame on at least two feet, had visible vesicles that were usually ruptured 
on at least two feet, and visible vesicles on the tongue, snout or lips. They were usually 
severely depressed, recumbent and anorexic, indicating severe pain.
5.3 Cytokines
Elements of the innate antiviral and pro-inflammatory response were evaluated 
by measuring the levels of mRNA, for IFNa, IFNp, IFNy (antiviral) and TNFa, IL-la 
(pro-inflammatory) detectable in tissues at “early” versus “late” stages of disease. The 
tissues sampled were the liver and spleen, cervical lymph node (CLN), mandibular
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lymph node (MLN), retropharyngeal lymph node (RPLN) and tonsil, floor of pharynx, 
soft palate (SP), tongue and coronary band epithelium (skin). All the samples were 
normalised to the housekeeping gene GAPDH (to eliminate the effect of extraction 
efficiency). Using the results from Experiments 1, 2 and 3, a database of “counts per 
gram” for each cytokine mRNA was generated. These data were then analysed using a 
statistical software package (SAS) whereby a mixed linear model was fitted allowing 
means (expected values), variances and co-variances to be estimated (see Section 2.7.3). 
Here the mean copy number (per gram of tissue) of antiviral and pro-inflammatory 
cytokine mRNAs are plotted to illustrate the change in level from normal (control), to 
early and late stages of disease. Trends in the differences of mRNA induction levels 
were easily identified and their significance evaluated. The results are summarised in 
Figures 5.1 to 5.3.
Antiviral mRNA Induction:
IFNa mRNA levels varied between tissue samples from normal, early and late 
stages of disease, however, despite finding a significant interaction between tissue and 
group (group being normal, early and late, P=0.0075), these changes were less 
pronounced than those with the other cytokines analysed. Figure 5.1 illustrates the 
changes in mRNA levels of IFNa. In normal pigs the highest levels of IFNa mRNA 
were observed in two of the lymphoid tissues, CLN and MLN, while the lowest levels 
were observed in tissues from the pharynx, tongue and skin. As IFNa is mainly a 
product of leukocytes, was expected that IFNa mRNA would mostly be present in 
lymphoid tissues. A continuous upward trend from the normal to early and then late 
stage of disease was seen in all of the lymphoid tissues (with the exception of the CLN). 
This upward trend was also seen in tongue tissues. Messenger RNA levels in CLN were 
reduced from early to late disease perhaps indicating that FMDV is down regulating 
IFNa mRNA production from this lymph node. As observed in Chapter 4, virus 
collected and accumulated at this site very quickly post infection and as pointed out in 
Chapter 1, FMDV has been shown to down regulate IFNa at the translational level in 
vitro (Chinsangaram et al., 1999). This does not explain why mRNA levels declined, but 
may have been the result of a feedback mechanism. Coronary band skin was the only
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tissue where a continuous downward trend was observed. In SP and pharynx tissues, 
after the initial increase, a reduction of IFNa mRNA was observed from early to late 
disease, but the levels still remained above normal -  suggesting that these tissues play an 
important role in terms of early IFNa production. This role may then be taken over by 
tonsil which goes on to produce more IFNa during late rather than early disease. Why 
mRNA levels of IFNa should increase in the tongue but decrease in the skin is not clear 
as both organs are rich in epithehal cells and it might be expected that they should 
behave in a similar way- indeed they do behave very similarly with respect to 
production of all of the other cytokine mRNAs. The difference may again be due to 
down regulation in skin and not tongue of IFNa mRNA.
IFNp mRNA levels were highest in CLN, MLN and tonsil in tissues from normal 
pigs and lowest in pharynx, tongue and skin tissues -  a similar pattern to IFNa. A 
significant interaction between tissue and group was observed for IFNp (P=0.0001), 
with an early increase in IFNp mRNA in CLN followed by a decrease in late disease. It 
may be that FMDV also has the ability to down regulate IFNp mRNA production, 
however only down regulation at the translational level has been shown to date 
(Chinsangaram et al, 1999). The tonsil was the only other lymphoid tissue where an 
increase was observed and the higher level of mRNA was maintained through the late 
stage of disease. So clearly tonsil has an important antiviral role in FMDV infection. 
Slight increases of IFNp mRNA levels were observed in tissues from both the SP and 
the pharynx; however these changes were minimal when compared with the level of 
increase seen in both tongue and skin tissues from normal to early and late disease. IFNp 
is mainly produced by fibroblasts and epithelial cells -  which are both found in the 
tongue and skin. Therefore the antiviral actions of IFNp manifest very soon after 
infection and continue to increase as disease progresses.
IFNy levels were highest in MLN and spleen tissues from normal pigs and lowest 
in tongue and coronary band skin samples. In the case of IFNy, there were two obvious 
groups of tissues levels of IFNy mRNA present throughout disease. The group 
containing higher levels of IFNy mRNA consisted of tissues from the CLN, MLN, 
RPLN, tonsil and spleen. It may be that a particular type of macrophage or natural killer
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cell is common to all of these tissues which then produce a constitutively higher amount 
of IFNy mRNA. An increase of IFNy mRNA levels was observed in all lymphoid tissues 
early in disease followed by a decrease to slightly above normal levels (P=0.0003). 
Samples from the pharynx showed limited increases. The tongue and skin tissues were 
the only ones that had increased IFNy mRNA levels at the early and late stages of 
disease. IFNy was apparent in lymphoid tissues in early disease followed by epithelial 
tissues later -  this may indicate that virus is concentrated in the lymph nodes and throat 
region early post infection and moves to the tongue and skin later in disease.
Pro-inflammatory mRNA Induction
The TNFa mRNA content in tissues through disease were very similar, almost 
identical to those observed for IFNy, with MLN and spleen tissues containing the 
highest levels in normal pigs. Also, as was the case for IFNy, tissues could be separated 
into two groups; with spleen and lymphoid tissues containing higher levels of TNFa 
mRNA than all other tissues. Despite the groupings, the only tissues where an increase 
of TNFa mRNA was observed were tongue and skin both at the early and late stages of 
disease (P=0.0001).
IL-la mRNA levels were very consistent in all of the tissues sampled. Tonsil, 
spleen and SP tissues contained the highest levels of IL-la mRNA in normal tissues, 
while liver contained by far the lowest levels. The same pattern was observed for all 
tissues through early and late disease with an increase at both stages (P=0.0011). The 
greatest increases were observed in coronary band skin and tongue tissues. Of all the 
cytokine analysed, IL-la was active generally in all tissues and responded quickly to 
FMDV infection.
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5.4 Discussion
This study used pigs derived from three experiments (1-3, see Sections 2.6.2- 
2.6.4). The objective was to gain a further understanding of the pathogenesis of FMDV 
by analysing the antiviral and pro-inflammatory mRNA induction responses at different 
stages of disease. This was achieved by selecting a number of cytokines considered to be 
representative of the innate immune response to infection. The antiviral component of 
the immune response was studied by examining changes in mRNA levels of IFNa, IFNp 
and IFNy, while the pro-inflammatory component was studied by measuring changes in 
the mRNA levels of ILla and TNFa.
The rapid progression of infection and the severity of FMD were confirmed In 
early disease (i.e. a clinical signs score of 1-3 and at 24-48 hours p. i.), pigs develop a 
pyrexia, their feet become warm and tender and small un-ruptured vesicles become 
visible around the coronary band area of one or two feet. However pig behaviour was 
not greatly disrupted at this stage and pigs continued to eat and move around quite 
normally. By comparison, as little as 24 hours later disease became severe and vesicles 
were present on all feet and often also on the lips/tongue. Pigs had ruptured vesicles had 
become recumbent and anorexic, indicating severe pain. So clearly a change takes place 
as pigs progress from normal to early or late disease and by tracking the mRNA profiles 
of antiviral and pro-inflammatory cytokine during these key stages, the behaviour of the 
virus can be better understood.
A comparison of the mRNA profiles in Figures 5.1-5.3 reveals an overall trend 
of upward regulation of most cytokines in lymphoid, throat and epithelial tissues at the 
early stage of disease followed by a general levelling of mRNA levels at the late stage of 
disease. In general CLN, MLN and tonsil tissues contained the highest levels of the 
cytokines studied at the normal stage of disease. The pattern of mRNA production for 
these tissues was very similar, increasing at the early stage of disease (24-48 hours p. i.) 
followed by a levelling, or in the case of IFNp, a reduction of mRNA level. Similarly, in 
the SP and pharyngeal samples, increased cytokine production was observed early in 
disease, followed by a levelling, or in the case of IFNp, a further increase late in disease. 
With the exception of IFNa mRNA, very sharp increases of cytokine mRNA were
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observed in tongue and skin samples at both the early and late stages of disease. This 
suggests that in early disease virus activates the innate immune system in the lymphoid 
tissues, the throat and the tongue and skin, while late in the disease, further activation is 
seen only in the tongue and skin tissues. So it would appear that virus first affects the 
lymphoid tissues followed by the tissues in the throat region. It then disseminates 
throughout the body initially utilising the lymph system and then the blood circulatory 
system to reach the epithelial cells in the tongue and skin. These sites have often been 
referred to as “preferred” sites of replication (Alexandersen et al, 2003). However they 
may actually be secondary sites of replication. Sites associated with the lymphoid tissue 
may be equally permissive and thus equally or more important in terms of early FMD 
pathogenesis. Once the virus has reached epithelial cells, a second wave of immune 
activity may take place in an attempt to counteract the extremely fast replication activity 
of the virus. This may explain why these are the only sites where a further increase of 
cytokine mRNA is observed late in disease.
It was concluded from these three experiments, that there were very few striking 
differences between the production levels of antiviral and pro-inflammatory factors in 
early and late disease. Changes could have occurred earlier or could have been transient 
and missed, so it was considered necessary to look at the activity of the innate immune 
system at an even earlier stage of disease -  as soon as two hours p. i. This will be 
described in the following Chapter.
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Chapter 6
TIME COURSE OF FMD INFECTION IN FIGS
6. Time Course of FMD Infection in Pigs
6.1 Introduction
The studies described in Chapter 5 showed that there is a general increase in 
antiviral and pro-inflammatory cytokine mRNA production by the early stage of FMD. 
These up regulated mRNA levels were maintained, with further increases seen only in 
tongue and coronary band epithelium samples. However, these differences were not 
pronounced from early to late in infection and any transient fluctuations in these levels 
may have been missed or unobserved. Therefore, cytokine mRNA levels were studied 
very early post infection and the mRNA profiles of the antiviral and pro-inflanunatory 
cytokines were followed in a time-course experiment. In addition, two toll-like receptors 
(TLR) were included to study factors that may have been affected early in infection. 
These studies were carried out by means of duplicate time course experiments 
(Experiments 4 & 5, Sections 2.6.5-2.6.6) and are reported in this Chapter.
6.2 Clinical Findings
It was found that inoculated pigs generally developed the first clinical signs at 
approximately 24 hours p. i. and in contact pigs it was at 48 hours p. i. respectively. As 
previously reported in Chapter 5, pigs infected by different means took varying lengths 
of time to develop clinical disease, once they had reached a certain stage of disease, i.e. 
a chnical score of 2, the rate of progression of disease was similar. This observation 
allowed the combination of data from inoculated and contact pigs to be shifted in terms 
of time aligned. Statistically, the inoculated and contact groups were not significantly 
different after 24 hours p. i. (see 2.7.3, Table 2.2(C)). A clinical score of 2 represented 
the earliest stage where observation of clinical signs could be scored with certainty. This 
score was therefore was selected as a reference point. It was calculated that the contact 
pigs lagged behind inoculated pigs by 38 hours to reach a clinical score of 2 (see 4.2). 
This time correction was performed before the data were re-analysed by SAS and 
allowed the inclusion of 8 pigs (4 inoculated and 4 contacts from Experiments 4 and 5) 
at every time point.
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6.3 Cytokines and TLRs
Elements of the innate antiviral and pro-inflammatory response were evaluated 
by measuring the levels of mRNA for IFNa, IFNp, IFNy (antiviral), TNFa, IL-la (pro- 
inflammatory) and the toll like receptors TLR3, TLR4 in tissues at eight time points 
during the course of disease. Also, as in Experiments 1-3, the organs sampled were Hver 
and spleen, cervical lymph node (CLN), mandibular lymph node (MLN), 
retropharyngeal lymph node (RPLN) and tonsil, floor of pharynx, soft palate (SP), 
tongue and coronary band epithelium (skin). All the samples were normalised to the 
housekeeping gene GAPDH (to eliminate the effect of extraction efficiency). Using the 
results from Experiments 4 and 5, a database containing “counts per gram” of each 
cytokine mRNA was constructed. These data were analysed using a statistical software 
package (SAS) whereby a mixed linear model was applied allowing means (expected 
values), variances and co-variances to be estimated. The mean copy numbers (per gram 
of tissue) of antiviral, pro-inflammatory cytokine and TLR mRNAs were plotted to 
illustrate the change in levels from 2, 4, 6, 24, 48, 72, 96 to 120 hours p. i. (see Section 
2.7.3).
Antiviral Cytokine Induction
The IFNa mRNA profile (Figure 6.1) showed a significant interaction between 
the fixed effects -  tissue, group and time (P=0.0391). IFNa mRNA levels generally 
remained unchanged during infection in samples from liver, spleen, lymphoid tissue, 
pharynx and tongue. However in SP samples, there appeared to be a slight gradual 
increase of IFNa mRNA during 48-72 hours p. i. In coronary band skin samples quite a 
sharp peak was observed at 48 hours PI. Interestingly, at 96 hours p. i., a general 
reduction in mRNA level for all tissues was observed.
A significant interaction was observed between tissue, group and time for IFNp 
mRNA (P=0.0001). IFNp mRNA levels remained mostly unchanged in tissues from 
spleen, MLN, RPLN, SP and pharynx. A gradual increase was seen in liver samples over 
the course of disease, peaking at 96 hours p. i. Tonsil and CLN also peaked at this time 
point having increased from 24 hours p. i. The largest increases in IFNp mRNA were
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seen in tongue and coronary band samples, where levels increased sharply at 48 hours 
p. i. (Figure 6.2).
A significant interaction between tissue, group and time was observed for IFNy 
mRNA (P=0.0001). As seen for IFNy mRNA in Section 5.3, there appeared to be a 
grouping of tissues in terms of levels of IFNy mRNA. Spleen and lymphoid tissue 
contained the highest levels, while tongue and coronary band skin samples contained the 
lowest levels; throat and liver tissues were in between. Early increases in IFNy mRNA 
were seen in tongue, SP and liver samples (no further increases were seen in SP). The 
largest increased level was seen in coronary band skin samples at 48 hours p. i. Levels in 
tongue tissue also peaked at 48 hours, while at 72 hours p. i. a peak was observed in 
pharyngeal samples; levels in liver samples also increased from 72 -  120 hours p. i. In 
addition at this stage (72 -  120 hours) reduced levels were observed in CLN and MLN 
samples, which had been previously unchanged (Figure 6.3).
Pro-inflammatory Response
Another significant interaction between tissue, group and time was observed for 
TNFa mRNA (P=0.0001). The mRNA profile for TNFa was almost identical to that 
observed for IFNy, with the tissues grouped identically in terms of cytokine level at 0 
hours p. i. (Figure 6.4). Even the magnitude of the increases observed in TNFa mRNA 
levels were the same as those seen for IFNy.
As was the case for all of the cytokines studied, a significant interaction was 
observed between tissue, group and time for IL-la mRNA (P=0.0001). At just 4 hours 
p. i. an increase in IL-la mRNA was observed in SP. This up-regulated level was 
maintained throughout disease. Liver, CLN, tongue and skin were the tissues where 
increasing levels of ILl-a mRNA induction were observed during infection. Levels in 
liver, CLN and tongue samples peaked late in disease, while skin levels remained high 
but did not peak. (Figure 6.5).
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TLR mRNA Induction:
A significant interaction was observed between tissue, group and time for TLR3 
mRNA (P=0.0001). TLR3 mRNA was present in tissues at lower levels than any of the 
cytokines studied and was lowest of all in coronary band skin tissues (Figure 6.6). 
However, it was coronary band skin where the greatest increase of TLR3 mRNA was 
observed; peaking at 48 and 96 hours p. i. TLR3 mRNA was present in the greatest 
quantity in the liver (the only one of the 7 immune markers found to be highest in liver 
samples) where levels gradually increased up to 48 hours PI, after which point levels 
declined to 120 hours p. i. Reduced levels were also observed in samples from SP, 
pharynx and MLN at 48 hours p. i. (when skin and liver tissues had increased levels).
As was the case for TLR3, a significant interaction was observed between tissue, 
group and time for TLR4 mRNA (P=0.0001). Unlike TLR3 however, TLR4 levels were 
greatest in samples from spleen but not liver (Figure 6.7). Levels in spleen gradually 
increased peaking at 48 hours p. i., followed by a sharp reduction at 72 hours p. i.; this 
down regulation of TLR4 mRNA was also observed in throat tissues, and lymphoid 
tissues with the exception of RPLN which actually peaked. TLR4 was the only immune 
marker studied that did not increase in tongue or skin samples at or after 48 hours p. i. In 
fact there was a down regulation of TLR4 mRNA at just 4 hour p. i. in coronary band 
skin samples (also seen in IFNp).
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6.4 Interferon (IFN) Bioassay
The measurement of cytokine mRNA by RT-PCR reflects cytokine protein 
concentrations, because the production of most cytokines is transcriptionally regulated 
(James, 1994). However, the detection of cytokine mRNA may not necessarily equate 
with functional activity of that cytokine in vivo. Nevertheless, the changing cytokine 
mRNA profile observed during the course of infection with FMDV provides a very good 
indication of both an animals response to infection as well as to the activity of the virus 
in the body. Although cytokine mRNA was the main focus of this study, some work at 
the protein level was also carried out in the form of an interferon bioassay (see Section
2.3.2). This assay measured the antiviral activity of IFNa in seram samples (from 0-96 
hours. Experiment 5).
A large increase in IFNa protein expression was observed in serum samples at 2- 
6 hours p. i. (Figure 6.8) in both inoculated and contact infected pigs. IFNa expression 
then began to decline steadily from 24 hours p. i. in both groups onwards with no protein 
detected at 96 hours p. i. The greatly increased expression of IFNa at just 2 hours p. i. 
illustrates the rapid response of the innate immune system to FMDV infection. Five out 
of the 6 pigs sampled in the 0-6 hour period in Experiment 5 were positive for virus in 
tissues (3 of these were positive samples from the CLN, 2 from SP, 1 from the pharynx 
and 1 from the coronary band epithelium) so it is not surprising that a type 1 interferon 
should respond quickly to the infection. This result was unexpected in the case of the 
contact pigs since they had only have been exposed to virus at 2-6 hours p. i. and only 
one out of the six contact infected pigs from Experiment 5 was positive for virus in any 
tissue in the 0-6 hour period (VA94 positive in CLN at 4 hours p. i.). However it is 
possible that virus was present in the contact infected pigs at this early stage but was just 
below the detection limit of the TaqMan assay.
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6.5 Discussion
Two duplicate time course tests were carried out, with tissue samples collected 
from time points as early as 2, 4 and 6 hours, then every 24 hours until 5 days p. i. In 
addition to cytokine mRNA levels, the mRNA levels of two toll-like receptors (TLRs)- 
TLR3 and TLR4, thought to provide innate immunity to viral infection (Doyle et al., 
2003) were also monitored. The data collected from these runs were combined and are 
presented in this Chapter. Additionally, data from inoculated and contact pigs were 
analysed after alignment of clinical scores by the application of a time shift (see Section
4.2).
As observed in Chapter 4, the first clinical signs appeared 24-48 hours p. i. and 
this coincided with peak viral loads in tissues and peak viraemia. Peak clinical disease 
occurred approximately 48 hours later (day 3-4 p. i.). Again at 24 hours p. i., virus levels 
were greatest in samples from the CLN, liver, tongue and skin, then at 48 hour p. i. peak 
viral loads occurred in tonsil, skin and tongue tissues.
In the early stage of disease, just hours p. i., some interesting patterns of 
cytokine/TLR mRNA induction were observed. The main tissues involved were the SP 
and the pharynx, liver, tongue and skin. It was noted that in the SP and pharynx tissues 
increased levels of IFNa, IFNy, TNFa, IL-la and TLR3 mRNA were induced. The early 
response of the SP and pharynx is expected, especially in contact infected pigs because 
virus may be deposited directly onto these tissues, which are among the preferred sites 
for virus replication. In the liver too, increased levels of IFNa, IFNy, TNFa, IL-la and 
TLR3 mRNA were observed. As these mRNAs are induced in immune cells such as 
macrophages, monocytes, dendritic cells and natural killer cells, it is very likely that these 
cells produce the early innate immune response to infection with FMDV. The tongue 
behaved quite differently from skin early in infection with up regulation of IFNa, IFNy, 
and TLR3 mRNA seen in tongue and down regulation of the same along with DFNp seen 
in skin. This may be a result of the different distributions of cell types that produce these 
mRNAs. It is possible that up regulation in the tongue occurs in immune cells while 
down regulation in the skin occurs in cells such as fibroblasts and epithelial cells.
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Large increased levels of IFNa protein were measured in serum samples early in 
disease. Although IFNa mRNA levels were increased in samples of liver, pharynx and 
tongue in the 0-6 hour period p. i., these increases were on a very small scale and were 
not likely to be fully accountable for the expression level observed in the serum. It is 
more likely that the source of the IFNa was immune cells responding to the infection. At 
24 hours p. i., IFNa expression continued to be greatly up-regulated, but not to the same 
degree as was seen at 0-6 hour p. i. This high level of interferon in the serum early in the 
infection may help to explain the viraemia pattern observed in contact infected pigs in 
Chapter 4 where no virus could be detected in the serum before the 48 hour p. i. (see 
Section 4.2). High levels of serum interferon may activate circulating phagocytes to clear 
virus from the blood. This also points to the possibility that FMDV is disseminated 
throughout the lymph system early in infection -  as a way to avoid the effects of 
interferon in the blood. The very early presence of virus mainly in lymph associated 
tissues supports this proposal. Although the levels of IFNa protein remained high at 24 
hours p. i., a steady decline was observed from this time onwards. This may be the result 
of the movement of IFNa producing cells into the tissues where virus replication in 
beginning to take place. It may also be the effect of FMDV host translation shut-down as 
has been observed in cell culture (Chinsangaram et al., 1999). As viraemia escalates, and 
viral loads in the tissues, levels of IFNa decline, by 96 hours p. i. IFNa was no longer 
detectable in the IFN bioassay.
Vesicular lesions began to appear at 24- 48 hours p. i. and at this stage different 
patterns of cytokine mRNA production emerged. Further increases were observed in 
samples from SP and pharynx, as well as increases in the tonsil tissues, for the first time, 
where increases in IFNa, IFNp and IL-la mRNA were observed. Levels of cytokine 
mRNA in the lymph node samples also increased, mainly in the CLN and MLN. It is 
likely that these lymph tissues, that drain the throat region, were exposed to virus that 
was present from just hours p. i. However, the main increases observed at this stage were 
in the tongue and skin samples where very large increased levels of IFNp, IFNy, TNFa, 
IL-la and TLR3 mRNA were measured. IFNa mRNA levels also increased but on a 
much smaller scale than those observed for the other cytokines and TLRs. These large 
increases in the tongue and skin tissues were expected since clinical signs were also
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apparent at this stage, particularly in the skin. Early vesicles have been observed at 24 
hours p. i., so antiviral and pro-inflanunatory cytokines are likely to respond strongly at 
these sites of viral replication. The only down regulation seen at this stage occurred in 
TLR3 mRNA, where levels declined in the tissues from the pharynx and MLN.
At the next stage of disease, 48-72 hours p. i., peak viral loads and peak viraemia 
occurred. In addition clinical signs became severe, with most pigs presenting fully 
developed vesicles, some ruptured. Up regulation of cytokine mRNA in the SP and 
pharynx continued, with a peak of IFNa mRNA production in the SP and a peak of IFNy 
and TNFa mRNA in the pharynx. TLR3 mRNA levels were also seen to increase in the 
SP and pharyngeal tissues at this stage. The tongue and skin samples continued to 
produce high levels of antiviral and pro-inflammatory cytokine mRNAs. These 
observations are consistent with the location of the virus, peak viraemia and peak viral 
load.
Lastly, after the occurrence of peak viral loads and viraemia, but coinciding with 
the most severe clinical signs at 72-96 hours p. i., more changes in the cytokine/TLR 
mRNA profiles were observed. By this time, pigs were very severely ill, unable to walk 
and reluctant to eat. The tongue and skin tissues continue to show high levels of the 
antiviral and pro-inflanunatory cytokine mRNAs, as might be expected since, although 
viral loads were dechning, the titres of virus present in these tissues were still high (see 
Chapter 4, Figures 4.1 and 4.2). Peak levels of IFNp, IFNy, TNFa and TLR3 mRNA 
were observed in liver samples which may be a reflection of the amount of damaged 
tissue in the body resulting in a greater demand on liver functions. It was observed in 
Chapter 4 that an increase in the liver viral load took place between 96-120 hours in 
inoculated pigs and it may be this increase that is inducing the antiviral and pro- 
inflammatory cytokine mRNAs. TLR3 and TLR4 mRNA production appeared to decline 
at this latter stage in a number of tissues. Reduction of TLR mRNA and not cytokine 
mRNA may indicate a change in the population of cells producing cytokine mRNA at 
this stage. A downturn in TLR mRNA but an overall increase in cytokine mRNA may 
indicate an increased involvement of the adaptive immune system in response to viral 
replication at this stage. B and T lymphocytes can produce both antiviral and pro-
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inflammatory cytokines (Gearing & Callard, 1994), but not TLR mRNA (Doyle et al, 
2002).
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Chapter 7
DISCUSSION
7. General Discussion
A study of the progression of FMD in pigs infected with an FMDV strain from 
the UK epidemic was undertaken. The most striking sign in pigs affected by FMD is the 
development of vesicles. In our observations an acute inflammation began to develop as 
early as 24 hours p. i. Clinically this manifestation appears to be an inflammatory 
process that is likely to be immune mediated. Heat and pain, then blanching are the first 
clinical signs to develop due to the collection of vesicular fluid and reduced blood flow 
in the overlying epithelium (see Figure 4.1a). Hyperaemia may be present peripheral to 
the lesions. Leucocyte migration into the inflammatory exudate is associated with 
inflammation (Konig & Liebich, 2004). Cytokines, IL-la and TNFa, play a role in the 
recruitment of these white blood cells from the blood into the tissues, where they can 
perform their various tasks such as phagocytosis, antigen presentation or tissue repair. A 
better understanding of the complex effects of cytokines in the tissue microenvironment 
could lead to improved methods for the control of FMDV infectivity and the resulting 
pathology. The aim of this study was to measure induced antiviral cytokine mRNA, pro- 
inflammatory cytokine mRNA and TLR mRNA at different stages of FMDV infection 
to elucidate the pathogenesis of the disease.
The likely course of viral spread in pigs from initial infection to severe disease 
was followed determining the viral loads in a number of tissues sampled at different 
time points. The same tissue types were also analysed for levels of antiviral cytokines, 
pro-inflammatory cytokines and TLR mRNAs, thus allowing comparisons to be made 
between the behaviour of the virus and the innate antiviral and inflammatory responses 
of the host.
This study confirms that FMDV is a rapidly replicating virus that causes severe 
clinical disease in infected pigs. It was also confirmed that while the method of infection 
can rate at which clinical signs develop; as soon as clinical disease became evident, its 
progression was the same regardless of the infection method used. This finding was 
supported by statistical analysis of the development of clinical scores in (see 2.7.3) 
inoculated and contact groups of pigs. The results showed that in terms of viral loads the
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groups were not statistically different between 24 and 120 hours p. i. (P=0.7623). Nor 
were the groups statistically different in terms of their cytokine and TLR mRNA 
production between 0 hours and 120 hours p. i. (with exception of IFNa at 0-6 hours p. i. 
(P=0.0006) and TLR4 at 24-120 hours p. i. (P=0.0095).
For convenience the time course of infection from 0 to 120 hours p. i. was 
divided into 3 arbitrary phases based on the clinical signs. Analysis of tissue viral loads, 
tissue cytokine/TLR mRNA induction and viraemia during the first phase of disease 
(prior to the development of vesicles) indicated that FMDV appeared initially to enter 
the pharyngeal region and lymphoid tissues of the throat. This observation agrees with 
the findings of previous cattle studies, where it was suggested that early virus 
multiplication was more likely to be occurring in the epithelia of the dorsal soft palate, 
the pharyngeal walls, tonsils and in the retropharyngeal lymph nodes (Burrows et al, 
1981). Subsequent work suggested that virus in the lymph nodes is most likely to be 
accumulated from other sites as the result of drainage and not viral replication 
(Alexandersen et al, 2003). A recent study lends further weight to the pharyngeal region 
as the primary site of infection (Alexandersen et al, 2001). This area is exposed to both 
inhaled and swallowed virus, and this study found that in early infection, tissues from 
the pharynx contained higher levels of virus compared with other tissues such as the 
skin, lung or liver. However, pigs are extremely difficult to infect by the respiratory 
route (Alexandersen & Donaldson, 2002), so the oral route of infection is the most 
likely. In the current study the SP, pharynx, tonsil and CLN all contained virus during 
the early 0-6 hour time period p. i., bearing in mind that this was not the case for all pigs, 
only some individuals tested positive (only MLN and pharynx were positive in contact 
pigs). The presence of virus in the CLN of inoculated pigs was likely due to its location 
close to the inoculation site, while presence of virus in pharynx of contact pigs was 
likely to be a result of infection by ingestion followed by virus deposition in the throat 
region. Contact exposed pigs may be infected by several different routes including the 
intra-ocular, pericutaneous, alimentary or respiratory routes. Previous results 
(Alexandersen et al, 2001) have shown that early infection occurs in the pharyngeal 
region, in particular the soft palate and tonsil. In natural infection, whether the virus 
reaches that area by the aerogenous or haematogenous route is not known, but the
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refractory nature of pigs to airborne challenge (Alexandersen et al, 2002a; 
Alexandersen, & Donaldson, 2002) suggests that the latter is more likely. The tissues in 
the pharyngeal region are thought to be preferred sites of initial viral replication 
(Alexandersen et al, 2001). In this study, at the same time when virus was detected very 
early in these lymphoid and pharyngeal tissues, induction of antiviral (IFNa) and pro- 
inflanunatory cytokine (IL-la) mRNA was observed in SP and pharynx (See Chapter 6). 
This observation supports the hypothesis of active replication of FMDV in lymphoid 
tissues early in disease as these cytokines are both induced by cells such as monocytes 
and macrophages that are likely to be the first line of defence. It is possible that viral 
replication within lymphoid or closely associated tissue ensued, even before the 
development of host innate responses and by the time the potent antiviral responses were 
able to down-regulate viral expression, a viral reservoir within lymphoid or closely 
associated tissues may have already been established. However this is not supported by 
the contact infected pig viral load data where virus levels in lymph nodes were lower in 
the first phase of disease.
Another possibility is that virus was bound to and transported by macrophages to 
tissues away from the primary site of infection by an association that has been described 
previously (Rigden et a l, 2002). It has been shown that FMDV has the ability to bind to 
macrophages and can remain bound and infective for as long as 24 hours before being 
released. During this time macrophages could utilise the lymph system for transport, 
explaining the lack of detectable virus in the serum of contact pigs at 24 hours p. i. (as 
seen in Chapter 4). If this phenomenon did take place then it may explain the perceived 
preference of the virus for lymphoid tissues. Very early induction of antiviral (IFNy) and 
pro-inflammatory cytokine (TNFa) mRNA was also observed in the liver, however virus 
was not detected in liver samples until 24 hours p. i., when it contained some of the 
highest viral loads in both groups of pigs. This very early induction of antiviral and pro- 
inflammatory cytokine mRNA may be an indication of the beginning of a very early 
systemic host response to the viral infection taking place in lymphoid and pharyngeal 
tissues, or it could be a response to virus being processed by macrophages. Increased 
induction of TLR3 and TLR4 cytokine mRNA was also observed in the liver during this 
early stage of disease, with further increases of TLR4 mRNA measured in the spleen
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(the only example where spleen was seen to play a role in the response to FMDV 
infection). The high levels of cytokine and TLR induction in the liver so early post 
infection is not surprising considering the large quantities of virus measured in this 
tissue at 24 hours p. i. (higher in inoculated than in contact infected pigs).
A comparison between the tongue and skin revealed very different cytokine 
mRNA induction patterns during this first phase of disease, with a lot of down- 
regulation of antiviral and pro-inflammatory cytokine mRNA in the skin but not in the 
tongue. The higher level of virus observed by 24 hours p. i. in skin may be an 
explanation for this as FMDV has been shown to have a down-regulatory effect on type 
1 interferon, albeit protein. However, a resulting negative feedback effect may cause a 
reduction in mRNA induction (Chinsangaram et al, 1999). The interferon bioassay 
described in Chapter 6 showed a rapid response in IFNa during the 0-6 hour p. i. period, 
followed by a rapid decline in protein levels, indicating that down-regulation by FMDV 
may have taken place.
By the beginning of the second phase of disease virus was disseminated 
throughout the body as was evident by its presence in all the tissues sampled from 
inoculated pigs and in all those from contact infected pigs with the exception of the CLN 
and RPLN (both of which were positive by 48 hours p. i.). This phase of disease was 
marked by the first appearance of clinical signs, including pyrexia in some cases, warm 
feet and newly formed, un-ruptured vesicles. In Chapter 5, where the response is 
compared of early and late clinical disease, it was observed that pigs with early lesions 
had increased levels of antiviral and pro-inflammatory cytokine mRNA in lymphoid and 
pharyngeal tissues compared with normal pigs. The time course experiments in Chapter 
6 also demonstrated further increased induction of cytokine mRNA beyond that seen in 
the first phase of disease in throat tissues and in the CLN and MLN, indicating that 
appreciable amounts of viral activity at these sites was likely even though virus 
dissemination throughout the body had taken place. Although the tongue and skin 
subsequently developed the highest peak viral loads of all the tissues analysed, at 24 
hours p. i. (first appearance of clinical signs) in inoculated pigs, the CLN and liver 
contained more virus than the tongue and skin, while in contact infected pigs, skin at 48
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hours p. i. (first appearance of clinical signs) contained the most virus followed by the 
liver. The liver presented interesting viral load and cytokine mRNA induction patterns; 
at 24 hours p. i. the liver contained among the very highest viral load but thereafter the 
virus levels did not increase (until the end of phase 3 in inoculated pigs). IL-la, TNFa 
and TLR3 mRNA levels all increased throughout phase 2 despite a plateau in viral loads. 
This may be a reflection of the liver’s role in clearing virus or may simply indicate that 
virus was not replicating in liver -  as would be expected -  but fragments of viral RNA 
associated with macrophages and granulocytes were measured.
It was noted later that the peak viral loads in tissues and peak viraemia in serum 
for each group of pigs actually coincided with the development of severe clinical signs 
and that clinical disease then continued to get worse past the peak of viral activity. So it 
appeared that the increased severity of disease may have been related more to the host 
effects such as the antiviral and pro-inflammatory cytokines than to viral replication. 
Towards the end of the second phase of disease very large increases in the levels of 
antiviral cytokine (IFNp, IFNy), pro-inflammatory cytokine (IL-la, TNFa) and TLR3 
mRNAs were measured in tongue and skin. These up-regulations in tongue and skin 
were recorded in Chapter 5 in comparisons between pigs with early vesicles and pigs 
with late vesicles. It was also noted in Chapter 5 that while cytokine mRNA remained 
up-regulated in lymphoid tissues and pharyngeal tissues, it did not increase when 
vesicular lesions progressed from early to late development, as was the case for tongue 
and skin. Similarly in Chapter 6, the time course experiments showed that the tongue 
and skin were producing very high levels of both cytokine and TLR3 mRNAs. This may 
reflect the actions of the virus as replication levels in the tongue and skin began to 
exceed those in the lymphoid and pharyngeal tissues and what appeared to be happening 
was that most tissues (with exception of the tongue and skin in inoculated pigs and the 
tonsil, CLN, tongue and skin in contact infected pigs) had reached a plateaux of viral 
load. By the end of the second phase of disease the majority of pigs had progressed from 
early to late disease and a clinical score of 4-5 was usually observed.
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The third phase of disease was characterised by a reduction in viraemia and viral 
loads but a continued increase in the severity of disease. This indicated, as previously 
mentioned, that the manifestations of disease were not directly or solely due to viral 
rephcation and that the deterioration of the pigs’ condition beyond peak viral loads and 
viraemia could be attributed to the antiviral and pro-inflammatory responses. The peaks 
of IFNy, TNFa and TLR3 mRNA observed in the tongue and skin during this phase 
were a clear indication that a strong inflammatory response was taking place. There 
were also suggestions that viral clearance was beginning to take place as increased 
induction of both antiviral and pro-inflammatory cytokines were observed in the liver 
coupled with a very late peak of virus measured in the liver at 120 hours p. i. As virus 
RNA was being assayed, the increased levels in the liver may have been representative 
of the role of the liver in the degradation of immune complexes and toxic waste material, 
which post infection, might contain degraded viral elements including viral RNA. Also 
observed at this late stage of disease were increased levels of antiviral and pro- 
inflammatory cytokine mRNA in the CLN. These may have been products of a new 
population of cells such as T-cells and B-cells, associated with secondary immune 
responses.
This study records the clinical, viral and cytokine responses of experimentally 
infected pigs during the early stages of infection and disease. Clinically, the pigs 
developed a severe disease as early as 24 hours p. i. It then progressed rapidly and 
culminated in the development of severe vesicular lesions on the feet, tongue, snout and 
lips. Antiviral and pro-inflammatory cytokine mRNA induction happened very early 
post infection and this was initially observed in the tissues and lymph nodes of the 
pharyngeal region as well as the liver. Later, further antiviral and pro-inflammatory 
cytokine and TLR mRNA inductions were observed in the pharyngeal region, however, 
mRNA induction in the tongue and skin overtook those observed in the pharyngeal 
region. At this time the tongue and skin became the major sites of viral replication and 
were the sites where severe clinical signs developed in the form of inflammation and 
vesicles. These observations provide the first detailed account during the pathogenesis of 
FMDV in pigs of cytokine and TLR responses in conjunction with an analysis of viral 
loads.
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It was shown that method of infection determined the rate of development of 
clinical signs in early disease. However, once signs became evident, they progressed at 
the same rate. Clinical disease progressed in severity beyond the peaks of viraemia and 
viral load, indicating that viral replication was not solely responsible for the severity of 
disease. It was very likely therefore, that cytokines and TLRs contributed to this, as up- 
regulated levels of mRNA were observed beyond the peak of viraemia and tissue viral 
load.
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APPENDIX
Appendix 1 Toll Like Receptors 
TLR3
The following sequences were aligned using MegAlign from DNAStar, USA.
Genbank Accession No. Species Comments
AY124007 Bos taurus Toll-like receptor 3 mRNA, partial 
cds.
U88879 Homo sapiens Toll-like receptor 3 mRNA, complete 
cds.
AF355152 Mus musculus Toll-like receptor 3 mRNA, complete 
cds.
NM_198791 XM_344520 Rattus norvegicus Toll-like receptor 3, mRNA.
PrimerSelect was (Applied Biosystems, USA) was used to choose primer sets and probes 
for TaqMan assays and are their locations are shown in Figure A l.l.
Selected clones with inserts were sequenced in both directions with M l3 forward and 
reverse primers to verify the presence and nature of inserts.
TLR4
The following sequences were aligned using MegAlign from DNAStar, USA.
Genbank Accession No. Species Comments
AF310952 Bos taurus Toll-like receptor 4 mRNA, complete
cds.
NM_138554 Homo sapiens Toll-like receptor 4 (TLR4),
transcript variant 1 mRNA
NM_021297 Mus musculus Toll-like receptor 4, mRNA.
AJ583830 and AY289532 Sus scrofa Toll-like receptor 4, gene and partial
consensus sequence cds, respectively.
PrimerSelect was (Applied Biosystems, USA) was used to choose primer sets and probes 
for TaqMan assays and are their locations are shown in Figure A1.2.
Selected clones with inserts were sequenced in both directions with M l3 forward and 
reverse primers to verify the presence and nature of inserts.
A1
Figure A l.l Alignment of bovine, human, mouse and rat TLR3 
partial sequences showing the locations of TaqMan primers and 
probe.
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The forward primer is shown in green, the reverse primer is shown in 
blue and the fluorgenic probe is shown in red. Mismatches in the 
sequences are shaded in grey.
A 2
Figure A1.2 Alignment of bovine, mouse and pig TLR4 partial 
sequences showing the locations of TaqMan primers and probe.
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The forward primer is shown in green, the reverse primer is shown in 
blue and the fluorgenic probe is shown in red. Mismatches in the 
sequences are shaded in grey.
A 3
Appendix 2 Standard Database
Table A2.1 Average Ct-values for 10-fold serial dilutions of GAPDH, cytokine and 
TLR standard cDNA
Average Log 
Copies/Reaction
GAPDH IFNa IFNp IFNy BLla TNFa TLR3 TLR4
9 16.84 19.29 19.40 19.17 21.75 17.28 18.21 16.02
8 19.99 22.82 22.97 22.82 25.23 20.51 21.21 17.79
7 23.31 25.86 25.96 26.16 28.63 24.26 24.52 21.53
6 26.69 29.57 29.44 29.49 32.15 27.644 27.62 24.03
5 30.13 33.73 33.2 33.13 35.15 31.88 30.77 27.48
4 34.12 36.75 36.58 36.10 40.65 35.58 37.23 30.53
3 37.68 41.38 40.44 38.41 40.44 39.94 33.88
Spectrophotometry was used to measure the amount of RNA produced by in vitro 
RNA transcription (see 2.5.9). Serial 10-fold dilutions were made of the standard RNA 
ranging from 10  ^copies to 10^  copies of the RNA fragment per micro litre. The RNA was 
reverse transcribed into cDNA which was then used in PCR reactions to generate a 
standard curve from which copy number in samples could be calculated. The correlation 
coefficients and regression formulae used to calculate copy numbers are shown on 
Figures A2.1-A2.8.
A 4
♦  G A PD H  Linear (GAPDH)
>
5
50
45
-3.4866X + 48.16740
35
30
25
= 0.9988
20
15
10
2 3 4 6 105 7 8 9
Log Copies/Reaction
Figure A2.1 GAPDH standard curve. Log copy numbers per PCR reaction are shown on 
the x-axis, while Ct values are shown on the y-axis; the higher the Ct value, the lower the 
number of copies detected.
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Figure A2.2 IFNa standard curve. Log copy numbers per PCR reaction are shown on the 
x-axis, while Ct values are shown on the y-axis; the higher the Ct value, the lower the 
number of copies detected.
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Figure A2.3 IFNp standard curve. Log copy numbers per PCR reaction are shown on the 
x-axis, while Ct values are shown on the y-axis; the higher the Ct value, the lower the 
number of copies detected.
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Figure A2.4 IFNy standard curve. Log copy numbers per PCR reaction are shown on the x- 
axis, while Ct values are shown on the y-axis; the higher the Ct value, the lower the number 
of copies detected.
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Figure A2.5 ILla standard curve. Log copy numbers per PCR reaction are shown on the x- 
axis, while Ct values are shown on the y-axis; the higher the Ct value, the lower the number 
of copies detected.
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Figure A2.6 TNFa standard curve. Log copy numbers per PCR reaction are shown on the 
x-axis, while Ct values are shown on the y-axis; the higher the Ct value, the lower the 
number of copies detected.
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Figure A2.7 TLR3 standard curve. Log copy numbers per PCR reaction are shown on the 
x-axis, while Ct values are shown on the y-axis; the higher the Ct value, the lower the 
number of copies detected.
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Figure A2.8 TLR4 standard curve. Log copy numbers per PCR reaction are shown on the 
x-axis, while Ct values are shown on the y-axis; the higher the Ct value, the lower the 
number of copies detected.
A8
A2.3 Control Pig Raw Count Database
A database containing the pig number, experiment number, run, RNA species, 
tissue, normalised counts and raw counts is provided in the data CD included.
A 9
